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ABSTRACT – At the Komfo Anokye Teaching Hospital in Kumasi, Ghana, exchange transfusions are 
performed manually in the Mother Baby Unit (MBU). Currently, these transfusions take multiple hours to 
perform. Because an automated process is absent, a doctor or nurse must be present throughout the entire 
transfusion to constantly turn valves and administer or remove blood from syringes. A low-cost, easy to 
operate, automated exchange transfusion device is essential in order to increase the number of available 





On average, one neonatal exchange transfusion (ET) is performed at the Komfo Anokye Teaching 
Hospital (KATH) in Kumasi, Ghana each day. The medical personnel at KATH currently perform 
neonatal ETs manually, which entails manually rotating valves and operating syringes. The entire ET 
process takes approximately 90-120 minutes to complete; therefore, occupying much of the doctor’s time. 
In order to increase the number of available medical personnel in the Mother Baby Unit (MBU) at KATH, 
it is crucial that KATH acquires a low-cost, easy to operate, automated ET device.  
 
The primary focus of this design is to create an automated ET device; however, there are several other 
customer requirements that must be taken into account during the design process to ensure that the device 
can be utilized by KATH in Ghana. For the ET device to be feasible, it first needs to be safe and 
consistent. The ET should also be easy to operate. The device must also have variable blood flow rate 
settings to be compatible for individual patient needs. Safety measures that are used when dealing with 
medical procedures, such as using disposable syringes will be taken into account. The ET device must 
also be inexpensive due to the minimal allotted budget for the MBU.  
 
Various brainstorming sessions took place to generate a viable automated ET device. After evaluating the 
brainstorming concepts, five of the best concepts were analyzed and further developed. The following 
five concepts were chosen for further evaluation: the out-of-phase slider, the in-phase slider, the gravity-
piston, the compressor system, and the automated four-way stop cock. Once these concepts were 
developed, a Pugh chart, as well as a thorough analysis was used to determine the alpha design concept—
the in-phase slider. 
 
The initial in-phase slider design was elaborated in detail for the prototype, primarily because of its 
versatility. It allows for an adjustable volume flow rate because of its user interface, it can be used with 
various syringes, it contains a feedback control system, it requires only one insertion point, and it can 
easily be transitioned into a manual process if needed. It utilizes a linear actuator as the motor, and a 
sliding mechanism to support the syringes and their movement. The in-phase slider does have a few 
disadvantages, however, such as the scarcity of component parts in Ghana (i.e. circuit board and motor). 
 
Through means of measuring and testing various components of the in-phase slider design, specific 
design parameters were determined, such as the component dimensions. A thorough analysis of the in-
phase slider design was then performed to determine the manufacturability and functionality of the 
design. Each component of the in-phase slider was evaluated in detail, in which the material selection and 
manufacturing process was validated by means of a detailed parameter analysis. 
 
After a detailed evaluation of the in-phase slider design, the fabrication plan for the prototype was 
established; therefore, providing a step-by-step plan for producing the design. Using this plan, the 
prototype was manufactured, and numerous validation tests were performed on it to insure functionality 
and reliability. Different colored water was used to resemble fresh and waste blood to validate fluid flow 
functionality, as this was the most important requirement our device had to meet. After all testing was 
completed, we concluded that our device could successfully perform an exchange transfusion and met all 
of our key engineering specifications; therefore it was ready to be displayed at the Design Expo. 
 
The in-phase slider functions exceptionally well when considering the time and budget constraints that 
had to be overcome. However, a few changes that could potentially be made if the process was to be done 
over again would be to: find a smaller, more inexpensive motor, add a casing to further protect the circuit 
board and user interface, and use proper medical tubing for more sufficient flow validation. In conclusion, 
the device can perform an automatic exchange transfusion successfully, and all key customer 
requirements and engineering specifications have been met. 
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Abstract – At the Komfo Anokye Teaching Hospital in Kumasi, Ghana, exchange 
transfusions are performed manually in the Mother Baby Unit (MBU). Currently, these 
transfusions take multiple hours to perform. Because an automated process is absent, a 
doctor or nurse must be present throughout the entire transfusion to constantly turn valves 
and administer or remove blood from syringes. A low-cost, easy to operate, automated 
exchange transfusion device is essential in order to increase the number of available human 
resources in the MBU, thus providing doctors and nurses with more time to care for other 
patients. 
 
Index Terms – automated technology, exchange transfusion, KATH, Kumasi, medical device, 
neonate 
INTRODUCTION 
This paper proves that the consolidation of undergraduate engineering design projects with 
international service learning provides an invaluable experience for undergraduate students. It 
requires students to explore cultural diversity to better understand the requirements of their 
engineering design project. A union between the engineering curriculum and service learning 
offers the students a skill set that incorporates critical thinking beyond the scope of a typical 
undergraduate student and cooperative learning. This paper will reveal the benefit of uniting 
service learning and undergraduate engineering design projects by divulging the project that four 
undergraduate students at the University of Michigan embarked on. 
Background Information 
The availability of medical personnel is a great issue in Ghana. In 2004, the World Health 
Organization (WHO) stated that Ghana only has 2.00 physicians per 10,000 peoplei. WHO also 
affirmed that there are only 9.00 nursing and midwifery personnel per 10,000 people in Ghana. 
This reaffirms that there are far more neonates that require medical attention than there are 
doctors/nurses who can offer medical attention. The Komfo Anokye Teaching Hospital (KATH) 
in Kumasi, Ghana is a prime example of a facility where this problem is prevalent. 
KATH is the lone hospital for over 100,000 people in urban Ghana. On average, one 
neonatal exchange transfusion (ET) is performed at KATH each day (J. Adabie, personal 
interview, February 7, 2009). The medical personnel at KATH presently perform neonatal ETs 
manually, which entails manually rotating valves and operating syringes, which is depicted in 
Figure 1 below. The entire ET process takes approximately 90-120 minutes to complete, thus 
occupying much of the doctor’s valuable time. The time a doctor spends performing an ET is 
time he is not spending with other neonates in critical condition. The lack of valuable human 
resources, primarily doctors, is one of the issues contributing to the high mortality rate in 
neonates. There is a 2.7% neonatal mortality rate in Ghana. 28.5% of deaths among children 
under 5 years of age is due to neonatal causesi. The limited medical staff prohibits many 
neonates from receiving the care they need; ETs play a major role in the time limitation problems 





MANUAL EXCHANGE TRANSFUSION PROCEDURE BEING PERFORMED TO A NEONATE AT KATH 
Objectives on Behalf of KATH 
As previously mentioned, the limited number of medical personnel in the Mother Baby Unit 
(MBU) at KATH prevents the patients from receiving the care they need. The shortage of 
available medical personnel is partially attributed to the time consuming ET process presently 
implemented at KATH. A low-cost, easy to operate, automated ET device is a sufficient solution 
in order to increase the number of available medical personnel in the MBU, thus providing 
doctors and nurses with more time to care for other patients. This will in effect increase the 
number of patients attended to each day, and hopefully, decrease the mortality rate of neonates in 
Ghana. As a group of four undergraduate engineering students pursued the automated ET device 
design project, the medical personnel at KATH established the following set of specifications for 
the project: 
• Produce an “automated” exchange transfusion device; therefore, the presence of the 
medical personnel will not be necessary for the entire ET. This will allow the medical 
personnel to care for other patients. 
• Create an inexpensive ET device. Funding is extremely limited in the medical field in 
Ghana; therefore, a cost of less than 200 USD should be targeted for this application. 
• Design the automated ET device to utilize local material resources and medical 
equipment available in Ghana. 
• Provide an easy-to-use device, where the process does not require medical personnel 
beyond the start and end of the transfusion process. This will offer medical personnel 
with more time to care for other patients in the MBU. The device must also be easily 
employed by medical personnel. 
• Institute an adjustable volume flow rate for the automated ET device. A suitable volume 
flow rate of blood flowing into and out of a neonate is 3 mL/min [3]; however, the 
volume flow rate may need to be increased or decreased depending on the type of blood 
being infused into the neonate due to the varying fluid viscosities of different blood 
components. 
Objectives to Foster Global Awareness 
The Kumasi community will not be the only people affected by this project. The consolidation of 
such a service learning project and engineering design project will provide the students with an 
excellent opportunity to foster global awareness and assist people in need. Student learning will 
occur, not only in the technical sense, but also in more tangible ways. To impose such service 
learning on the students, the following objectives were established:  
• Broaden their problem solving skill set to encompass more than just technical aspects, but 
to also consider cultural, environmental, and social aspects. 
• Increase their social network by interacting with a variety of different individuals and 
professionals. 
• Gain exposure to different disciplines and cultures through their communication with 
various individuals (i.e. medical doctor, electrical engineer, people of Ghana). 
• Enhance their understanding of medical technologies and the medical guidelines 
associated with designing medical devices. 
• Increase their insight on the ethical dilemmas encountered due to cultural and societal 
differences. 
• Improve their ability to adapt to unforeseeable details. 
• Grow in their knowledge that people, not technologies, are the ultimate focus of 
engineering through socially relevant projects. 
Relationship of Participants 
The students completed their capstone mechanical engineering design course under the 
instruction of Dr. Kathleen Sienko, a professor at the University of Michigan’s mechanical 
engineering department, who is also an organizer of the University’s Global Intercultural 
Experience for Undergraduates (GIEU). The GIEU provides opportunities for students to go 
abroad to develop intercultural skills, global perspective, and cultural sensitivity. Students bring 
back with them a greater understanding of global situations and processes. One such observation 
brought back to the University was the aforementioned situation in the Mother Baby Unit (MBU) 
at the Komfo Anokye Teaching Hospital (KATH) in Kumasi, Ghana. The dire situation at the 
MBU eventually made its way to the four-student mechanical engineering team who decided to 
do something by designing the automated exchange transfusion device. 
DESIGN DESCRIPTION 
The design of the automated exchange transfusion device consists of both mechanical and 
electrical subsystems. The purpose of the mechanical subsystem is to actuate the syringe 
plungers and cause the flow of blood to and from the patient. A secondary mechanical subsystem 
is that of the blood pathway between the syringes, blood bags, and patient. The blood pathway 
subsystem is a unique configuration of tubing, one-way valves, and Y-junction connectors. The 
purpose of the electrical subsystem is to power and control the linear actuator and its function of 
driving the mechanical sliding mechanism. The result of the three subsystems is a mechatronic 
system that completes the overlying objective of exchanging the blood of a neonatal patient. 
System Configuration 
The configuration begins with an IV insertion point which consists of a 23-gauge needle into the 
umbilical vein connected to a 16-outer diameter gauge catheter within the umbilical cord. The 
catheter leads out of the umbilical cord to a three-way junction which splits the blood flow into 
two directions. In one direction is a waste-blood suction syringe and waste-blood disposal bag. In 
the other direction is a fresh-blood suction syringe and fresh-blood bag. Both waste-blood and 
fresh-blood sides of the system contain three-way junctions between the respective bag of blood, 
the respective suction syringe, and the initial three-way junction just outside of the umbilical 
cord. All junctions in the system are open to the flow in both directions. Equipped on two of the 
three sides of each junction are disposable one-way valves configured in a way to allow 
functioning of the system and to eliminate the need for manual toggling of the three-way 
junctions. 
Process Description 
The ET process is prefaced by priming the entire system with the blood intended to be 
transferred. The tubing, junctions, and valves need to be filled with blood before the process 
begins. The suction syringes also begin in their fully compressed position and operate 
simultaneously and in-phase with each other. Both syringe heads are connected to a slider 
mechanism which operates in the same direction as the syringe plunger and is powered by a 
linear actuator. Attaching the syringe heads to the same slider allows the syringes to operate 
simultaneously and in-phase with each other. 
 The cycle begins when the slider, and thus the syringe plungers, move back and the 
syringes intake fluid into their bodies. On the side with the fresh blood bag, fresh-blood is 
removed from the bag past the one-way valve and into the syringe. During this phase, blood is 
not removed from the neonate with this syringe because of the one-way valve configuration. On 
the side with the waste-blood bag, waste-blood is removed from the neonate past the initial three-
way junction, and into the syringe. During this phase blood is not removed from the waste-blood 
disposal bag because of the one-way valve configuration. This phase continues until the syringe 
plungers are fully extended back and the syringes are full with their respective fresh-blood and 
waste-blood. 
 The next phase of the cycle begins when the slider, and thus the syringe plungers move 
forward and the syringes force fluid out of their bodies. On the side with the fresh-blood bag, 
fresh-blood in the syringe is forced out past both three way junctions and into the neonate. 
During this phase fresh-blood is not forced back into the fresh-blood bag because of the one-way 
valve configuration. On the side with the waste-blood bag, waste-blood in the syringe is forced 
out into the waste-blood disposal bag. During this phase waste-blood is not forced back into the 
neonate because of the one way valve configuration. This phase continues until the syringe 
plungers are compressed all the way and the syringes are empty of all their respective fluids. 
When this phase completes, the first phase begins again, and the cycle repeats. A complete cycle 




Blood f ow di ection during withdrawal phase: l r Blood flow direction during insertion phase: 
FIGURE 2 
DIAGRAM OF PROTOTYPED AUTOMATED EXCHANGE TRANSFUSION SYSTEM. 
Mechanical Subsystem 
The mechanical subsystem consists of a holding block, a slider, a track, and a linear actuator. 
The subsystem can be seen in Figure 3 with two 25 mL syringes in place. Not included in the 
picture is the linear actuator, which is also a part of the mechanical subsystem, and is connected 






EARLY CAD DESIGN OF THE MECHANICAL SUBSYSTEM CONTAINING 





PROTOTYPE OF AUTOMATED EXCHANGE TRANSFUSION DEVICE. 
 
 The linear actuator that was used to actuate the slider was purchased and was the most 
inexpensive on the market. It is depicted in Figure 5. The linear actuator is connected to the 
slider by a pin and the velocity of the shaft will be micro-controlled to obtain the desired volume 
flow rate of the syringe, which will depend on the diameter of the syringe. The motor itself is 12 
V DC and at the loads expected for our application the shaft can actuate up to 0.59 in/sec. For the 
maximum desired flow rate and for a 25 mL syringe diameter, a linear velocity of 0.00088 in/sec 
is needed. This posed a lower limit, rather than an upper limit problem with the motor speed. 
However, after analysis of the voltage resolution out of the micro-driver, we calculated that the 







LINEAR ACTUATOR USED IN THE EXCHANGE TRANSFUSION DEVICE PROTOTYPE. 
 
 The linear actuator comes equipped with a position potentiometer as well, which comes 
into play with the feedback control schedule, which is described in the Electrical/Circuit 
Subsystem section below. 
Electrical/Circuit Subsystem 
While the mechanical subsystem is the bones of the exchange transfusion system, the 
electrical/circuit subsystem is the lifeblood. An electrical aspect to an automated exchange 
transfusion device is absolutely essential. If the device is to be automatically controlled and 
powered; a circuit, power source, and controller must be implemented. The overlying 
specification that must be met in order for the ET device to insure the safety of the neonate is the 
control of the blood volume flow rate. The component of the system that makes this happen is 
the microprocessor. The other electrical components exist to provide support, or input to the 
microprocessor (except the buzzer alarm which serves as its own engineering specification).  
 The automated ET device was designed to accommodate the various needs of the neonate 
and the medical personnel. To oblige to the needs of the medical personnel, the automated ET 
device must also be compatible with an assortment of syringes ranging from 20 to 25 mL in 
volume. The ET device will also be required to stop when a specified volume of blood has been 
transfused. In order to adapt to all of these variables, the automated ET device must have a user 
input to inform the ET device of the necessary parameters. From the user input, the ET device’s 
operation will adjust accordingly. 
 The user interface consists of three rotary encoders and a LCD. The three rotary encoders 
will allow the medical personnel to input the necessary system parameters. The three encoders 
and the LCD will be soldered onto the top of the circuit board with the LCD screen just above 
the three rotary encoders as depicted in Figure 6. The encoders can either be spun or pressed by 





DIAGRAM OF THE USER INTERFACE WHICH IS LOCATED ON TOP OF THE ELECTRICAL CIRCUIT BOARD. 
 
 Control of the blood volume flow rate will be conducted with a position schedule. When 
the user inputs a desired blood volume flow rate and syringe diameter into the microprocessor, it 
calculates the necessary linear velocity of the actuator shaft. With the minimum and maximum 
positions of the actuator set prior to start, the microprocessor determines where and when exactly 
the shaft should be between the minimum and maximum set points to achieve the desired blood 
volume flow rate. This is known as a position schedule. 
The linear actuator is equipped with a built-in potentiometer that detects position of the 
shaft, which is fed back to the microprocessor. If the shaft is detected as being at a position that 
is ahead of schedule, the microprocessor pauses the motor and the shaft movement until the 
schedule catches up to the shaft position. If the shaft is detected as being at a position that is 
behind schedule, instead of speeding the motor up, the microprocessor just shifts the schedule 
back to coincide with the current schedule. 
Tubing Subsystem 
The tubing subsystem is the connection between the blood reservoirs, the syringes, and the 
neonate. It is the pathway for the blood. The pathway that the blood takes from fresh blood bag, 
to syringe, to neonate; and waste blood from neonate, to syringe, to waste bag, is thoroughly 
described in the preceding section Process Description. While the tubing and its related 
components such as the one-way valves is considered its own subsystem, its design has already 
fully been described in the Process Description section.  
VALIDATION 
Once full system assembly was completed, testing began and several different experiments were 
conducted to verify that the device met all key customer requirements and engineering 
specifications. To have a better understanding of fluid flow throughout the system, red and blue 
colored water was used for all system tests to act as the blood coming out of the neonate, and the 
blood going into the neonate, respectively. Three IV bags were also used for testing purposes: 
one bag was filled completely with red water to act as the fresh blood bag, one bag was left 
empty to act as the waste blood bag, and the last bag was filled completely with blue water to act 
as the neonate. Descriptions of the validation tests and results are described below. 
Setup Time and Ease of Use 
Before conducting validation tests on the device while it was transfusing fluid, the time required 
to prepare the system was tested. This preparation time consisted of securing the two syringes to 
the device, inputting sample desired values for the volume flow rate, total volume to be 
transfused, and inner diameter of the syringes into the user interface, and prepping the tubing 
with water to act as blood to eliminate any air bubbles from the tubing before attempting to run 
the system. To test the preparation time, six random participants were gathered. Each participant 
took two turns trying to set up the system. For the first attempt, each of the six participants was 
given personal help by one of our group members to set up the system. On average, the setup 
time for this test took approximately 16 minutes and 16 seconds. For the second attempt, each 
participant had to set up the system using only the instruction manual; no help from any of the 
group members was given. On average, the setup time for this test took approximately 19 
minutes and 17 seconds. Both tests resulted in an average setup time of less than the desired 20 
minutes, thus ensuring that the setup time and ease of use engineering specifications were both 
satisfied. 
Volume Flow Rate 
Once the preliminary tests were completed, it was time to power the system to begin testing the 
functionality of the device as it was transfusing fluid. Because an adjustable and consistent 
volume flow rate is so important to the proper functionality of our system, several tests were 
conducted to ensure that the rate stayed consistent with the input value, and that the system could 
run properly at volume flow rates between 0 and 10 mL/min. For tests running at 2,4,6,8 and 10 
mL/min, the time required to displace 15 mL of fluid was recorded. After calculating the 
measured volume flow rate, this rate was compared to the desired volume flow rate. For each of 
the 5 different flow rates tested, an accuracy of over 99.5% was achieved. A table displaying the 
full results of the experiment can be seen in Table 1. This easily satisfied the adjustable volume 
flow rate engineering specification. It should be noted that it is reasonable to assume that the 
system had a constant flow rate at all times because the linear actuator’s potentiometer is 
constantly detecting position to ensure a steady volume flow rate. 
 
TABLE 1 
VALIDATION RESULTS OF VOLUME FLOW RATE TEST 
 
 
Total Volume Transfused 
To validate that the total volume to be transfused was correct, the system was run twice for a full 
two hour cycle at a volume flow rate of 10 mL/min. For these two tests, the fresh blood IV bag 
was filled with 1800 ± 25 mL of red water. The waste blood IV bag was then filled with only 
about 50 ± 25 mL of blue water, and finally the IV bag representing the neonate was filled with 
1500 ± 50 mL of blue water. After both two-hour tests, the new total volumes from the bags 
were recorded. For both tests, the fresh blood bag was reduced by 600 ± 50 mL of water, the 
waste blood bag was increased by 600 ± 50 mL of water, and the bag representing the neonate 
remained at a constant volume. A picture clearly depicting these results can be seen in Figure 7. 
From these results, it was concluded that the total volume to be transfused was correct for each 
system test. For further verification that fluid flow was correct going into and out of the bag 
representing the neonate, a color change was witnessed near the end of the bag where the fluid 
was flowing in. The color of the water changed from a solid blue to a more purple color as the 
“fresh blood” red water was injected and mixed with the old, “waste blood” blue water. This 





VALIDATION RESULTS OF BLOOD DISPLACEMENT TEST 
 
In summary, the automated exchange transfusion device successfully functions as 
intended. The one way valves allow the fluid to flow properly into and out of the IV bags and the 
neonate, and the motor and pumping mechanism allow the transfusion to take place at various, 
but constant volume flow rates. The desired total volume to be transfused is accurate, and the 
device is compatible with multiple size syringes. Also, with proper preparation, air bubbles will 
be eliminated from the system thus eliminating any kind of danger regarding air embolism. All 
of these factors combined allow us to conclude that the automated exchange transfusion device 
functions safely and successfully. 
PROTOTYPE COST 
It was also necessary to design the automated exchange transfusion device to be made up of low-
cost, locally available materials to Ghana. KATH is a relatively low-budget hospital in urban 
Ghana and the utilization of low-cost, locally available materials would greatly increase the 
purchasability of the device. Initially, a target of 200 USD or less per unit was set. This cost 
would include all components needed to complete the transfusion except basic medical supplies 
such as syringes, connecting tubing, and IV blood bags. The cost of the prototype rose slightly 
over the target, however the cost per unit after developing the prototype and with diminishing 
costs that occur when mass manufacturing, the device is expected to be less than 120 USD. 
 
 
CONCLUSIONS AND REFLECTIONS 
In summary, all of the objectives on behalf of KATH have been met. A successful automated 
transfusion device has been fabricated, and all key customer requirements were fulfilled. The 
device functions as intended, and the important specifications such as an adjustable volume flow 
rate, a simple and quick setup time, and an automatic shut off function were all accomplished. 
The objectives to foster global awareness have also been met successfully. The four University 
of Michigan undergraduate students who worked on the project united service learning with an 
engineering curriculum to develop a medical device using technical experience, while also 
gaining knowledge and exposure to different disciplines and cultures throughout the process. 
To create a medical device that would potentially be used in a foreign country without 
ever actually visiting that country, critical thinking beyond the scope of a typical undergraduate 
student and cooperative learning was essential. The students involved with the project had to 
broaden their problem solving skill set to encompass more than just technical aspects. Cultural, 
environmental, and social aspects in Ghana all had to be considered as well. Conversations with 
medical staff at the KATH hospital in Ghana helped give valuable insight to these non-technical 
aspects of the project. Funding for medical equipment and safety guidelines are different in 
Ghana than they are in the United States, so exploration and understanding of those differences 
helped the group to develop a more practical exchange transfusion device for Ghanaian life. 
The engineering students involved with the project also had to look beyond the technical 
aspects of the project to increase their insight on the ethical dilemmas encountered due to 
cultural and societal differences. Funding in Ghana for medical equipment is limited, so 
decisions had to be made regarding when to sacrifice cost limitations for safety and reliability. 
Because the device would potentially have human lives in its hands if it was ever implemented, 
there were constant ethical considerations that had to be addressed throughout the design 
process. In the end, safety with a greater cost was ruled to be more important than sacrificing 
safety to lower cost. This was most importantly shown in the selection of the motor, where a 
more expensive linear actuator was chosen over a cheaper, but far less consistent gear/crank 
mechanism. 
The ethical issue of this medical device being automatic was also addressed. Because 
medical staff availability is so limited in Ghana, the staff could have a tendency to take the 
device for granted if it were to be implemented and the neonate receiving the transfusion could 
be left alone for too long. Although the device will be completely automatic beyond the start-up 
and prepping, the vitals of the neonate along with proper functionality will still need to be 
frequently monitored to ensure safety of the neonate at all times.  
For the automated exchange transfusion device to be successfully implemented as a real 
medical device in the future at the KATH hospital in Ghana, further work would absolutely be 
essential. The device was developed with available resources to the students working on it, and it 
was created under a very limited budget. To become a medical device to be used on neonates in 
Ghana, a greater material selection process would need to be conducted to ensure the safety and 
the durability of the device to the highest extent. Animal testing with the device would also need 






Appendix A: Updated Design Review III Document 
Nomenclature 
Important symbols and acronyms used throughout this report are presented in Table 1. 
 
Table 1. Important Nomenclature 
 
Symbol Unit Definition 
AS --- Additive Solution 
CV --- Central Vein 
ELBW --- Extremely Low Birth Weight 
FDA --- Food and Drug Administration 
FFP --- Fresh Frozen Plasma 
HBV --- Hepatitis B Virus 
HCV --- Hepatitis C Virus 
HIV --- Human Immunodeficiency Virus 
KATH --- Komfo Anokye Teaching Hospital 
MBU --- Mother Baby Unit 
PRBC --- Packed Red Blood Cell 
RBC --- Red Blood Cell 
VLBW --- Very Low Birth Weight 
WB --- White Blood 
WBC --- White Blood Cell 
WHO --- World Health Organization 
 
Introduction 
The following sections will discuss the problem the Mother Baby Unit (MBU) of the Komfo Anokye 
Teaching Hospital (KATH) in Kumasi, Ghana is currently facing. 
Problem Definition 
The availability of medical personnel is a great issue in Ghana. In 2004, the World Health Organization 
(WHO) stated that Ghana only has 2.00 physicians per 10,000 people [1]. WHO also affirmed that there 
are only 9.00 nursing and midwifery personnel per 10,000 people in Ghana. This reaffirms that there are 
far more neonates that require medical attention than there are doctors/nurses who can offer medical 
attention. KATH is a prime example of a facility where this problem is prevalent. 
 
Dr. John Adabie Appiah, the Child Health Directorate at KATH, is the mentor for this project, and he is 
one of the doctors in charge of the Mother Baby Unit (MBU) at KATH. KATH is the lone hospital for 
over 100,000 people in urban Ghana. On average, one neonatal exchange transfusion (ET) is performed at 
KATH each day (J. Adabie, personal interview, February 7, 2009). The medical personnel at KATH 
presently perform neonatal ETs manually, which entails manually rotating valves and operating syringes. 
The entire ET process takes approximately 90-120 minutes to complete, thus occupying much of the 
doctor’s valuable time. The time a doctor spends performing an ET is time he is not spending with other 
neonates in critical condition. The lack of valuable human resources, primarily doctors, is one of the 
issues contributing to the high mortality rate in neonates. There is a 2.7% neonatal mortality rate in 
Ghana. 28.5% of deaths among children under 5 years of age is due to neonatal causes [1]. The limited 
medical staff prohibits many neonates from receiving the care they need; ETs play a major role in the 




Presently, ETs are performed manually at KATH. The following provides the step-by-step procedure 
currently used for neonatal ETs at KATH: (1) Attach the apparatus to the neonate’s umbilical vein with 
the valves oriented, so that blood can be extracted directly from the neonate to the syringe. (2) After the 
syringe is filled, toggle the valves to close the path between the neonate and the syringe and to open a 
path between the syringe and the disposal container. (3) Completely empty the extracted blood from the 
syringe into the disposal container.  (4) Toggle the valves to close the path to the disposal container and 
open a path between the syringe and the fresh blood container. (5) Fill the syringe with the fresh blood. 
(6) Toggle the valves to close the path between the syringe and the containers of blood and to open the 
path between the syringe and the neonate. (7) Transfer the fresh blood from the syringe into the neonate. 
(8) Repeat the process until a sufficient amount of blood has been transferred into the neonate. A visual 




Figure 1. Current blood transfusion process (procedure described above). 
 
An infant must be monitored by a doctor or nurse at all times during this process, which may take several 
hours. It would be very beneficial for KATH to have an automated ET device; therefore, the presence of a 
doctor and/or nurse is no longer necessary. An automated ET device would provide the doctor/nurse more 
time to care for other patients. 
 
As a result of the problems stated above, we have been asked to develop a low-cost, easy to operate and 




Blood transfusion is the process of transferring blood or blood-based products from one individual into 
the circulatory system of another. In the year 2000, there were over 90 million blood transfusions 
worldwide [2]. The neonatal population receives the majority of all blood transfusions. There are no strict 
guidelines outlining how to perform a blood transfusion procedure. In this section, we will investigate the 
need for blood transfusions, the requirements associated with blood transfusions, specifically in neonates, 
the equipment used to perform a blood transfusion, and the transfusion methods in developing countries. 
Individual Blood Components for Transfusion 
Whole blood is made up of the following components: red blood cells (RBC), plasma, and platelets. The 
separation of whole blood into its constituent components is widely practiced for use when only these 
specific components are required. Each blood component can be processed using different methods and 
derivatives, thus leading to over ten types of blood products. Neonates are primarily transfused with the 
following types of blood products: whole blood, packed red blood cells, platelets, and fresh frozen 
plasma. 
 
Whole blood: Whole blood (WB) is desegregated blood collected into an approved container containing 
an anticoagulant-preservative solution [3]. WB contains RBCs, plasma, clotting factors, platelets, and 
approximately 109 white blood cells (WBC) [2]. Table 2 provides the composition of WB, as well as the 
hematocrit level of WB (p. 4). WB is transfused to increase the oxygen-carrying capacity of the patient’s 
blood to maintain adequate tissue oxygenation by replenishing blood volume and red cell mass [2]. WB 
provides oxygen-carrying capacity, blood volume expansion, and stable coagulation factors [3]. WB may 
also be useful for patients with both RBC volume deficits, such as patients with hemorrhages. The use of 
WB is discouraged in most situations, as the use of specific blood components is more appropriately 
tailored to the unique needs of the patient [2]. WB should not be used if a patient is at risk of circulatory 
overload because whole blood  has a higher volume than red cells [3]. 
 
Packed red blood cells: Packed red blood cells (PRBCs) are the most commonly transfused blood 
component [2]. Table 2 provides the composition of PRBCs, as well as the hematocrit level of PRBCs (p. 
4). PRBCs have the same red cell volume as WB; therefore, PRBCs have the same oxygen-carrying 
capacity as WB in a significantly reduced volume. PRCBs are mainly used for resolution of symptomatic 
anemia and improvement of tissue oxygenation [4]. PRBCs require more time for transfusion compared 
to WB, because PRBCs have a high ratio of red cells to plasma, which increases viscosity [3]. Fresh 
RBCs, less than 7 days old, are typically used for an infant’s initial small-volume transfusion [5]. RBC 
units with an additive solution (AS) are used for pediatric infusions; however, AS-RBCs are not used 
routinely in newborns because of concerns about reactive hyperinsulinemia, renal toxicity, and dieresis-
associated fluctuations in cerebral blood flow, which could be triggered by the higher concentrations of 
dextrose, adenine, and mannitol in AS units. 
 
Platelets: Platelets play a significant role in hemostasis by repairing breaks in small blood vessel walls 
through the formation of blood clots [2]. Deficiencies in the platelet amount and/or function can have 
unpredictable effects that range from clinically insignificant prolongation of the patient’s bleeding time to 
major life-threatening hemorrhaging. Platelets are typically transfused when a patient has 
thrombocytopenia or when a patient is experiencing platelet function defects (often caused by decreased 
platelet production or increased platelet destruction) [2, 3]. Platelets should be administered when the 
patient’s platelet count falls below 50 × 109/L and the patient shows clinical signs of microvascular 
bleeding. Platelet transfusions should be considered in cases where the platelet count falls below 20 × 
109/L, even if there is no clinical evidence of bleeding, because there is a danger of hidden bleeding, such 
as into the brain tissue [3]. Platelets used for transfusion may come from two different sources: (1) those 
prepared by separating rich plasma from a routine whole blood donator (“platelet concentrates” or whole 
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blood derived platelets), and (2) those collected from a single donor using the cytapheresis process 
(“single donor platelets” or apheresis derived platelets) [2]. The recipient of platelet concentrate is 
exposed to 5 to 8 times more blood donors per transfusion than a single donor platelet recipient. The 
composition of platelets is revealed in Table 2 below. 
 
Fresh Frozen Plasma: Plasma is the aqueous, acellular portion of WB, which consists of proteins, 
colloids, nutrients, crystalloids, hormones, and vitamins [2]. Fresh frozen plasma (FFP) is plasma that is 
frozen within 6 to 8 hours of collection and stored at -18˚C or colder. The composition of FFP is shown in 
Table 2 below. Transfusion of FFP is appropriate for the following: (1) replacement of specific 
coagulation factors not available in concentrate form, (2) management of multiple factor deficiency, 
which is usually the result of liver disease, and (3) treatment of antithrombin II (ATIII) deficiency [2, 6]. 
FFP should not be used as a general volume expander because it carries the risk of disease transmission 
and safer, less expensive products are readily available [2]. 
 








Blood (WB) 500 
250 mL red cells 
250 mL plasma 
63 mL anticoagulant 
10 mL/kg body 
weight transfused 
over 2-4 hours 





CPD or CPDA 
200 mL red cells 
50 mL plasma 
10 mL/kg body 
weight transfused 
over 2-4 hours 





200 mL red cells 
50 mL plasma 
100 mL adenine saline solution 
10 mL/kg body 
weight transfused 
over 2-4 hours 





300 ≥ 3 x 10
11 platelets 
< 104-106 WBCs and plasma 
Can be dosed at 10 
mL/kg body 
weight, but most 
times is dosed by 
¼, ½, and whole 







≥ 5.5 x 1010 platelets 
Variable numbers RBC, WBCs, 
and plasma 
10 mL/kg body 
weight transfused 
by gravity, pump, 








10-15 mL/kg body 
weight transfused 




Neonatal Blood Transfusion 
Neonates are among the most frequent to receive blood transfusions [7]. Preterm neonates comprise the 
most heavily transfused group of patients [4]. Approximately 85% of extremely low birth weight 
(ELBW), less than 1.0 kg newborns receive a transfusion within the first 2 weeks of life [4, 8]. As many 
as 80% of all very low birth weight (VLBW), less than 1.5 kg newborns receive multiple RBC 
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transfusions [7]. An ET in the neonate constitutes a massive transfusion since it involves the replacement 
of one to two whole blood volumes [2]. 
 
Reasons for a blood transfusion in a neonate: The following factors contribute to the decision of 
whether or not an ET should be performed: gestational age, evidence of hemolysis, degree of anemia, rate 
of rise of bilirubin, and concurrent clinical conditions [2]. The primary reasons for a blood transfusion in 
a neonate are hemolysis, volume replacement, respiratory arrest, cardiac disease, and anemia. 
 
Hemolysis: Hemolysis is the destruction of red blood cells, which leads to the release of hemoglobin from 
within the RBC into the blood plasma [3]. Hemolysis is the underlying cause of kernicerterus, 
neurological complications caused by rapidly-rising unconjugated bilirubin concentration. The release of 
hemoglobin into the plasma causes an increase in unconjugated bilirubin concentrations because the 
immature liver cannot metabolize the breakdown of hemoglobin. ETs are preformed to neonates primarily 
to prevent kernicerterus. In many countries, the main cause of hemolytic disease of the newborn is due to 
the Rh D incompatibility between mother and fetus. Hemolytic disease is the most common and clinically 
important cause of jaundice, a yellowish discoloration of the skin. 
 
Volume Replacement: Acute blood loss is primarily due to the event of an acute hemorrhage or due to 
phlebotomy loss [2]. A blood transfusion is of the highest priority when dealing with an acute hemorrhage 
in order to replace the intravascular volume and to stop the bleeding. It is more important to maintain 
intravascular volume during acute blood loss than to increase the oxygen-carrying capacity of a neonate 
with hemoglobin levels of 3 to 4 g/dL with RBC transfusions. Signs of moderate-to-severe acute blood 
loss include the following: irritability or stupor, pallor or mottling, tachycardia, tachypnea, decreased 
pulmonary intensity, delayed capillary refill, cool extremities, hypotension, metabolic acidosis, and 
oliguria or anuria. 
 
Phlebotomy is act of obtaining blood from a vein. Weekly phlebotomy loss among preterm infants during 
the first two weeks of life averages 10% to 30% of total blood volume (10-25 mL/kg) [8]. The 
replacement of blood drawn for laboratory testing is a critical factor responsible for multiple RBC 
transfusions in critically ill neonates [2]. 
 
Respiratory distress and cardiac disease: In neonates with severe respiratory distress, such as those 
requiring high volumes of oxygen with ventilator support, it is customary to maintain the hemoglobin 
level greater than 13.0 g/dL [2]. It is also advised that neonates with severe cardiac disease maintain a 
hemoglobin level greater than 13.0 g/dL. By maintaining a hemoglobin level greater than 13.0 g/dL, it is 
believed that the transfused donor RBCs containing adult hemoglobin will provide optimal oxygen 
delivery through the period of diminished pulmonary function. 
 
Anemia: The decision to transfuse RBCs should be based on hemoglobin and hematocrit levels because 
all neonates experience a decline in circulating RBC volume beginning during the first weeks of life [2]. 
Factors other than hemoglobin concentration that must be considered in the decision to transfuse in the 
chronic anemia setting include: the patient’s symptoms, signs, and functional capacities; the presence or 
absence of cardiorespiratory and central nervous system disease; the cause and anticipated course of the 
underlying anemia; and alternative therapies, such as iron and/or recominany human erythropoietin 
therapy. Neonates with late anemia may be considered for a blood transfusion if anemia is thought to be 
the cause of: poor weight gain, fatigue while feeding, tachypnoea and tacahycardia, or other signs of 
decompensation [3]. 
 
Guidelines for neonatal blood transfusions: Guidelines for transfusing neonates and infants are 
controversial, and practices vary widely among institutions [2]. Generally, RBC transfusions are given to 
maintain a level of hemoglobin or hemocrit believed to be most desirable for the existing clinical 
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conditions. RBC transfusions are given based on the patient’s hemoglobin levels, hematocrit levels, and 
clinical condition. Table 3 provides the basic RBC transfusion guidelines for neonates and infants (p.  
provided in Table 2 (p. 4). 
 
Table 3. RBC transfusion guidelines for neonates and infants [2, 5]. 
 
Hemoglobin Level Hematocrit Level Patient’s Clinical Condition 
Less than 13 g/dL Less than 40% • * Severe cardiopulmonary disease and/or 
• * Severe respiratory distress 
Less than 10 g/dL Less than 30% 
• * Moderate cardiopulmonary disease  
• * Mid-moderate respiratory distress 
• Perioperative and/or  
• Critical care  
Less than 8 g/dL Less than 24% 
• * Symptomatic anemia 
• Unexplained breathing disorders and/or  
• Unexplained poor growth 
* It is important that terms used to describe clinical conditions such as “severe” and 
“symptomatic” be defined to fit local practices and needs for each infant being 
considered for transfusion. 
 
Infusion rates: Infusion rates vary based on the clinical condition of the patient, as well as the type of 
blood component being infused. 
 
RBC infusion rate: Acceptable RBC replacement rates in neonates are typically 5 to 10 mL/hr/kg [5]. 
Neonates should not receive a blood transfusion that lasts over 4 hours; therefore, transfusions of RBCs in 
volumes of 10 to 20 mL/kg over 2 to 4 hours are generally tolerated for neonates and infants [2].  With 
rapid blood loss or in massive transfusion situations, rates as fast as 1.5 mL/min/kg can be used; however, 
the patients should be carefully monitored for drops in ionized calcium levels and blood pressure [5]. 
RBC transfusions over 25 mL/kg, or greater than one blood volume in 24 hours, require careful attention 
to possible metabolic and thermal alterations [2]. The rate of infusion should not exceed 2 mL/kg/hour in 
the presence of cardiac failure [4]. A transfusion of 10 mL/kg of AS-RBC would be expected to raise the 
newborn’s hematocrit level by 7-8%; however, a transfusion of 10 mL/kg of CPDA-1 PRBCs would be 
expected to raise the newborn’s hematocrit level by 9-10%. 
 
Other blood components infusion rate: The recommended dose of platelets for neonates is 1 unit of 
platelets per 10 kg of body weight, which amounts to 5 mL/kg [4]. The infusion of 5 mL/kg of platelet 
concentrate should be able to raise the blood platelet count by at least 50 x 109/L in a neonate [9]. A 
neonate may receive platelets in volumes of 10-20 mL/kg in cases of severe thrombocytopenia [4]. The 
volume of FFP to be transfused to a neonate is typically between 1 and 20 mL/kg. 
 
Risks associated with neonatal blood transfusion: ETs have their medical risks, which must be 
acknowledged during the design process of any blood transfusion device. The risks involved are generally 
more consequential for neonates than for adolescents or adults, since their bodies are less developed and 
more fragile. Appendix A-1 provides a list of various complications that arise from ETs in neonates. 
Some of the complications listed in Appendix A-1 are explained in detail below. 
 
Infections: Although it is mandatory to test collected blood for HIV, HBV, and HCV, syphilis, and 





Air embolisms: Air embolisms are another serious concern to design against [10]. An air embolism is a 
medical condition caused when gas bubbles enter the blood stream and can cause hypoxia, stroke, or heart 
attack. This is usually caused externally and by the misuse of the syringe. Therefore, a procedure will be 
generated to empty the functioning syringe(s) of any and all air bubbles before the automatic blood 
transfusion procedure begins. This is standard practice whenever a syringe is used for any purpose by a 
professional. 
 
Thromboembolism: Another cardiovascular risk involved with ETs is the occurrence of 
thromboembolism [2]. Similar to an air embolism, thromoboembolism occurs when a blood clot inside a 
blood vessel breaks off due to fluid flow forces and enters into the circulatory system and obstructs blood 
flow.  
 
Volume Overload: Neonates are at increased risk of fluid overload from transfusion because the volume 
of the blood component issued may exceed the volume that a neonate can safely endure [4]. 
 
Mechanics of manual exchange transfusion in neonates: There are two general techniques for ET: the 
isovolumetric method and the discontinuous technique. 
 
Isovolumetric method: The isovolumetric method, first described by Wallerstein, entails simultaneously 
withdrawing and replacing blood in order to avoid sudden changes in arterial pressure [2]. Due to the 
simultaneous withdrawal and replacement of blood, there must be two sites of vascular access. The 
umbilical vein is typically used to withdraw blood from the neonate; however, if the umbilical vein 
cannot be cannulated, peripheral blood vessels may be used to perform the blood transfusion. The 
isovolumetric method carries the risk of a second catheter; however, it eliminates the risk of swings in 
blood volume and pressure.  
 
Discontinuous technique: The discontinuous technique described by Diamond et al. is the most 
commonly ET method [2]. Small aliquots of blood are withdrawn and replaced through a single catheter 
with a special four-way stopcock. Typically, no more than 5% of the neonate’s blood volume (5 mL/kg 
body weight) is removed or replaced during a 3 to 5-minute cycle. The total time duration for a double-
volume exchange is 90 to 120 minutes or 45 to 60 minutes for a single-volume exchange. This process is 
much like the one used in Ghana. 
 
Technical considerations for neonatal blood transfusion: There are many technical requirements that 
must be met by the mechanical devices used to transfuse blood. Neonates have small veins; therefore, the 
needle size and catheter size must be considered in order to minimize hemolysis. The temperature of the 
blood is also an impacting factor, which can be easily affected by the transfusion device. 
 
Needle: Needles come in a variety of sizes and designs. Stainless steel needles are primarily used for 
neonatal blood transfusions, because they are easy and less painful to insert [5]. 20 to 25 gauge needles 
should be used to withdraw and replace blood from a neonate, because such small gauge needles 
minimize the likelihood of producing hemolysis in the neonate [2].  
 
Catheter: The catheter should be large enough to achieve good flow rates but not so large that it causes 
mechanical damage to the vein [5]. Short, long diameter catheters were confirmed to have high flow rates 
with the flow under a pressure 17 times greater than in a longer, small diameter catheter [2]. There are 
various types of catheters; however, over-the-needle catheters causes less trauma to the vein for a short-
term peripheral therapy [5]. Over-the-needle catheters have a plastic cannula that fits snuggly over an 





Temperature of blood: Excessive heating of blood components alters the red cell membrane, which in 
turn affects the elasticity, deformability, and osmotic fragility of the RBCs [2]. The damage caused by 
excessive heating will depend on the exposure time, as well as the temperature. It is recommended that 
tubing is covered with aluminum foil or routed in such a way to avoid exposure to potential heat sources. 
The blood can also cool substantially before reaching the patient, especially when the blood is flowing at 
slow flow rates. Cold blood infusion risks hypothermia in neonates; therefore, the blood must be 
regulated at an optimal temperature.  
 
Existing neonatal blood transfusion systems: There is no exact method for performing a neonatal blood 
transfusion; however, there are various existing mechanisms that assist in the blood transfusion method. 
 
Electromechanical pump systems: Electromechanical pump systems are used to deliver cellular blood 
components, intravenous fluids, and medications [2]. Electromechanical pump systems provide accuracy 
in the volume to be delivered and the flow rate required. Neonatal electromechanical pump systems are 
more accurate in the short term (up to 60 minutes) when infusing at rates less than 5 mL/hours and the 
occlusion pressure is set lower than 300 mmHg). 
 
Pumps: There are various types of pumps available that utilize different mechanisms of delivery in order 
to distribute blood to a patient. A peristaltic mechanism squeezes the administration set tubing to create 
flow [2]. The peristaltic-type pump produces a great deal of red blood cell damage; therefore, it is not 
recommended for use. A piston-actuated syringe-type mechanism uses a constant high speed refill cycle 
of the syringe followed by a slow ejection phase controlled by a check valve. A piston-actuated 
diaphragm cassette mechanism works by having blood fed into the cassette by gravity, where the flow is 
then controlled by two pistons acting against two check valves. The diaphragm cassette mechanism also 
produces a great deal of hemolysis; therefore, it is not recommended for use. 
Blood Transfusions in Developing Countries 
Blood transfusion practices in developing countries vary greatly from the blood transfusion practices of 
developed countries. The greatest differences in practices are due to the amount of material resources 
available to operate blood transfusion systems, the distribution of diseases and the treatment. In 
developing countries, pediatric blood transfusions make up a large percentage of transfused patients, 
specifically in subSaharan Africa. As a result of these challenges, blood transfusion services among 
resource-restricted countries vary considerably in their levels of development, safety, and quality. 
 
Conditions requiring transfusions: The majority of neonatal transfusions are given for basic, usually 
urgent or life-threatening conditions, rather than for support of tertiary care needs [2]. Major causes of 
pediatric anemia in developing countries consist of the following: malaria infection, nutritional anemia 
due to inadequate dietary iron, thalassemia, hemoglobinopathy, HIV infection, chronic or recurrent 
infections, and accidents. 
 
Malarial anemia: Malaria causes anemia primarily through repeated episodes of hemolysis [2]. Anemia 
can become quite severe in young children who have not yet achieved a degree of immunity against 
malaria. In developing countries of subSaharan Africa and parts of Asia, malaria is a primary cause for 
pediatric hospitalization due to severe anemia. 
 
Nutritional anemia: Iron deficiency anemia is highly prevalent in many developing countries due to 
inadequate dietary intake of vitamin B12 or folate [2]. The WHO estimates that 50 % of children in 




Thalassemia: Thalassemia is a genetic autosomal recessive blood disease, which results in reduced rates 
of synthesis of one of the globin chains that make up hemoglobin, and this in turn causes anemia [2]. The 
treatment of thalassemia places major demands on the blood supply in developing countries, especially in 
Southeast Asia, Africa, and the Middle East. 
 
Hemoglobinopathy: Sickle-cell disease is one of the most common hemoglobinopathies [2]. Over 80% of 
the world’s population with sickle cell disease is born in Africa; however, transfusions in pediatric sickle-
cell disease patients are reserved for those with severe anemia (hemoglobin level less than 5 g/dL). 
Unfortunately, the regions of Africa where the hemoglobin gene is most common coincide with those 
where the HIV pandemic is greatest; therefore, patients with sickle-cell disease are recognized as a group 
at risk of acquiring HIV infection. 
 
Material resources: Many developing countries have a short supply of the material resources needed to 
perform blood transfusions [2]. Throughout developing countries, there is a chronic shortage of blood 
products. This shortage has intensified by the problem of inappropriate transfusion practice and the failure 
to use sound medical guidelines for transfusion. It has been estimated that 13% to 47% of all pediatric 
transfusions in Africa are given unnecessarily. The blood inventory in many developing countries consists 
of only 1 or 2 days’ supply; therefore, more often than not, the patient’s family must locate a suitable 
donor to supply blood. 
 
Whole blood, usually collected in CPDA-1 anticoagulant, is the most commonly available blood product 
[2]. PRBCs are frequently unavailable in developing countries, while FFP and platelets are similarly 
scarce in many resource-restricted countries. Private hospitals and major teaching hospitals may have 
PRBCs, FFP, and platelets for their use but typically only in short supply. 
 
Small volume transfusions are sometimes performed by removing aliquots of blood into small volume 
bags, sterile syringe sets, or buret sets when available [2]. Infusions pumps are not widely available; 
therefore, infusions rates are typically determined by the drip-rate method. Various developing countries 
lack reliable sources of electricity and refrigeration, which has hindered the establishment of good blood 
transfusion methods. 
 
Risks of infectious disease transmission by transfusion: In the year 2000, 31% of all donated blood 
units were not screened for one or more of the three most serious transfusion-transmitted viruses: HIV, 
HBV, and HCV [2]. Almost all of these screening lapses occurred in the world’s developing world. 
Transfusion-transmitted HIV infection is one of the most serious adverse consequences of blood 
transfusion in children in developing countries. Approximately 10% to 15% of HIV transmissions in 
subSaharan African are attributed to transfusions; however, the proportion of infections attributable to 
transfusions in pediatric populations is actually much higher, as over half of transfusions are administered 
to children. 
 
Guidelines for neonatal blood transfusions: The guidelines for neonatal blood transfusions are similar 
to those in developed countries; however, the guidelines tend to be more conservative due to the increased 
risk of adverse affects. Due to the high risk of transfusion-transmitted infectious disease and acute blood-
product shortage in many developing countries, the guidelines listed in Table 4 are typically followed to 
determine if a neonate needs a blood transfusion (p. 10). Blood transfusions for neonates with a 
hemoglobin level less than 5 g/dL are only considered necessary if the neonate is experiencing respiratory 
distress or cardiac failure; however, if the neonate is clinically stable, it is advised that the patient is 
closely monitored and treated for the cause of anemia [2]. If a neonate acquires a hemoglobin level 
greater than or equal to 5 g/dL, then a transfusion is usually not necessary. Transfusion is only considered 




Table 4. Typical guidelines for pediatric7 transfusion in developing countries [2]. 
 
Hemoglobin Level Patient’s Clinical Condition 
Less than 4 g/dL ---- 
Less than 5 g/dL Respiratory distress or cardiac failure are present 
 
Transfusions to neonates must be administered slowly, especially when whole blood is used; otherwise, 
the neonate may experience volume overload [2]. Whole blood transfusions are often administered at a 
dose of 20 mL/kg over 2 to 4 hours. When PCRBs are available, they are typically given at a dose of 15 
mL/kg. 
Benchmarking 
The following section will describe various transfusion devices that are currently employed in the hospital 
setting, as well as various transfusion devices that have been patented by the United States. 
 
Four-Way Stopcock 
The Holden Neonatal Intensive Care Unit (NICU) at Mott Hospital in Ann Arbor, Michigan presently 
uses a manual ET process for neonates (Robin Jahnke, personal interview, February 11, 2009). The 
components needed for the manual ET process are provided in an ET Tray, which consists of two 20 mL 
syringes, an extension tube, a 5 Fr and a 8 Fr umbilical catheter, a blood administration set, and a fluid 
collection bag, which is illustrated in Figure 2 below. This device works much like the process presently 
used at KATH; however, the four-way stopcock excludes the necessity of having multiple valves. The 




Figure 2. Manual four-way stopcock device presently used at various hospitals. 
 
DRE SP1500 Plus Syringe Pump 
In 2008, the U.S. Food and Drug Administration (FDA) approved the use of syringe pumps in medical 
facilities. A syringe pump provides accurate continuous infusion of medications at expanded flow rates. 
Syringe pumps can typically provide infusion via intravenous, intra-arterial, epidural and subcutaneous 
routes of administration. 
 
DRE Inc. recently introduced the DRE SP1500 Plus syringe pump into the medical field, which is 
illustrated in Figure 3 below [11]. The DRE SP1500 Plus can infuse medications at rates ranging from 0.1 
mL/hr to 1500 mL/hr. It also supports all major syringe brands with volumes ranging from 10 mL to 100 
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mL; however, the device allows multiple syringes to be stacked thus providing a no volume limit. The 
SP1500 Plus syringe pump allows physicians to quickly and simply enter parameters, such as the infusion 
rate limit and the total infused volume, which must be taken into account during the infusion procedure. 
The SP1500 Plus has the capabilities of operating both manually and automatically; therefore, allowing 
the physician to interrupt the process if needed and perform the process manually, or the physician may 
care for other patients while the infusion process is taking place. The SP1500 Plus runs off of a NiMH 
rechargeable battery. It is easily transportable for the device is 135 mm by 305 mm by 195 mm and only 




Figure 3. DRE SP1500 Plus Syringe Pump [11]. 
 
Although such a device provides various advantages to infusing products, such as blood, the device only 
takes into account infusing blood and not ejecting blood from a patient. The device is also extremely 
expensive. 
 
Exchange Transfusion System (Out-of-Phase) 
Patent 4,457,747 introduces an automated ET device, particularly for newly born babies or children [12]. 
The device is depicted in Figure 4 (p. 12). This device uses two coupled, automatically driven syringes, 
one in a blood withdrawal system and one in a fresh blood injection system. The coupled system insures 
that the volume removed from a baby in the withdrawal system will be simultaneously replaced by an 
equal volume of fresh blood from the injection system. As depicted in Figure 4 (p. 12), the syringes are 
out-of-phase of each other, which entails that when the syringe on the left is injecting fresh blood into the 
neonate, the syringe on the right side is ejecting blood from the neonate. When the syringe on the left is 
filling up with fresh blood, the syringe on the right is emptying the waste blood into a waste container; 
therefore, the neonate is neither receiving nor disbursing blood during the refill phase. This device is run 
on an electric motor, which is connected to a box panel, depicted in Figure 5 (p. 12). The electric motor 
has appropriate gears to reduce the volume flow rate as desired. Although this device has various 
advantages, having two insertion points into the infant (the umbilical vein and a peripheral vein) is not 
plausible. The injection and ejection of blood from a neonate must be within a large blood vessel; 
otherwise, the injection and ejection of blood in a peripheral vein will cause the vein to collapse (R. 

















Figure 5. Box panel holding syringes, which 
are connected by a slider [11]. 
 
 
Blood Transfusion System (In-Phase) 
Patent 7,083,587 is very similar to that of Patent 4,457,747 described above; however, the automated ET 
device consists of an in-phase system, as well as a single injection point [13]. The device is depicted in 
Figure 6 below. A Y-shaped connector is used; therefore, the patient only needs one injection point. At 
one end of the Y-shaped junction is a waste blood syringe, while at the other end of the Y-shaped junction 
there is a fresh blood supplying syringe. The system functions by having motor push and pull a slider, 
which operates the syringes. First the syringe is pulled outwards; therefore, the top syringe ejects blood 
from the neonate, while the bottom syringe fills up with fresh blood. The suction process is depicted in 
Figure 6  below. When the syringe is then pushed forward, the top syringe empties the waste blood into a 
waste blood container and the bottom syringe injects the fresh blood into the neonate. The injection stroke 




Figure 6. Suction stroke process of in-phase blood transfusion device. [13]. 
 
This patented design was created for the following reason: to replace a time-consuming, manual ET 
procedure with a system that can operate without the constant supervision of a nurse or doctor. This 






Figure 7. Injection stroke process of in-phase blood transfusion device. [13]. 
 
Information Sources 
To familiarize ourselves with the ET process and equipment, the precautions and risks in caring for 
neonates, and pre-existing ET device designs, we consulted a variety of sources and mediums of 
information. As a starting point, we utilized internet search engines for general knowledge. As we 
researched more into our specifications, we resorted to more reliable sources of information; namely 
medical journals and books, United States patents, and interviews with pediatric professionals.  
 
We found many great sources to obtain coarse information about the topics regarding our project. Medical 
journals and books were our first source of bulk information past the preliminary knowledge gathering 
stage. A combination of PubMed and Google led us to Pediatrics: The Official Journal of the American 
Academy. We obtained enough information from these journals to begin a list of specifications for our 
device. Newborn blood volumes, blood flow rates for different weight classes of neonates, and risks such 
as air embolism, were among the specifics we acquired from the journal. These are all engineering 
considerations we must take into account for our design. Another medical book which included the 
procedure for a manual ET was The Clinical Use of Blood by the World Health Organization.  
 
With a solid understanding—gained from medical journals, books, and other supporting documentation—
of ET and its related topics, we were prepared enough to interview local pediatric professionals. This 
phase of knowledge gathering was the most efficient medium and provided the most information 
regarding medical factors that we need to keep in mind, such as max blood flow rates and possible air 
embolisms. 
Project Requirements and Engineering Specifications 
After conducting numerous hours of background research to learn as much as possible about ETs, we 
were ready to develop a list of qualitative customer needs that would be essential to the success of our 
automated ET device. To advance our goals, each customer need was quantified in some way to create an 
engineering target or specification that we will be trying to reach during the design process. Medical 
journals, United States patents, medical personnel at Mott’s Children Hospital, and Dr. John Adabie, our 
mentor from KATH, were the key resources we used to help quantify our customer needs. Once we 
derived our engineering specifications, we created a QFD diagram (Appendix A-2) to map the customer 
needs against the engineering specifications to quantifiably determine which specifications would be most 
important to address. We used a 1, 3, 9 scale to indicate weak to strong relationships respectively between 
the customer needs and the engineering specifications. Table 5 summarizes these relationships (p. 15). 
(Table 5 includes updated customer requirements and specifications in bold, underlined black font.) The 
specifications we deemed most important are explained individually below.   
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Necessity of Medical Personnel during ET Process 
The overlying customer need and main motivation behind designing an automated ET device is to 
increase the number of available medical personnel; therefore, providing doctors and nurses with more 
time to care for other patients. The device is meant to replace the manual ET procedure that is currently 
used at KATH through means of being automatic. Being such a broad customer need, all that can be said 
about it so far is that the device will operate with synchronous intrusion/extrusion strokes, and it will 
ultimately rely on the success of meeting the other customer needs, such as the ease of use, ease of 
assembly, and ease of mobility. 
Inexpensive 
Funding is extremely limited in the medical field in Ghana; therefore, the ET device needs to be as 
inexpensive as possible. We are targeting a cost of US $200 or less per device (all parts included). 
Automated infusion pumps, an existing medical device used at various U.S. hospitals, costs as little as 
$495 and as high as $1500. Much of this expense is due to the high technology incorporated with the 
design. The use of disposable parts presently available at KATH will help drive the cost down of each 
device. The main concern for keeping the cost minimal is the cost of the driving mechanism used to run 
the device. The driving mechanism was chosen to be a linear actuator, and this will be the most expensive 
component of the automated ET design. 
Ease of Use 
The device must be easily employed by medical personnel. The device will be automated; however, that 
does not necessarily mean that it is easy to operate. The ET device must have a self explanatory user 
interface. Ideally, the start-up process should be the only time a doctor or nurse is actually using the 
device other than when it shuts off at the end of the transfusion. Although the automated ET device will 
function with limited interaction from the medical personnel, the neonates must be intermittently 
monitored by medical personnel to examine the neonate’s vitals. 
 
To begin the transfusion process, the volume flow rate will need to be set to between 0 and 10 mL/min 
according to the size of the neonate, and then the motor mechanism will need to be started. The device 
should not require any form of human interaction beyond that point until the end of the transfusion, 
outside of occasional check-ups to make sure there have been no malfunctions. An easy-to-use device, 
where the process does not require medical personnel beyond the start and end of the transfusion process, 
will offer medical personnel with more time to care for other patients in the MBU. 
Automatic Shut off 
An automated shutoff system is essential in the design of an automated ET device. If the system does not 
automatically turn off, the neonate will be at greater risk of experiencing volume overload. To insure the 
safety of the neonate, a feedback system will need to be implemented. The feedback system will detect 
the amount of blood administered into and out of the neonate. When the system has reached the indicated 
blood volume, the feedback system will ignite an automatic shut off. The microcontroller within the 
circuit board will be responsible for shutting down the process once the desired total volume of blood has 
been transfused. 
Prevents Air Bubbles 
One of the biggest risks when using a hypodermic on a patient is the transmission of air bubbles from the 
syringe into the circulatory stream. The topic of air embolism was discussed previously in the “Risks 
associated with neonatal blood transfusion” section above (p. 6). The automated ET device must insure 
the safety of the neonates by means of preventing air bubbles from forming in the syringe(s). A specific 
procedure needs to be conducted to eliminate all air bubbles before the automatic ET process begins. This 
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procedure will entail ‘priming’ the tubing, or filling the tubing with blood before turning the system on. 
This will eliminate the possibility of air bubbles forming in the tubing or the syringes. The procedure will 
be designed to reduce the volume of air in the syringe to less than 0.1 mL. A bubble as small as 10 mL in 
the heart may cause hypoxia, and a bubble only a fraction of a milliliter located in the brain may cause a 
stroke. Therefore, this design criterion is one of primary importance.  
Ease of Assembly/Disassembly 
The device will have many parts, but the assembly process should not be laborious. It should take no 
more than 10 minutes to assemble/disassemble the device. The device should come with a clear, one-page 
instruction manual that makes assembly as easy as possible. The device will be made with available parts 
already at KATH; therefore, the staff at KATH should be familiar with most of the components already, 
creating an easier assembly process. Also, the motor/linear actuator should not weigh more than 10 lbs 
(4.54 kg), so picking it up for assembly is not an issue for any doctor or nurse. 
Functions with Battery Power 
AC power is not the most reliable source at KATH given that the power goes out occasionally. A 
dependable power source is needed to operate the ET device, especially because there is a life on the 
other end of this device. If the device fails, the infant is at a greater risk of dying. In order to take 
advantage of the AC power, but also insure a reliable electrical source, a battery operated system should 
be implemented. This system may also employ an AC power system, while using the battery operated 
system as a backup. In order to implement a battery into the ET design, the battery must be readily 
available in Ghana. The battery must also supply enough power to operate the entire system. Due to such 
criteria, the supplied battery power should be no more that the power emitted by 4 standard D sized 
batteries  (1.5 Volt, 4500mAh) in series, which will need to cost no more than US $0.50/battery. 
Applicable with Various Syringe Sizes and Brands 
Syringes come in various geometries. Since a syringe is being used as the pumping mechanism in the ET 
device, it is crucial to design a system that is compatible with various types of syringes. Syringes do not 
only have various geometries, but they also have various properties, such as the frictional force between 
the plunger and the syringe. Ideally, the ET device should accommodate syringes that range from 20-25 
mL because a neonate should not have more than 25 mL injected or ejected in a single stroke. To create a 
system that accommodates such a wide range of syringe volumes and types, there will ideally need to be a 
feedback system to control the pumping of the syringes. 
Minimizes Disease Transmission 
The automated ET device will be dealing with blood transfers; therefore, the need for this device to 
prevent disease transmission is vital to insure the safety of the neonates. In order to meet this requirement, 
our device will have to meet the Ghanaian health regulations. Also, to enhance the probability of 
preventing disease, our device will consist of approximately 50% disposable materials. 
Instruction Manual 
The device should come with a short, less than five-page instruction manual that clearly explains how to 
use it properly. We are trying to develop a simple design that will have a high success rate; therefore, a 
complex  












Constant monitoring from doctor is 
not required 9 
Synchronous intrusion/extrusion strokes 
(mL/stroke) 25 
Inexpensive 3 Total cost (USD) ≤ 200 
Ease of use 9 Operating/assembly instructions (pages) ≤ 1 
Automatic shutoff 9 Feedback system Yes 
Prevents air bubbles 9 Volume of air bubbles pre-process (mL) ≤ 0.1 
Ease of assembly/disassembly 9 Setup time (minutes) ≤ 5 
Functions with battery power 3 Battery replacement time (days) ≤ 7 
Applicable with various syringe 
sizes and brands 9 




Prevents disease transmission 9 Disposable Components (% of total) 50 
Instruction manual 3 Operating/Assembly Instructions (pages) ≤ 5 
Adjustable volume flow rate 9 Volume Flow Rate (mL/min) 0-10 
Transfuse various types of blood 
(PRBC, FFP, platelets, etc.) 3 Volume Flow Rate (mL/min) 0-10 
Easily maintained and repaired 3 Disposable Components (% of total) 80 
Utilizes available spare parts 3 Spare Part Replacement Time (days) ≤ 7 
Operable for both blood transfusion 
and exchange transfusion 3 Number of insertion points 1 
Mobile 3 Total Weight (N) ≤ 65 
Blood volume control 3 Total blood transfused (mL/kg) Feedback system 
10 
Yes 
Safety of neonate 3 Motor Noise Level (dB) IV insertion point 
≤ 45 
1 
Functions with AC power 9 Operating Voltage/Frequency (V, Hz) 220, 50 
Easy transition to manual process 1 Time to transition from automatic process to manual process (seconds) < 60 
Minimize the size 1 Volume Dimensions (m3) 6688 
Ease of sanitizing/cleaning 1 Disposable Components (% of total) 50 
Minimize sound 1 Motor Noise Level (dB) ≤ 45 
Alarm device to detect malfunction 1 Alarm Noise Level (dB) 70 
Alarm device to detect the end of 
the process 1 Alarm Noise Level (dB) 60 
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instruction manual should not be necessary. Along with written instructions, the instructions manual 
should have a schematic diagram of the device so the procedure is easy to follow visually. Any 
instructions manual longer than five pages in length will require unnecessary time spent reading, and that 
is unacceptable as our main goal of this project is to open up more time for the medical staff so more 
babies can be cared for. A repair and maintenance instruction manual will be included as well to assist the 
staff at KATH make any repairs that may be needed throughout the lifetime of the device. 
Adjustable Volume Flow Rate 
The volume flow rate in which blood can be safely infused and ejected from a neonate is a critical 
specification. A suitable volume flow rate of blood flowing into and out of a neonate is 3 mL/min [3]; 
however, the volume flow rate may need to be increased or decreased depending on the type of blood 
being infused into the neonate due to the varying fluid viscosities of different blood components. In order 
to prevent hemolysis of blood components due to mechanical damage from rapid infusions through the 
small-gauge needles that are needed for neonates (<24 gauge), a low volume flow rate (3 mL/min) must 
be utilized [3]. The neonate is also at risk of having a volume overflow, which is often caused by a rapid 
volume flow rate. The automated ET device must have an adjustable flow rate. Although neonates 
typically receive blood at 3 mL/min, we would like to create a device that operates at 0-10 mL/min to 
incorporate any need for a larger volume flow rate. 
Transfuse Various Blood Components 
KATH transfuses various types of blood components into neonates, such as whole blood, PRBCs, FFP, 
and platelets. Whole blood and PRBCs are the primary blood component that is administered into 
neonates; however, these two blood components have varying fluid properties. Due to the varying fluid 
properties of the blood, the volume flow rate required will also vary.  
Easily Maintained and Repaired 
The ET device needs to be easily maintained and repaired. 90% of medical supplies shipped to foreign 
countries like Ghana do not arrive in working condition (B. Teninty, personal interview, January 20, 
2009). The automated ET device should be easy to repair; therefore, the device does not merely prop a 
door open, but rather maintains its original function. A majority of the parts will be disposable, such as 
the plastic tubing, syringes, and valves. Such parts should be replenished within a week's notice if they 
ever run out. If other parts such as the linear actuator or power supply are damaged in the shipping 
process, the one-page instructions manual should signify how to fix the issue. An automated ET device 
will be extremely beneficial to KATH; therefore, we must insure that the device is easily repaired. 
Utilizes Available Spare Parts 
A device that utilizes spare parts currently available at KATH will play a major role in the design process.  
If many of the components presently at KATH are utilized then the less the hospital will have to spend on 
importing equipment. When spare parts run out, KATH should be able to receive new parts within one 
week’s time. 
Operable for Both Blood Transfusions and Exchange Transfusions 
The automated ET device must also be able to function as a blood transfusion device; therefore, blood 
will no longer be ejected from the neonate, but only administered into the neonate. A blood transfusion is 
often required is a neonate is hemorrhaging, in which the blood must be administered as quickly as 
possible in order to replenish the neonate’s blood supply. By only having one insertion point, it will create 
an easier transition between the ET process and the blood transfusion process. A tube or valve may need 
to be removed from the system; however, this is a design based specification. 
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Ease of Mobility 
The device must be easily transported from ward to ward, and incubator to incubator. Even though the 
neonatal ETs at KATH take place on open tables, we intend to make our device capable of fitting easily 
into an incubator occupying an infant. A normal incubator box is approximately 19×40×22 inches 
(0.48×1.02×0.56 m), however this must contain both the baby and the device comfortably. To insure 
plenty of room for the neonate, the ET device should not consume more than one third of the incubator 
space (5573 in3 or 0.091 m3). The relatively small device volume will assist in making the device more 
mobile. The device shall also not weigh more 15 lbs (4.54 kg). In order to aid the medical personnel in 
transportation of the ET device, the device needs to be picked up with a minimum amount of work. The 
minimized weight and size values will make the device easier to move. 
Blood Volume Control 
An automated process does not require medical personnel to constantly monitor the neonate’s progress; 
therefore, the doctors and nurses will not be aware of the amount of blood that has been transfused into 
and out of the neonate. The device must be able to detect the amount of blood that has been injected into 
and ejected from the neonate. The total blood volume inputted into the neonate is typically 10 mL/kg of 
the neonate. The volume of blood entering and exiting the neonate will be calculated by the number of 
cycles that occur within time of operation. This number will then be an input into a feedback system, 
which will cause the system to stop after the correct amount of blood has been transfused. 
Safety of the Neonate 
There are many safety considerations to take into account when dealing with ETs in neonates. ETs must 
take place in fairly large blood vessels, which becomes a fairly large concern considering that neonates 
have very small blood vessels. Due to the small blood vessels of neonates, ETs are limited primarily to 
the larger blood vessels, such as the umbilical vein. The umbilical vein is the best blood vessel to use for 
an ET, because it is larger in size and does not require surgery to access. Due to the limited number of 
large blood vessels in neonates, the ET process should only require one IV insertion point. 
 
The motorized device will be next to the neonate during operation, because tube length between the 
insertion point and the syringes must be kept at a minimum to reduce flow energy losses. Due to the close 
proximity between the device and the baby, the device should not operate at a noise level greater than 45 
dB, which is roughly equivalent to a refrigerator hum. 
 
The automated ET device should also be constrained to the volume dimensions stated in the ease of 
mobility section above. As stated, the neonate and the device will share the same tabletop or incubator. 
We want the neonate to have sufficient space to move in without coming into contact with the device. 
Functions with AC Power 
The most convenient power source available would be an AC power source (with the exception of the 
power occasionally going out). This would supply the device with power that does not waste one’s 
energy, especially through means of a mechanical powering system. For AC power to be a viable means 
of powering the ET device, the device will need to be compatible with a 220 V, 50 Hz electrical supply. 
Easy Transition to Manual Process 
The automated ET device will consist of many of the same components currently used at KATH to insure 
that the ET device can easily transition from an automated process to a manual process. The device must 
allow the medical personnel to easily stop the process and insert a syringe into the system in which they 
can eject and inject blood manually. It should take less than 60 seconds to transition from the automated 
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process to the manual process. This is an essential feature, especially if the device is not working as 
desired. 
Minimize the Size 
The size of the device needs to be small enough to be moveable, as well as to be operable in the 
environment needed. The environment will be the MBU, so a preferred specification would be to have the 
device operable inside an incubator. This would only be feasible if the neonate was also able to fit 
comfortably inside the incubator. A standard incubator is 19x40x22 inches, while an infant comfortably 
consumes approximately 19x24x22 inches; therefore, the automated ET system needs to fit within a 
volume of 19x16x22 inches. 
Ease of sanitizing/cleaning 
The automated ET device will primarily consist of disposable parts presently available at KATH; 
however, approximately 50% of the system components will not be disposable. Due to use of blood 
components within the ET system, sterilization is necessary to eliminate the risk of transmitting 
infections. To insure a quick and easy sanitizing process, there will be a minimal number of non-disposal 
products. The components that are not disposable but come in contact with blood will be sanitized using a 
bleach-water solution. 
Minimize Sound 
In a hospital, extraneous noise can be very distracting if not dangerous. Due to this, the regular running of 
our device needs to be quiet. A maximum dB level of the device during regular operating system can be 
no more than 30dB. 
Alarm Device to Detect Malfunction 
The device is intended to be automatic and functional without the presence of medical personnel. The 
device should be equipped with an alarm system that will activate upon malfunction of the device or any 
sort of deviation from the ET process. This is a safeguard against any sort of emergency related to the 
malfunction of the device. If the device locks up before the end of process, if the blood flow rate changes 
from the initial setting, or any other numerous malfunctions, an audio alarm of 70 ± 5 dB will activate 
notifying personnel immediately. 70 ± 5 dB is roughly the same magnitude of an alarm clock. It would be 
audible from anywhere in the ward—even if music is being played on the radio, which according to first-
hand accounts is sometimes the case. Hearing loss for a sustained exposure does not occur until 
approximately 90 ± 5 dB. The alarm would potentially be the same sound for any type of malfunction, but 
the requirement of having an alarm device to detect malfunction is no longer of high priority for a 
feedback system will be implemented to insure the proper volume flow rate. 
Alarm Device to Detect the End of Process 
Once again, since the device is intended to be automatic and functional with personnel being present, the 
device will be equipped with an alarm system that will activate upon the end of the ET process. This 
alarm will be quieter and less striking than the alarm for a malfunction. It will be an audio alarm of 60 ± 5 
dB—the equivalent of an electric shaver or the strike of a piano key. The alarm is intended to notify 
personnel that the process has completed; however, this alarm has less urgency than the malfunction 
alarm, because our device will be designed to cease operation at the end of a pre-determined process 
anyway. The 60 ± 5 dB sounds does not come within the sustained 90 ± 5 dB range needed for hearing 
loss. The requirement of having an alarm device to detect the end of process is no longer of high priority 
for a feedback system will be implemented to insure the process ends after the neonate has been infused 
with the indicated amount of blood. 
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Concept Generation of Full Systems 
The brainstorming process is a key factor to developing a successful prototype; therefore, various 
brainstorming techniques were employed during the concept generation phase. From the brainstorming 




Before the brainstorming process could take place, it was essential to develop a functional decomposition 
diagram (provided in Appendix A-3) outlining the inputs and outputs of our device. This assisted us in 
determining the key components and subsystems to highlight in our brainstorming process. 
 
Before coming together to brainstorm ideas for design concepts as a group, we utilized an individual 
concept generation process to come up with as many ideas as we could on our own. For this part of the 
process, we focused on developing whole systems. The focus was to not spend too much time worrying 
about what may or may not work with the systems, but rather just to get as many ideas as possible written 
down, regardless of how impractical or improbable they would be to implement. Each team member was 
expected to develop between 3 and 4 whole systems prior to coming together for group brainstorming. 
 
Once our group had developed concept ideas individually, we came together to discuss our ideas and to 
brainstorm new ones based on what we had developed already. Also for this meeting, we broke down our 
developed whole systems into subsystems to brainstorm different ideas for some key components of our 
system (i.e. power source, valve control, and insertion possibilities). For this brainstorming session, 
similar to the individual process, we did not worry about developing practical concepts. We merely 
wanted to develop as many systems as we could to have as many ideas as we could.  
 
We began the group session discussing the ideas we had come up with individually. We then moved onto 
developing new systems that had sprouted from our individual ideas, as well as developing new ideas for 
our subsystem components. We chose to separate our whole system concepts into categories of how they 
would be powered (i.e. electronically, mechanically, or by gravity). Once we had derived as many ideas 
as we could on a large chalk board, we copied all of our concept ideas onto small Post-Its for recording 
purposes. (The various design concepts that were formed during the brainstorming process are provided 
in Appendix A-4.)  
 
After our group concept generation session, we displayed our ideas to our discussion section in the form 
of an informal presentation to get some peer feedback for further brainstorming. From this session, we got 
some valuable feedback that helped solidify some ideas we already had, and some new ideas that would 
help advance some of our concept generations.  
 
The next step was to put together all of the brainstorming we had done so far, combine ideas and 
components, and come up with the best 5 concepts to consider for a final concept selection. Once we 
chose our top 5 whole systems, we developed them further on dry erase boards to have a visual idea of 
how the entire system might look if created. The five concepts we chose to decide between for final 
concept selection are explained in the following sections. 
Out-of-Phase Slider 
One concept that was developed during the brainstorming process is referred to as the out-of-phase slider, 
which is depicted in Figure 8 (p. 21). The out-of-phase slider system consists of a driving mechanism and 
a pumping mechanism. The driving mechanism is revealed as a motor-crank system in Figure 8; however, 
there is much flexibility in regards to the design of the driving mechanism, especially since the primary 
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focus of the driving mechanism is to power the pumping mechanism. The driving mechanism, in this case 
a motor, crank-connecting rod system, applies a force onto a slider. The slider is connected to two 
syringes, in which one syringe is located to the left of the slider and the other syringe is located to the 
right of the slider. This slider-syringe component acts as the pumping mechanism. 
 
The pumping mechanism allows the syringe to act as a pump, in which the slider will push the plunger of 
the syringe back and forth; therefore, allowing the syringe to fill up with blood, as well as empty blood. 
The syringes are then connected to the neonate via a catheter and some tubing. Figure 8 below illustrates 
that there is also a junction intersecting the connection between the syringe the neonate. Each junction is 
connected to a reservoir, which either supplies fresh blood to the system or serves as a waste blood 
container. Each junction consists of a check (one-way) valves. A check valve insures that the blood can 
only flood in one direction. The check valve located at the junction near the fresh blood will insure that 
blood can only flow out of the reservoir. The check valve will also serve the purpose of preventing blood 
flowing from the neonate towards the syringe. The check valve located at the junction near the waste 
blood container insures that waste blood can only flow into the waste blood container; therefore, waste 




Figure 8. Out-of-phase slider design concept schematic. 
 
The pumping mechanism process has the two syringes pumping out of phase; therefore, when the syringe 
on the right is ejecting blood from patient, the syringe on the left hand side is simultaneously injecting 
blood into the patient. Similarly, as the syringe on the right is pumping waste blood into the waste blood 
container, the syringe on the left is being filled with fresh blood. This system provides the neonate with a 
stable blood pressure for the loss of blood is immediately replenished, which is due to the two insertion 
points. This design also provides a break in which blood is neither being injected into nor ejected from the 
neonate. 
In-Phase Slider 
One concept that was developed during the brainstorming process was the in-phase slider. The in-phase 
slider is very similar to the out-of-phase slider; however, the two syringes pump in-phase with each other. 
The in-phase process indicates that each syringe simultaneously fills with blood and simultaneously 
empties of blood. In order to create an in-phase system rather that an out-of-phase system, the two 
syringes must remain on the same side of the slider, as depicted in Figure 9 (p. 22).  
 
The syringes are connected to the neonate similarly to the out-of-phase slider system; however, a Y-
shaped junction connects the two syringes to a single injection point. It is plausible to connect the two 
syringes together via a Y-shaped junction because blood is not being injected into and ejected from the 
neonate simultaneously. Rather, the syringe located on the bottom of Figure 9 (p. 22) will eject blood 
from the neonate when the slider is forced away from the syringes, while the syringe on top will be 
ejecting blood from the fresh blood bag. The slider will then push forward towards the syringes, which 
will cause fresh blood to be injected into the neonate via the top syringe. This will also cause waste blood 
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to be injected into the waste blood container. The in-phase slider system also consists of check valves 
similar to that of the out-of-phase slider, which prevents blood from flowing in the incorrect direction. 
This system insures only one insertion point, which creates a much easier process for the medical 
personnel, especially since neonates have a minimal number of relatively large blood vessels. The process 





Figure 9. In-phase slider design concept schematic. 
Gravity-Piston 
One concept derived during the brainstorming session is referred to as the gravity-piston mechanism. It is 
powered solely by the force of gravity and obviates the use of a motor. The system consists of a 
cylindrical tank of fresh-blood positioned above the neonate and an empty cylindrical tank with null 
pressure, positioned lower than the neonate and concentric with the fresh-blood tank as shown in Figure 
10 below. Each cylinder is equipped with a piston initially at the top of each cylinder and the pistons are 
linked by a shaft. The neonate has two IV insertion points, one for insertion of blood and the other for 
extraction of blood. The insertion IV is connected to the higher tank of fresh-blood and the extraction IV 
is connected to the blood disposal tank below. The flow from the tank is blocked by a two-way valve until 
the process is ready to begin. A closed two-way valve is outside of the extraction IV until the process is 









The process begins when both valves are manually opened and blood naturally flows from the neonate 
into the disposal tank below which contains a pressure less than that of the neonate’s circulatory pressure. 
The blood flows into the tank and onto the piston initially positioned at the top of the tank. The weight of 
the blood forces the piston down and forces the piston in the high tank down proportionally by means of 
the connecting shaft. This downward force by the piston through the force of gravity pushes the blood 
from the fresh-blood tank through the IV needle and into the neonate’s circulatory system. To prevent the 
volume flow rate from exponentially increasing because of the increasing weight on the bottom piston a 
spring-damper system on the shaft was proposed to be implemented. 
Compressor System 
Another concept derived during the brainstorming session is the compressor system. It is powered by the 
force of gravity and the pressure differences between the neonate’s circulatory system and blood 
reservoirs. The system consists of a bag of fresh-blood positioned above the neonate and a bag for waste-
blood positioned below the neonate. The waste-blood bag is initially a vacuum which would induce a 
natural flow of blood out of the neonate and into the disposal bag. The pressure in the fresh-blood bag is 
initially higher than that of the neonate’s circulatory system to induce a natural flow of blood out of the 
fresh-blood bag and into the neonate. In order for the child not to suffer from a net loss of blood, or from 
a vein rupture due to an excess of blood, the flow rates between the reservoirs of blood and the neonate 
will have to be equivalent. This implies that the pressure difference between the fresh blood reservoir and 
the neonate would have to equal the pressure difference between the neonate and the waste blood 
reservoir. To account for this, the waste-blood bag is equipped with a pressure sensor to detect the 
pressure inside the bag and to sends this information back to a microcontroller. The fresh-blood bag is 
placed in a sealed, rigid container that is equipped with a compressor that is linked to the microcontroller. 
There are also two-way valves outside of both the neonate and the fresh-blood bag to hold back flow until 




Figure 11. Compressor system schematic. 
Automated Four-Way Stopcock 
This system would incorporate the method currently used at the University of Michigan Hospital in the 
neonatal intensive care unit, with a few added features to make the system automated. With this four-way 
stopcock system, there are 3 tubes sprouting off the 3 open holes on the sides of the stop cock. One of the 
tubes is for removing blood from and injecting blood into the neonate, another is for removing blood from 
a fresh blood bag, and the last is for ejecting waste blood into the waste blood reservoir. The fourth part to 
the four-way system is the syringe that is on top of the stop cock that removes and injects the blood 
throughout the procedure. For the manual system, there is a valve that is on the stop cock that gets turned 
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by the doctor/nurse performing the ET when it is time for a new part of the process to take place. The 
concept we designed for this system would incorporate two motors to eliminate the human interaction. 
One motor would be a DC motor to power the pumping system, and the other would be a step motor to 
automatically turn the valve to different positions at the appropriate times. A visual of the manual process 
this system is based off of is provided in Figure 2 (p.10). 
Concept Selection of Full System 
After we developed our top five concepts into more complete designs, we needed to conclude which of 
the five systems satisfied the most customer requirements and engineering specifications. We had 
preliminary intuition that the in-phase slider mechanism would be the best choice of the five concepts, but 
we developed a Pugh chart to back up our intuition with quantified results, depicted in Table 6. Results 
from Pugh chart indicating that the in-phase slider is the best design concept.. We made a list of our most 
important customer requirements, and then compared how each system related to the current method 
being used at KATH for each requirement. If the system improved the customer requirement, a score of 1 
was given for that category. If the system had a negative impact on the customer requirement, a score of   
-1 was given. If the difference was negligible, a score of 0 was given. The scores were added up for each 
system, and the Pugh chart results verified our intuition that the in-phase slider mechanism was the best 
design. (The entire Pugh chart, which includes the criteria in which we evaluated the five designs, is 
provided in Appendix A-5.) 
 
Table 6. Results from Pugh chart indicating that the in-phase slider is the best design concept. 
 











Way Stop Cock 
Σ+ +7 +7 +6 +6 +6 
Σ- -5 -4 -9 -10 -7 
ΣTOT 2 3 -3 -4 -1 
 
 
The out-of-phase slider was a very similar design compared to the in-phase slider. The major negative 
impact of the out-of-phase slider, however, was the requirement of two insertion points. Based on our 
conversation with Robin Jahnke, a nurse from Mott hospital, it is essential that the transfusion system 
requires only one insertion point due to the difficulty of using any insertion point other than the umbilical 
vein in a neonate. Because of this issue, we decided against the out-of-phase slider. 
 
The controller gravity system and the gravity piston system ranked as the worst designs quantitatively. 
They both were designed without a motor, so they fulfilled the inexpensive customer requirement 
compared to some of the other designs. However, both of these systems would have trouble keeping a 
consistent volume flow rate, and both would require medical personnel at KATH to transfer blood from 
the blood bags they are in currently to a special container, which would greatly inconvenience the KATH 
staff. This would also increase the amount of sterilizing that needs to be completed, which could increase 
the potential of transmitting infections. 
 
The automatic four-way stop cock system would be a very easy-to-use system, but two motors would be 
necessary to operate the system. A stepper motor and some sort of servo motor would both be required to 
automate this system. With two motors, cost was a major issue for this system and that ultimately resulted 




The in-phase slider improved on the most customer requirements compared to the negative impacts it 
would have. Some of the key customer requirements the in-phase slider satisfies are: it will allow for a 
controlled volume flow rate with the help of the feedback system, it will be applicable with various 
syringes, it only requires one insertion point, and it could be operable for both blood transfusions and 
exchange transfusions. The main downside of this system is the expense and possible maintenance of the 
high-tech electrical parts, but we feel the advantages significantly outweigh the disadvantages. Because of 
these reasons, we selected the in-phase slider to be our alpha design. 
Sub-Function Concept Generation and Selection 
After performing our first concept generation and selection processes to narrow down which full system 
would be selected as our prototype, we had to conduct a second concept generation process to decide 
which sub-functions would be used for the in-phase slider. A description of the sub-functions considered 
for each problem and the chosen solutions are as follows. 
Driving Mechanism 
When we first designed the in-phase slider, we envisioned a CAM system with a gear/crank and 
connecting rod to move the slider back and forth. However, there was a need for developing other options 
since we had not really explored alternative driving mechanisms. Also, we decided a CAM would be 
extremely impractical for a medical device such as the in-phase slider. After our brainstorming session 
with the discussion section, a method of using a belt or chain instead of the CAM mechanism was brought 
to our attention. A belt or chain would produce a more constant actuation than the CAM would, because it 
would be moving in a linear motion for the majority of its revolution as opposed to a circular motion. 
However, after further research into a possible belt or chain mechanism, we learned that belts are prone to 
a high failure rate and are difficult to maintain and repair. Because of these issues, we decided to again 
look for alternative methods. As we researched further, we found linear actuators online that perfectly 
performed the driving mechanism task that our device would require. A linear actuator moves in a back 
and forth, linear motion and would be able to drive our slider and the syringe plungers in and out, 
removing and inserting blood accordingly. Because we found linear actuators that would be more than 
capable of driving our slider for an affordable price, we selected a linear actuator to be our final driving 
mechanism. 
Volume Flow Rate Detection 
To detect volume flow rate in our system, we originally anticipated using a pressure transducer to detect 
the flow rate outside of the y-junction of our system, just before the blood would enter or just after the 
blood would leave the neonate. We chose this point because it would give the best feedback in terms of 
the actual flow rate entering the child. However, after questioning the feasibility of detecting flow rate 
inside the tubing using a pressure transducer, we decided to explore new options. 
 
Choosing the linear actuator as our driving mechanism actually took care of this volume flow rate 
detection problem, which was another reason we chose it. The linear actuator contains a potentiometer, 
which is used as a position transducer to detect position. Instead of directly detecting volume flow rate, 
the potentiometer will constantly detect the position of the actuator. The microprocessor will then 
calculate the volume flow rate using the position of the actuator, the amount of blood that has been 
inserted or removed, and the cross-sectional area of the syringe being used.  If the actuator ever reaches a 
position faster than it should, the actuation will either stop or slow down to allow the device to get back to 
its intended volume flow rate. 
 
For this application, a pint of fresh blood should be sufficient enough for a neonatal ET; however, an ET 
requiring more than a pint of blood will require the ET device to be set to transfuse one pint of blood. 
After the one pint ET is complete, the medical personnel will then need to reset the ET device to transfuse 
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the remaining amount of blood needed. A current sensor would be ideal for this scenario for it would 
detect leaks, as well as when the fresh blood bag is nearing empty; however, due to the short timeline of 
this project, as well as the lack of funding, it is not incorporated into the design.  
Slider 
We generated numerous ideas for our slider before we reached a final decision. For the slider itself, we 
first created a CAD drawing of a block-shaped slider using CATIA. We then developed an appropriate 
holder that would allow the slider its necessary movement, and also hold the syringes in place so that only 
the syringe plungers would be able to move along with the slider. We first designed the holder to have 
circular grooves that the syringes would fit into, but upon discussing manufacturing and stability with 
Bob Coury, we changed the grooves to triangular slits. 
 
A second generation process of the slider and holder brought us to the idea of purchasing a track used for 
opening and closing a desk drawer. Upon finding an inexpensive ball-bearing track made of stainless steel 
online, we decided to purchase that to allow the movement of the slider. The cost of purchasing the 
stainless steel track was a small amount greater than what manufacturing the block slider would have 
been. However, we concluded that the manufacturing time saved would be more beneficial to our team. 
Once we purchased the track, we made a new CAD of a simpler slider that will allow for the attachment 
of the syringes. We plan on using rapid prototyping to manufacture this slider. 
 
The ball-bearing track will need to be protected from debris and fluids to insure that the track does not 
become corroded and rusted. To insure that the ball-bearing track is not impacted by debris and fluids, the 
track will need to be encased. The ET device including the linear actuator, syringe holder, and slider, will 
be encased by walls, which are described in detail in the “Fabrication” section below; however, the track 
may need its own encasing to prevent corrosion. 
 
To hold the syringes in place in the grooves of the holder, we first developed the idea of using some kind 
of vice-grip mechanism. This would prevent unacceptable movement and rotation of the syringes, but the 
possibility of compressing and damaging the syringes if the vice-grip was tightened too much resulted in 
this method not being chosen. Using straps such as nylon backpack straps to hold the syringes in place 
was also an idea we generated, but the risk of slipping would be too great for a device such as ours. ¼”  
plate of Plexiglas will be used to hold down the syringes and prevent them from rotating and translating. 
Since various sized syringes will be applicable for this device, a porous material will be fixated to the 
plate of Plexiglas and to a piece of PVC. The porous material will allow syringes of various sizes to fit for 
the porous material will allow the top plate holding the syringes to adjust its height as needed. A butterfly 
nut will then be used to tighten the syringes in place as desired. The instructions for the device will direct 
the medical personnel to tighten the butterfly nuts so that a snug fit exists between the Plexiglas top place 
and the syringes. The butterfly nuts should not be overly tightened to prevent the PVC and Plexiglas from 
wear. Because this design resulted in the least amount of anticipated issues between our three concepts 
generated, we decided to choose it as our method to secure the syringes to the holder. 
Concept Description—Alpha Design 
The in-phase slider mechanism is an exchange transfusion system utilizing a one-way valve 
configuration, a dual-syringe pumping mechanism, and one IV insertion point into the neonatal umbilical 
vein. One main objective of the in-phase slider ET device is to eliminate the necessity of having personnel 
present to manually perform syringe-pumping and valve-turning. Another main objective of the alpha 
design is to reduce the total number of syringe strokes for completion of a full exchange transfusion 
process. A third main objective of the alpha design is to have a system that eliminates the human factor 
when inserting blood into the patient by having a constant blood volume flow rate in and out of the 




The configuration begins with an IV insertion point which consists of a 23-gauge needle into the 
umbilical vein connected to a 16-outer diameter gauge catheter within the umbilical cord. The catheter 
leads out of the umbilical cord to a three-way junction which splits the blood flow into two directions. In 
one direction is a waste-blood suction syringe and waste-blood disposal bag. In the other direction is a 
fresh-blood suction syringe and fresh-blood bag. Both waste-blood and fresh-blood sides of the system 
contain three-way junctions between the respective bag of blood, the respective suction syringe, and the 
initial three-way junction just outside of the umbilical cord. All junctions in the system are open to the 
flow in both directions. Equipped on two of the three sides of each junction are disposable one-way 
valves configured in a way to allow functioning of the system and to eliminate the need for manual 
toggling of the three-way junctions. Refer to Figure 12 for an embodiment of the configuration just 
described (p.28).  
Process Description 
The ET process is prefaced by priming the entire system with the blood intended to be transferred. The 
tubing, junctions, and valves need to be filled with blood before the process begins. The suction syringes 
also begin in their fully compressed position and operate simultaneously and in-phase with each other. 
Both syringe heads are connected to a slider mechanism which operates in the same direction as the 
syringe plunger and is powered by a CAM mechanism with a gear/crank and arm. Attaching the syringe 
heads to the same slider allows the syringes to operate simultaneously and in-phase with each other. 
 
The cycle begins when the slider, and thus the syringe plungers, move back and the syringes intake fluid 
into their bodies. On the side with the fresh blood bag, fresh-blood is removed from the bag past the one- 
way valve and into the syringe. During this phase, blood is not removed from the neonate with this 
syringe because of the one-way valve configuration. On the side with the waste-blood bag, waste-blood is 
removed from the neonate past the initial three-way junction, and into the syringe. During this phase 
blood is not removed from the waste-blood disposal bag because of the one-way valve configuration. This 
phase continues until the syringe plungers are fully extended back and the syringes are full with their 
respective fresh-blood and waste-blood.  
 
The next phase of the cycle begins when the slider, and thus the syringe plungers move forward and the 
syringes force fluid out of their bodies. On the side with the fresh-blood bag, fresh-blood in the syringe is 
forced out past both three way junctions and into the neonate. During this phase fresh-blood is not forced 
back into the fresh-blood bag because of the one-way valve configuration. On the side with the waste-
blood bag, waste-blood in the syringe is forced out into the waste-blood disposal bag. During this phase 
blood waste-blood is not forced back into the neonate because of the one way valve configuration. This 
phase continues until the syringe plungers are compressed all the way and the syringes are empty of all 
their respective fluids. When this phase completes, the first phase begins again, and the cycle repeats. 
Driving Mechanism 
The driving mechanism of the slider is powered by a stepper motor which is energized and controlled by a 
microcontroller. A stepper motor was chosen over a servomotor because our system does not need a high 
speed motor to drive a 5 mL/min blood flow rate. The torque that the slider will require can be 
sufficiently provided by a stepper motor. Stepper motors are also used for their accuracy in low torque 
systems. Given the low amount of torque that the slider will ultimately need to drive the syringes, a 
stepper motor will be sufficient. The motor shaft will provide torque to a crank and a connecting rod will 
transmit the rotational torque into a translational force to move the slider. The microcontroller will have a 
user input in terms of blood volume flow rate output by the syringe, thus allowing flow rate to be 












Blood Volume Flow Rate Control 
A negative feedback, closed-loop control is included in the alpha design. The output blood volume flow 
rate will likely be less than the user inputted value due to energy losses between the stepper motor and the 
syringes. An electronic pressure transducer will read the pressure at the junction just outside of the 
umbilical vein and feed the signal back to the microcontroller. The pressure reading will be converted to a 
blood volume flow rate by the microcontroller using the tubing geometry. Then a proportional control 
will increase (or decrease) the power to the stepper motor, thus closing the gap between the inputted and 
outputted blood volume flow rates. (A proportional-derivative control and a proportional-integral-
derivative control are being investigated as well.) The feedback control will also allow for compatibility  
with different syringe and tubing sizes and eliminate the need for blood volume flow rate to be a function 
of geometry. The feedback system will allow an automatic shutoff process to be implemented into the 
system as well. 
Engineering Analysis 
The following section will provide the vital analyses that must be completed to create a functional 
prototype. 
 
Rigid Body Kinematics and Dynamics 
The input to the pumping mechanism is ultimately the speed and torque of the motor. The volume flow 
rate is also directly proportional to the velocity of the slider. These two relationships can be 
interconnected using kinematics. A kinematics model will provide a relationship between the motor speed 
and the flow rate (i.e. the speed of the slider), which is essential when developing a feedback system 
based on the volume flow rate. The schematics of the motor would also be necessary to analyze the 
kinematic model. The relationship between the motor speed and the flow rate will be needed to determine 
the force analysis on this system. 
 
For our design, it would be preferred that the power consumption is minimal; therefore the torque-angular 
velocity of the motor must be minimized as well.  This would reduce the amount of power needed to be 
supplied by the motor , which would reduce the cost of the entire system. 
 
Fluid Dynamics 
Determining a model for the fluid flow is also a key element in our design. Since the flow rate is the key 
quantity that needs to be controlled, this should be the key element that should be analyzed. To analyze 
fluid flow within the tubing of the alpha design, a fluid flow model can be incorporated. A fluid flow 
model relates the fluid properties (i.e. density, viscosity) and the flow rate of the fluid. Before such an 
analysis can be completed, it is essential to determine whether the flow within the tubing is laminar or 
turbulent. Reynolds number (Re) can be utilized to determine the type of flow. Re is determined in 
equation 1 below , where ρ is the density of the fluid, V is the mean fluid velocity, D is the diameter in 
which the fluid flows, and µ is the dynamic viscosity of the fluid. 
 
 (Eq. 1) 
 
From Reynolds number, we determined that there would be laminar flow. Since the blood flow is laminar, 





 (Eq. 2) 
 
where ΔP is the pressure drop across a tube of length L and diameter D. 
 
Modeling vs. Testing 
Our first modeling endeavor will be a virtual simulation software such as Adams developed by MSC. This 
will give us a force analysis and will be able to tell us whether our forces are reasonable. 
 
After the prototype is built, testing between the voltage of the motor and the output flow rate of the fluid 
will be conducted. This will be our most critical relationship. Since our actual motor will be a stepper 
motor rather than a servo motor, a comparison of the model with the actual system will be paramount. We 
will compare these results with our transfer function and make necessary changes.  
 
Our next test will be to test the controller by manually changing the voltage of the motor and testing to 
see if the controller will correct the disturbance. 
 
Design Drivers 
Absolute design drivers consist of the motor and its transfer function. A motor that can actually drive the 
system is essential for it is what makes the system “automated.” The motor must be able to function with 
the transfer function given by the feedback system. The transfer function is ultimately keeping the flow 
rate at the required value; therefore, it is vital to insure that the modeling is correct. Every other design 
requirements such as dimensions, power supply, and material will be determined off of this. 
Parameter Analysis 
The following sections will discuss the engineering analysis conducted on each component of our device 
to determine its potential success before manufacturing or purchasing took place. A thorough engineering 
analysis of the automated ET design was performed by evaluating basic engineering principles. (i.e. A 
stress analysis and a fracture analysis were performed on the components that would experience large 
loads.) The engineering analysis is quite basic because the device is relatively simple, and minimal forces 
and pressures are exerted within the system. 
Mechanical Components 
 
Linear Actuator: To measure the force required to move the syringe plunger in and out, we performed 
several tests in Professor Gillespie’s lab using a force transducer. We used a vice to hold the syringe in 
place, and then pushed in the plunger when it was fully removed with the force transducer at a constant 
rate. We performed this experiment several times for each syringe, and tested approximately 5 different 
types and sizes of syringes. The maximum force required to push the most difficult plunger in was 
approximately 3 N. We used a factor of safety of 3 to account for additional frictional forces that would 
need to be overcome because of the slider, and also because removing the plunger was more difficult than 
pushing in the plunger. We were not able to measure the force required to remove the plunger because of 
equipment limitations (i.e. the force transducer could not perform this measurement). With this factor of 
safety, we concluded that we would need a driving mechanism capable of at least 10 N of force, or 2.25 




Beyond measuring the plunger force of several syringes, we also measured the plunger length for each 
syringe using a pair of calipers. The biggest and longest syringe to be used with our device is a 25-mm 
syringe; therefore, we measured the plunger length of that syringe to determine the requirement of 
actuation for our driving mechanism. The plunger length for the 25-mm syringe was approximately 4 in, 
so we concluded that an actuation of at least 5 in. would be sufficient for our driving mechanism. 
However, we didn’t want the driving mechanism to take up unnecessary space because minimizing the 
size of the device was one of our key customer requirements, so we also wanted to keep the actuation 
capability under 6 in. 
 
After performing this parameter analysis on our syringes, we conducted online research to find the 
cheapest linear actuator we could find that met our minimum requirements. After extensive research, the 
best linear actuator for our system was found on www.surpluscenter.com. This linear actuator (Model 
Number LACT6P) has a 5.90 stroke length and a 107 lb. force capability. The stroke length was ideal for 
the actuation range we were hoping to find, and the 107 lb. force capability easily exceeds the minimum 
2.25 lb. force required. This linear actuator was purchased for 79.95 USD, and satisfies all parameter 
analysis requirements for our driving mechanism. It also eliminates the need for a motor as one is built 
into the linear actuator already, thus it greatly helps with cost efficiency. The purchased linear actuator 
also contains a built in potentiometer, which will be utilized for measuring the volume flow rate of the 
system. 
 
Track: A ball bearing track is utilized in the final design because a ball bearing track will prevent 
toggling between the slider and the track. Previously, a track consisting of two slots was designed, which 
is illustrated in Figure 13 (p. 32); however, after much analysis, the design had a great risk of failure due 
to toggling. We decided to use a ball bearing track made of steel, which is depicted in below (p. 32). A 
full analysis of the ball bearing track is provided in the sections below. 
 
Friction: Friction is a major concern especially since the friction of the track will impact the blood 
volume flow rate. Since roller bearings are utilized in the track, the coefficient of rolling must be 
evaluated. 
Assuming the worst case scenario where the frictional force is at a maximum, the maximum coefficient of 
friction can be determined. The maximum force due to friction will occur when the linear actuator is 
operating at its maximum force. The maximum force (Fmax) utilized by the linear actuator is 10 N.  
 
 (Eq. 3) 
 
Equation 3 above expresses that the maximum frictional force (Ff) is equivalent to the force needed to 
move the slider (Fneeded) subtracted from the maximum force utilized by the linear actuator (Fmax). 
Assuming the standard friction relationship, then Eq. 4 below can be applied 
 
   (Eq. 4) 
 
where μ is the coefficient of friction and Fnormal is the normal force acting on the track. By combing Eq. 3 
and Eq. 4 on can acquire the maximum coefficient of friction (μmax) by means of Eq. 5 below. 
 
  (Eq. 5) 
 
For calculations specific to the final design, a maximum force of 10 N, a force needed of 3 N and the 
weight of the slider on top of the track being no more than 2 N provides a maximum allowable coefficient 







Figure 13. Previous track design, which was 
eliminated due to its high risk of toggling. 
 
 
Figure 14. Ball bearing track design utilized 
in the final design. 
 
The coefficient of friction for the rolling slider (μroll) is defined in Eq. 6 below 
 
  (Eq. 6) 
 
where RF is the rolling friction constant on the stainless steel and r is the radius of the rollers. RF for 
stainless steel is 0.039, while the r of the rollers is 0.40 mm. From this calculation, the μroll equals 0.0978, 
which is much less than the 3.5 maximum. 
 
Toggling: Toggling is a major concern when dealing with sliding mechanisms. Toggle is due to high 
tolerances between moving parts, as well as high friction that could result in slipping.  
The rolling slider is manufactured to have to have side walls on in all directions to ensure the slider will 
move only in the direction of the track. Through visual inspection the tolerances of the slider are far finer 
than those that could have been attempted from us in the shop; therefore, toggle will not be a problem 
with the track. 
 
Slider: There are two modes of failure for the slider: fracture and yield due to bending. The fracture and 
bending of the slider will be evaluated. 
 
Bending: The maximum bending moment would occur if there were a point load on the very end of the 




Figure 15. A 3D model illustrating the 
location of the maximum bending moment.
 
 
Figure 16. A layout of the slider’s triangular 
cross-section.
 
To solve for the maximum bending moment at any arbitrary distance (x) from the point of the triangle as 
depicted in Figure 16 above. The base (b) of the cross sectional area becomes a linear function of x with 
the relation based on similar triangles depicted in Eq. 7 below. 
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 (Eq. 7) 
 
The thickness (t) of the cross sectional area remains constant. The area moment of inertia (I) for any 
arbitrary cross-sectional area would have the following form (Eq. 8): 
 
 (Eq. 8) 
 
By taking a point load (P) at the tip of the triangle, the moment at any arbitrary point x down the triangle, 
would be equal to Px. The maximum bending stress (σbs)  felt at each cross-sectional area would have the 
form following form: 
 
 (Eq. 9) 
 
where M is the moment and c is the distance from the center of the cross-sectional area to the top edges 
which is equivalent to half the thickness. At any arbitrary distance x down from the tip of the triangle, the 
maximum bending stress would be as depicted in Eq. 10 below. 
 
 (Eq. 10) 
 
To determine the maximum bending stress, a risk factor of 3 was multiplied into Eq. 10 above. From Eq. 
10, it was determined that the σbs will equal 1.06 MPa; therefore, the yield strength material property 
must be greater than the maximum bending stress. The slider is being made from ABS, which has a yield 
strength of 41 MPa, which will exceed expectations.  
 
Fracture mode: Another failure mode could be due to crack fracture. A basic, first approximation would 
be to simplify the triangle holder with a plane stress mode of the order equivalent to the 1.06 MPa 




Figure 17. Worst possible crack scenario for the slider’s triangle face 
 
If the worst case scenario is assumed (depicted in Figure 17above), where an inherent crack already exists 
in the material that is 40% the width of the material then the resulting minimum fracture toughness 
required by the material can be determined using Eq. 11 below. 
 
· √ · 0.40 · 1.06 · · 0.40 · 3.175 · 10 0.0670  √   (Eq. 11) 
 
The fracture toughness of ABS plastic is 3.23 MPa√  , which is much great than 0.0670 √ ; 
therefore, the design will not fail due to crack fracture. For Ghanaian production, the slider should be 
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manufactured out of PVC, a readily available material in Ghana. (Please Reference Appendix D for a 
thorough material analysis.) 
 
Full Mechanical Sub-System: The mechanical portion of our design has to weigh less than a specified 
value as well as be smaller than a specified volume. 
 
Weight: The material used to create the mechanical subsystems is limited based on the weight constraint. 
The mechanism must weigh less than 65 N. If the worst case scenario is assumed, where the entire ET 
mechanism is made of the same material, then the maximum density can be determined using the total 
volume of the system as well as the targeted weight requirement. The maximum density of the material 
will provide a density specification, which can be utilized to find a viable material. For the final design, 
Cambridge Engineering Software was used to determine a sufficient material. 
 
The weight of the motor (13.2 N) and the track (2.2 N) are known; therefore, the maximum density can be 




  (Eq. 12) 
 
where the WeightTarget is the target weight of the system, or 65 N in this case, RF is the safety factor of 
1.2, Track is the weight of the track, Motor is the weight of the motor, Vtotal is the total volume of the 
material that makes up the system (2.51·10-3m3 for the housing and less than 0.23·10-3m3 for all of the 
components for a total of 2.74·10-3m3), and g is the gravitational acceleration (9.8 m/s2). From Eq. 12, the 
maximum allowable density is 1442 kg/m3.  
 
Both materials being used in the prototype and final design, ABS plastic and PVC, fit material 
requirements.  ABS plastic has a density of 1,135 kg/m3 and PVC has a density of 1,400 kg/m3which are 
both less than 1442 kg/m3. For Ghanaian production, the slider, syringe holder, and casing should be 
manufactured out of PVC, a readily available material in Ghana and the casing. (Please Reference 
Appendix D for a thorough material analysis.)  
 
Electrical Components 
There are various electrical components involved in the operating system of the automated ET device. 
The operating system will allow functionality based on various user inputs, such as the required blood 
volume flow rate, amount of blood of be exchanged, and the volume of the syringes. The operating 
system will also allow the system to function based on feedback; therefore, insuring that the ET device 
functions at the correct rates and requirements. The schematic of the electrical system is provided in 
Appendix E-1. The electrical system contains the following components: the microprocessor, the 
oscillator, the Universal Serial Bus (USB), the linear regulator, the LCD, the power plug, the LED, the 
buzzer, the mini header, the motor driver board, the microSD, the rotary encoders, the motor, and the 
potentiometer. From the schematic of the electrical system, a circuit board diagram was created by 
placing the electronic components correctly on the circuit board. The circuit board diagram is illustrated 






Figure 18. Front and back view of the circuit board diagram. 
 
Microprocessor: The main component of the operating system is the microprocessor. The 
microprocessor is the central processing unit (CPU), which controls the logic of the device. The 
microprocessor consists of various interfaces. The control unit of the microprocessor functions based on a 
set of instructions, which orchestrates the operations of the other units. The execution path taken by the 
control unit can depend upon the status bits produced by the various input components. The 
microprocessor also serves as a memory interface, thus allowing programs and data to be stored. The 
microprocessor involves an interrupt or exception controller, which enables the microcontroller to 
respond to requests from the external environment or to error conditions by allowing interruption of the 
ongoing process. The interrupt/exception controller will detect system malfunction, as well as the end of 
cycle; therefore, the interrupt/exception controller will yield all operations and sound an alarm to inform 
the medical personnel. To insure the microprocessor functions correctly, instructions will be programmed 
into the microprocessor using C programming language. There are various types of microprocessors, 
which vary primarily based on the number of bits the processor operates on at one time. Cost and the 
number of bits are the two main concerns in determining the optimal microprocessor for the automated 
ET device design. Based on these two concerns, the PIC32MX440F512H microprocessor was determined 
to be the optimal microprocessor for our design. It is a 32-bit flash microcontroller. (The specifications of 
the micrprocessor are provided in Appendix E-2.) 
 
Oscillator: The electronic oscillator acts as a frequency control. The electronic oscillator provides an 
output frequency of 4 MHz to the microprocessor, which amplifies the frequency of the microprocessor. 
The amplification of the microprocessor frequency acts as an electronic filter, which filters out noise 
travel created by the electromagnetic devices. A schematic of the electronic oscillator is provided in 
Figure 19 on page 35. The oscillator (part number SIT8002AI-23-33E-4.00000T) was chosen based on its 
frequency output, as well as its ability to operate with 3.3 V. (The specifications of the oscillator are 




Figure 19. Electronic schematic of the oscillator. 
 
Universal Serial Bus (USB) Connector: The Universal Serial Bus (USB) connectors enables the 
microprocessor to be connected to a host computer; therefore, allowing the microprocessor to be 
reprogrammed. The schematic of the USB is depicted in Figure 20 below. The USB is connected to the 
microprocessor through the “USB D+” and “USB D-” connectors, which is depicted in Fig. # (p.#). USBs 
also provide power to low-consumption devices; therefore, the USB outputs 5V into the circuit, which is 
depicted in Figure 21 below. The 5V output is connected to the linear regulator. The USB is also 
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grounded. USB connectors are fairly standards; therefore, a USB connector with five circuits, with a SMT 
solder tail, and of minimal size was chosen. The specifications of Model 538-67503-1020 USB 









Figure 21. USB connector used in circuitry.
Linear Regulator: The linear regulator acts as a voltage regulator. The linear regulator is made to act like 
a variable resistor, continuously adjusting a voltage divider network to maintain a constant output voltage. 
The linear regulator used is a shunt regulator, which operates by way of the Schottky diode’s action of 
maintaining a constant voltage across itself when the current through it is sufficient enough. The Schottky 
diode is a semiconductor diode with a low forward voltage drop and a very fast switching action. A 
normal diode has between a 0.7 and a 1.7 voltage drop, while a Schottky diode voltage drop is between 
approximately 0.15 and 0.45—this lower voltage drop translates into a higher system efficiency. The 
voltage output of 5V from the USB connector is input into the linear regulator, where it is then converted 
to 3.3V before being outputted into the microprocessor. (The schematic of the linear regulator is depicted 
in Figure 22 on page 36.) 
 
 
Figure 22. Electronic schematic of linear regulator. 
 
The Schottky diode was chosen primarily due to its high efficiency. Schottky diode part number 
MSS1P4-E3/89A is used in the circuitry of the automated ET device. (The specifications of the Schottky 
diode are depicted in Appendix E-5.) The linear regulator used for the automated ET device is part 
number SI9183DT-33-T1-E3-3.3V, which provides a maximum voltage output of 3.3 V, a maximum 
current output of 150 mA, and a dropout voltage of 135 mV. This linear regulator is ideal because it 
outputs 3.3 V, which is the voltage required by the microprocessor. (The specifications of the linear 
regulator are illustrated in Appendix E-6.) 
 
Liquid Crystal Display (LCD): A liquid crystal display (LCD) is an electronically-modulated optical 
device shaped into a thin, flat panel made up any number of color or monochrome pixels filled with liquid 
crystals and arrayed in front of a light source or reflector. An LCD will be utilized to display various 
values, such as the volume flow rate and the amount of blood transfused. A 16 character by 2 line display 
with a blue background and a yellow backlight was chosen to display important data. LCD part number 
GDM1602K was chosen primarily due to its low cost and its capability of showing 32 characters on its 
screen. The LCD is illustrated in Figure 23 below. The electronic schematic of the LCD is depicted in 
Figure 24 below. All of the inputs and outputs of the LCD are connected to the microprocessor, except for 
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Figure 24. Electronic schematic of the LCD. 
 
Power plug: The automated ET device will be powered by AC power; therefore, the AC power must be 
converted to DC power. The power plug encompasses the following two components: the AC adapter and 
the DC power jack. The AC adapter, depicted in Figure 25 (p. 37), will convert the input voltage of 120 
VAC to 12 V DC. The AC adapter is then connected to the DC power jack, depicted in Figure 26 (p. 37), 
which transfers the 12V DC to the circuitry. For this device to be compatible with Ghanaian power 
outlets, an AC adapter will need to be of the correct orientation. The AC Adapter will also need to convert 
the 220 V, 50 Hz AC power to 12 V DC power. For Ghanaian use, the AC Adapter (Part number 





Figure 25. AC adapter used to convert AC 











The microprocessor cannot handle 12 V; therefore, a rectified diode and a voltage regulator are 
implemented into the circuitry to decrease the voltage output. A rectifier diode is employed to convert AC 
current to DC current. The rectifier diode part number NRD4001 was chosen primarily based on cost and 
functionality. (The specifications of the rectifier diode are provided in Appendix E-8.) The voltage 
regulator serves the purpose of automatically maintaining a constant voltage level. The voltage regulator 
must output a voltage of 5V; therefore, voltage regulator part number L7805CD2T was chosen for this 
application. Voltage regulator part number L7805CD2T outputs a current of 1.5A and a voltage of 5V. 
This regulator also provides short circuit protection, as well as thermal overload protection. (The 
specifications of the voltage regulator are provided in Appendix E-9.) The voltage regulator then outputs 
5V to the LCD. The schematic of the power plug and voltage regulator is provided in Figure 27 below. 
Part number PJ-202A was utilized as the DC power jack. (The specifications of the DC power jack are 




Figure 27. Electronic schematic of power plug. 
 
Light Emitting Diode (LED): A light emitting diode (LED) is an electronic light source. The LED will 
be used to inform the user whether the device is on, off, or has completed its cycle. In order to indicate the 
three settings of the system, a two color LED will be required. The chosen LED (part number CMD15-
22SRUG) emits the colors red and green through a clear lense; therefore, the LED will not emit any light 
when the power is off, the LED will be programmed to emit green when the device is running, and lastly, 
the LED will be programmed to emit high energy red when the device has completed its cycle. The LED 
will be connected to the microprocessor through the following two main connections, which are depicted 
in Figure 28 (p. 38): 100 Soft LED and 100 Soft LED2. The microprocessor will supply 3.3V to operate 




Figure 28. Electronic schematic of the LED. 
 
Buzzer: The buzzer will sound at the end of the process to notify medical personnel. The buzzer chosen 
for this application utilizes a transistor. The buzzer sounds based on the actuation of the transistor by a 
frequency of 2 kHz. The continuous connection and disconnection of the transistor creates a vibration 
effect, which produces approximately a 95 dB sound. The transistor connects and disconnects by means 
of the “BUZSIG” connection illustrated in Figure 29 below. (The specifications of the transistor are 
provided in Appendix E-12.) A magnetic buzzer (part number CEM-1203) was utilized for the automated 
ET device because it could be easily implemented into the circuitry. (The specifications of the magnetic 






Figure 29. Electronic schematic of the buzzer. 
 
Mini Header: The mini header provides the source code used to program the microprocessor. Although 
the microprocessor can be reprogrammed through the use of the USB connector or the card connector 
microSD, the mini header provides the initial code used to program the microprocessor. The mini header 
operates from a voltage source of 3.3 V. The mini header then outputs the source code to the 
microprocessor, which is illustrated in Figure 30 below. The mini header (part number 2211S-08G) was 
chosen based on its compatibility with the microprocessor. (The specifications of the mini header are 




Figure 30. Electronic schematic of the mini header. 
 
Motor Driver: The motor driver controls the motor by means of starting and stopping the motor, 
selecting forward or reverse rotation of the motor, selecting and regulating the speed of the motor, 
regulating or limiting the torque of the motor, and protecting the motor from overloads and faults. The 
motor driver is connected to the motor through the “Motor +” and “Motor -” connections depicted in 
Figure 31 (p. 39). The motor driver operates with a maximum power voltage of 15 V; therefore, both the 
12 V DC source and the 3.3 V source are utilized in powering the motor driver. The motor driver is then 
connected to the microprocessor through the “MotorPWM,” “MotorDir2,” and “MotorDir1” connections 









Figure 32. Motor driver used to control the 
DC motor.
 
The microprocessor is responsible for instructing the motor driver, in which the motor driver then alters 
the motor parameters as indicated by the microprocessor. The motor driver (part number TB6612FNG), 
illustrated in Figure 32 above, was chosen based on its voltage operating range of 4.5 to 15.0 V, its peak 
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output current of 3.2 A, and its cost. (The specifications of the motor driver are provided in Appendix E-
15.) 
 
Card Connector MicroSD: A card connection microSD (illustrated in Figure 33 below) will be utilized 
much like that of the USB connector. The card connector microSD acts as a backup method for 
reprogramming the microprocessor. The card connector microSD is powered by 3.3 V as depicted in 
Figure 34 below. The card connector is then connected to the microprocessor through the following 
connections as illustrated in Figure 34 below. : “SPI_DO_3,” “SPI_CLK_3,” “SPI_DI_3,” and 
“SPI_CS_3.” These four connections are utilized to reprogram the microprocessor. The card connector 
microSD (part number 2908-05WB-MG) primarily based on its cost. (The specifications of the card 










Figure 34. Electronic schematic of card 
connector microSD.
 
Rotary Encoders: A rotary encoder is an electro-mechanical device used to convert the angular position 
of a shaft to an analog or digital code. Three rotary encoders are used for user input. The rotary encoders 
will allow the user to turn the device on and off, as well as input the optimal blood flow rate, the total 
volume of blood to be exchanged, and the minimum and maximum positions the linear actuator will need 
to move to insure that exactly one full stroke is achieved. The rotary encoders output data to the 
microprocessor through the “ROTA,” “BTN,” and “ROTB” connections illustrated in Figure 35 below. 
Rotary Encode (part number RE130F-41-175F-12P), illustrated in Figure 36 below, was chosen primarily 













Figure 36. Rotary encoder used by medical 
personnel to set ET parameters.
Motor: The DC motor is provided with the linear actuator. The DC motor has two connection points in 






Figure 37. Electronic schematic of the motor. 
 
Potentiometer: The potentiometer is also provided within the linear actuator. The potentiometer serves 
great importance within the automated ET device because it determines the distance the plunger has 
travelled within a given amount of time. The microprocessor can then take the given distance and time, 
and calculate the volume flow rate. Based on this volume flow rate, the microprocessor can then instruct 
the motor driver to either slow down or speed up the motor speed. A schematic of the potentiometer is 




Figure 38. Electronic schematic of the potentiometer. 
Medical Components 
A majority of the medical supplies utilized by the automated ET device will be provided by KATH; 
however, the medical supplies offered at KATH are unavailable for the purpose of experimentation and 
analysis. Medical supplies similar to those provided by KATH must be employed to determine 
functionality of the automated ET device. The following medical supplies are available at KATH: 
syringes, tubing, catheters, needles, and IV bags. These medical supplies are fairly standard; therefore, the 
functionality of the automated ET device should not be affected by the use of slightly different medical 
supplies than those provided at KATH. For the automated ET device to function properly, the following 
two medical components must also be implemented at KATH: one-way valves and Y-connectors. 
 
Syringes: Syringes vary geometrically and dimensionally from manufacturer to manufacturer. Syringes of 
the same volume are typically very similar in size and shape; however, there often slight discrepancies 
between syringes coming from different suppliers. Due to the inconsistencies between manufacturers, the 
automated ET device will accommodate all 20-25 mL syringes. The prototype will be tested with a 
variety of 20 and 25 mL syringes to insure that the syringes at KATH will be compatible with the 
automated ET device. 
 
Tubing: KATH presently uses tubing with an inner diameter (ID) of 2.5 ± 0.5 mm when performing a 
neonatal ET. To insure that the tubing at KATH will be compatible with the automated ET device, tubing 
with an inner diameter of 2.5 mm will be utilized in the system. The 2.5 mm ID tubing was donated by 
DirectMed. 
 
Catheters: Assistant Professor Kathleen Sienko acquired a catheter from KATH during her visit to Ghana 
in February 2009; therefore, the acquired catheter will be implemented into the automated ET system. If 
the catheter fails, Robin Jahnke provided us with a couple catheters from the neonatal ET package, which 
can be implemented if needed. The catheter should not affect the volume flow rate of the blood; therefore, 
the slight discrepancies between the catheter used for the prototype and the catheter used at KATH should 




Needles: KATH presently uses 21 or 23 gauge size needles when performing a neonatal ET; therefore, 
the automated ET device prototype must also be tested with 21 and 23 gauge size needles. Assistant 
Professor Sienko also acquired needles from KATH during her visit to Ghana; therefore, these needles 
will be utilized in the automated ET system. 21 and 23 gauge needles are standard sizes, which will make 
it easy to acquire more needles if needed. 
 
IV bags: IV bags are presently used at KATH to dispose of the waste blood; therefore, an IV bag will be 
needed for the automated ET system. An IV bag does not affect the performance of the exchange 
transfusion. The IV bag must be large enough to accommodate all of the waste blood and it must connect 
to the system properly to insure that the blood does not leak from the system. 2 Liter Graduated IV Bags 
(Model Number BA-006) IV bags are being provided by DirectMed, which will be utilized in the 
automated ET system. 
 
One-way (check) valves: One-way valves must be implemented into the automated ET system to prevent 
the fresh blood from mixing with the waste blood. One-way valves are not currently available at KATH; 
however, one-way valves must be implemented to insure the proper function of the automated ET device. 
Due to the extremely small tubing being used, the one-way valves must mate with the tubing. The one-
way valves utilized by the automated ET device have a 3.175 mm diameter; therefore, the one-way valves 
will act as the female component (surrounding the tubing—the male component). The tubing and the one-
way valves should mate properly because the tubing has an inner diameter of 2.5 mm; therefore, the outer 
diameter of the tubing will exceed 2.5 mm coming very close to 3.175 mm. The one-way valves (Model 
Number AG090312, Item Number 64046) are being supplied by the United States Plastic Corporation. 
 
Y-connectors: Y-connectors are required to insure the functionality of the automated ET device. The Y-
connector provides a junction between the fresh blood and waste blood insert, which insures that the 
neonate only needs one IV insertion point. The Y-connectors will also be used to connect the blood bags 
to the automated ET device. The Y-connectors will have an inner diameter of 2.5 mm to insure a tight 
connection between the Y-connector and the 2.5 mm ID tubing. The Y-connector will be a male 
component; therefore, it will insert into the tubing. Y-connectors (Model Number CY-001) are being 




Figure 39. Model CY-001 Y-connector provided by DirectMed. 
Final Design Description 
Our design consists of both mechanical and electrical subsystems. The purpose of the mechanical 
subsystem is to actuate the syringe plungers and cause the flow of blood to and from the patient. A 
secondary mechanical subsystem is that of the blood pathway between the syringes, blood bags, and 
patient. The blood pathway subsystem is a unique configuration of tubing, one-way valves, and a Y-
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junction connectors. The purpose of the electrical subsystem is to power and control the linear actuator 
and its function of driving the mechanical sliding mechanism. The result of the three subsystems is a 
mechatronic system that completes the overlying objective of exchanging the blood of a neonatal patient. 
A diagram of the entire system is depicted in Figure 44 on p.46. 
System Configuration 
The configuration begins with an IV insertion point which consists of a 23-gauge needle into the 
umbilical vein connected to a 16-outer diameter gauge catheter within the umbilical cord. The catheter 
leads out of the umbilical cord to a three-way junction which splits the blood flow into two directions. In 
one direction is a waste-blood suction syringe and waste-blood disposal bag. In the other direction is a 
fresh-blood suction syringe and fresh-blood bag. Both waste-blood and fresh-blood sides of the system 
contain three-way junctions between the respective bag of blood, the respective suction syringe, and the 
initial three-way junction just outside of the umbilical cord. All junctions in the system are open to the 
flow in both directions. Equipped on two of the three sides of each junction are disposable one-way 
valves configured in a way to allow functioning of the system and to eliminate the need for manual 
toggling of the three-way junctions. Refer to Figure 44 for an embodiment of the configuration just 
described (p.46).  
Process Description 
The ET process is prefaced by priming the entire system with the blood intended to be transferred. The 
tubing, junctions, and valves need to be filled with blood before the process begins. The suction syringes 
also begin in their fully compressed position and operate simultaneously and in-phase with each other. 
Both syringe heads are connected to a slider mechanism which operates in the same direction as the 
syringe plunger and is powered by a linear actuator. Attaching the syringe heads to the same slider allows 
the syringes to operate simultaneously and in-phase with each other. 
 
The cycle begins when the slider, and thus the syringe plungers, move back and the syringes intake fluid 
into their bodies. On the side with the fresh blood bag, fresh-blood is removed from the bag past the one-
way valve and into the syringe. During this phase, blood is not removed from the neonate with this 
syringe because of the one-way valve configuration. On the side with the waste-blood bag, waste-blood is 
removed from the neonate past the initial three-way junction, and into the syringe. During this phase 
blood is not removed from the waste-blood disposal bag because of the one-way valve configuration. This 
phase continues until the syringe plungers are fully extended back and the syringes are full with their 
respective fresh-blood and waste-blood. 
 
The next phase of the cycle begins when the slider, and thus the syringe plungers move forward and the 
syringes force fluid out of their bodies. On the side with the fresh-blood bag, fresh-blood in the syringe is 
forced out past both three way junctions and into the neonate. During this phase fresh-blood is not forced 
back into the fresh-blood bag because of the one-way valve configuration. On the side with the waste-
blood bag, waste-blood in the syringe is forced out into the waste-blood disposal bag. During this phase 
blood waste-blood is not forced back into the neonate because of the one way valve configuration. This 
phase continues until the syringe plungers are compressed all the way and the syringes are empty of all 
their respective fluids. When this phase completes, the first phase begins again, and the cycle repeats. 
 
With the general configuration of the system and the exchange transfusion process described, the 
components that make up the entire system will now be described. To aid in understanding all of the 
components in the system and their interactions with one another, the system will be divided up in 
mechanical, electrical, and tubing subsystems. In the mechanical subsystem section, the individual 
components will be described, and their interactions with each other will be described as well. In the 
electrical/circuit subsystem section, the aspects that directly resolve engineering specifications will be 
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described, while the other electrical support components are described in the preceding Parameter 
Analysis of Electrical Components section. In the tubing subsystem section, a brief evaluation has been 
given, however reference to preceding sections is given as adequate description for final design.  
Mechanical Subsystem 
The mechanical subsystem consists of a holding block, a slider, a track, and a linear actuator. The 
subsystem can be seen in Figure 40 (p. 44) with two 25 mL syringes in place. Not included in the picture 
is the linear actuator, which is also a part of the mechanical subsystem, and is connected to the slider with 
a pin. The linear actuator is depicted in Figure 41(p. 44). The mechanical subsystem is the only system 
out of the three that contains machined parts by the ME 450 exchange transfusion team. The drawings of 




Figure 40. Assembled mechanical subsystem, minus the linear actuator. 
 
Linear Actuator: The linear actuator is a considerable step forward from the crank and connecting rod 
driving mechanism of the alpha-design. The linear actuator is designed specifically to accommodate the 
motions needed for our design, without all of the kinematics and power transmission in the middle. The 
linear actuator will be connected to the slider by a pin and the velocity of the shaft will be micro-
controlled to obtain the desired volume flow rate of the syringe (will depend on the diameter of the 




Figure 41. 5.90” Stroke 107 lb. 12 V DC Linear Actuator 
 
up to 0.59 in/sec. For the maximum desired flow rate and for a 25 mL syringe diameter, a linear velocity 
of 0.00088 in/sec is needed. This posed a lower limit, rather than an upper limit problem with the motor 
speed. However, after analysis of the voltage resolution out of the micro-driver, we calculated that the 
motor will be able to handle speed low enough for our application. 
 
The linear actuator comes equipped with a position potentiometer as well, which will come into play with 




Lastly, the actuator is attached to the main board with a light duty mounting bracket, which can be seen 




Figure 42. Commercial mounting bracket supplied by same manufacturer of linear actuator. 
 
Slider and Track: The slider is the component that the syringe plungers attach to. It also is the 
intermediate object that transmits the force of the actuator to the plungers. It can be seen in Figure 43 
above, and is dimensioned in Appendix F. The important feature of the slider is its ability to accept and 
attach to it various size plungers, while not using any loose parts to do so (which can be lost during the 
process). The solution to this is the V-shaped slot design which can be seen on the front face of the slider. 












Figure 44. System diagram of the final design.
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Plungers of different diameters will simply fall into the slot until the V design stops it from going any 
further. This method, as opposed to a uniform slot will make the slider compatible with a much larger 




Figure 45. Plunger heads of various size can fit into and remain in the V-shaped slot. 
 
The track component depicted Figure 46 below complements the slider and provides a means for it to 
move smoothly and as effortlessly as possible. The track is a 3/4” extension slide with lift-out release, 
which can be purchased (see BOM) and can be cut down to size per the initial fabrication section. The 
slider attaches to the platform on the track with four screws and the platform itself rides on a series of low 











Figure 47. The slider attached directly the platform that slides on the track. 
 
Holding Block: The holding block’s purpose is to hold the syringes in place while the plungers are 




Figure 48. Holding block with brace. 
 
The holding block has a similar groove design to the slider. It utilizes V-shaped grooves to allow the 
placement of various diameter syringes. After two identical syringes (20-25 mL recommended) are placed 
in the grooves and their collars are placed within the holding slot (Figure 49, p. 49), the brace is brought 
down onto the syringes and fastened (Figure 50, p. 49). It should be noted that the bracer is meant only to 
keep syringes from escaping in the vertical direction. As long at the bracket is snug against the syringes, 









Figure 49. Syringes in place in the holding block, with collars contained in the slot, and syringe bodies 





Figure 50. Brace is flexible and need not be tightened all the way to the holding block. 
 
Casing (Enclosure) and Base Board: The base board is the plane that the linear actuator, track, and 
syringe holder are fastened to. The board is necessary to keep the four components stationary and relative 
to each other (see manufacturing and fabrication place for precise dimensions).  The casing will be a box 
with dimensions 23.00” x 6.00” x 4.00” and has the circuit board and LCD placed within its sides for ease 
of use as well as an opening in the front for the tubing and a hole in the back for a power cord. The walls 
are made up of box joints and fastened to the base. For demonstration purposes, our prototype’s walls are 
made up of plexi-glass to allow users to view the process, whereas the final design’s walls would be made 
up of PVC, due to its higher durability (allowing greater protection for the components if assembly was 
ever dropped) as seen in Figure 51 below. The base board would also be made up of PVC for the final 
design due to the same reason; however the prototype has a base board made of wood to allow alterations 
to be made easier if needed.  
Collar inserted in slot 




Figure 51. View of prototype’s container with LCD and computer chip. 
 
Electrical/Circuit Subsystem 
While the mechanical subsystem is the bones of the exchange transfusion system, the electrical/circuit 
subsystem is the lifeblood. An electrical aspect to an automated exchange transfusion device is absolutely 
essential. If the device is to be automatically controlled and powered; a circuit, power source, and 
controller must be implemented. The overlying specification that must be met in order for the ET device 
to insure the safety of the neonate is the control of the blood volume flow rate. As discussed in earlier 
sections of the report, this is a critical specification that must be met. The component of the system that 
makes this happen is the microprocessor. The other electrical components exist to provide support, or 
input to the microprocessor (except the buzzer alarm which serves as its own engineering specification). 
All of components used in the electrical/circuit subsystem have been documented and discussed in the 
parameter analysis section of the report. Therefore, this subsection of the final design description will take 
a function-based approach. 
 
User Input Devices: The automated ET device was designed to accommodate the various needs of the 
neonate and the medical personnel. To oblige to the needs of the medical personnel, the automated ET 
device must be compatible with an assortment of syringes ranging from 20 to 25 mL in volume. To insure 
the safety of the neonate, the ET device must be capable of operating at various volume flow rates. The 
ET device will also be required to stop when a specified volume of blood has been transfused. In order to 
adapt to all of these variables, the automated ET device must have a user input to inform the ET device of 
the necessary parameters. From the user input, the ET device will adjust accordingly. 
 
The user interface will consist of three rotary encoders and a LCD. The three rotary encoders will allow 
the medical personnel to input the necessary system parameters. The three encoders and the LCD will be 
easily accessed by the medical personnel. The three encoders and the LCD will be soldered onto the top 







Figure 52. User interface as it appears on the circuit board. 
 
The three rotary encoders will be placed a sufficient distance from each other to insure enough room for 
the medical personnel to turn the encoders. The encoders can either be spun or pressed by the user. Each 
encoder can input multiple user inputs; however, the input sequence is determined by the programming of 
the microprocessor. The rotary encoders will be programmed as follows. 
 
Rotary encoder 1 will accommodate for various size syringes. Syringes with a 20 to 25 mL volume have 
varying plunger lengths depending on the manufacturer of the syringe, which influences the distance the 
linear actuator needs to actuate. If the linear actuator moves too far out or too far in, it may cause the 
syringe to fail; therefore, causing the entire system to fail. In order for the automated ET device to adapt 
to various syringe sizes, the minimum and maximum position of the linear actuator must be defined. The 
user will be prompted by the LCD screen to set the minimum position of the actuator. The user will then 
turn the rotary encoder clockwise (the linear actuator is moving in the outward direction) or 
counterclockwise (the linear actuator is moving in the inward direction) until the plunger is fully extended 
from the syringe. The user will then press rotary encoder to set the given position. The user will then be 
prompted by the LCD screen to set the maximum position of the actuator. The user will then turn the 
rotary encoder as previously stated until the plunger is fully compressed into the syringe. The user will 
then press rotary encoder 2 inward to set the given position. The cycle will start by ejecting blood from 
the neonate; therefore, the linear actuator will be in the correct starting position for when the process 
begins. Rotary encoder 1 will act as a pause/resume function while the ET is in process; therefore, the 
neonate can receive the necessary nutrients, such as calcium. Rotary encoder 1 will just need to be 
pressed once during the ET process to pause. The LCD screen will then display that the process has been 
paused. Rotary encoder 1 will then need to be pressed again to resume the ET process. 
 
Rotary encoder 2 will maintain two functions: adjusting the volume flow rate and inputting the diameter 
of the syringe. The current volume flow rate value will be displayed on the LCD screen for the user’s 
reference. In order to adjust the volume flow rate, the user will rotate the encoder clockwise to increase 
the volume flow rate and rotate the encoder counterclockwise to decrease the volume flow rate. As the 
user rotates the encoder, the volume flow rate on the LCD will change values for the user’s reference. The 
user will then press rotary encoder 2 for at least 3 seconds and then release the rotary encoder. The user 
will then be prompted to input the inner diameter of the syringe. The syringe diameter will be displayed 
on the LCD screen; therefore, the user will rotate the encoder in the clockwise direction to increase the 
diameter of the syringe or in the counterclockwise direction to decrease the diameter of the syringe. The 
user will press the encoder inward to set the diameter. The inner diameter of the syringe is an important 
dimension for the automated ET device to acknowledge, because this will be used in determining the total 
blood volume that was exchanged. 
 
Rotary encoder 3 will allow the user to alter the total blood volume to be infused into the neonate. The 
total blood volume to be infused will be displayed on the LCD; therefore, the user will either rotate the 
encoder clockwise to increase the total blood volume transfused or rotate the encoder counterclockwise to 
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decrease the total blood volume transfused. The rotary encoder should be pressed inward to start/stop the 
process. 
 
Flow Rate Control with a Position Schedule: Control of the blood volume flow rate will be conducted 
with a position schedule. When the user inputs a desired blood volume flow rate and syringe diameter into 
the microprocessor, it calculates the necessary linear velocity of the actuator shaft. With the minimum and 
maximum positions of the actuator set prior to start, the microprocessor determines where and when 
exactly the shaft should be between the minimum and maximum set points to achieve the desired blood 
volume flow rate. This is known as a position schedule. 
 
 The linear actuator is equipped with a built-in potentiometer that detects position of the shaft, which is 
fed back to the microprocessor. If the shaft is detected as being at a position that is ahead of schedule, the 
microprocessor pauses the motor and the shaft movement until the schedule catches up to the shaft 
position. If the shaft is detected as being at a position that is behind schedule, instead of speeding the 
motor up, the microprocessor just shifts the schedule back to coincide with the current schedule. 
 
 It operates this way because being ahead of schedule (having a higher than desired flow rate) is an issue, 
while being behind schedule (having a lower than desired flow rate) is not so much. This simple schedule 
method eliminates the need for any continuous feedback control of the motor speed. At any given time 
during operation, the motor is either operating at a nominal speed, or it is paused. 
 
Process: The device will permit medical personnel to leave the neonate unattended while the device is 
transfusing blood into and out of the neonate. Since the medical personnel will not be constantly 
monitoring the neonate, the LCD will output the total amount of blood that has been transfused at that 
given moment, as well as the volume flow rate. This will provide the medical personnel with an update on 
the progress of the transfusion. A user manual will be provided to assist the medical personnel with the 
setup, as well as the operation of the device. 
 
The automated ET device will calculate the total blood volume transfused (Vtot) into the neonate by the 
following equation: 
 
 (Eq. 13) 
 
where ID is the inner diameter of the syringe, which was input into the user interface, and x is the total 
distance the linear actuator traveled in the forward direction, which is determined by the potentiometer. 
Once the total blood volume transfused meets the value input by the medical personnel, the process will 
automatically stop. The automated ET device will start to buzz and the LED will shine red to get the 
attention of the medical personnel. 
 
If a malfunction occurs before the specified blood volume is transfused, the automated ET device will 
react in the following way. The automated ET device will start to buzz and the LED will shine red to get 
the attention of the medical personnel; however, the LCD screen will display the word 
“MALFUNCTION.” The primary malfunction that will be detected is leakage. A leak will cause a change 
in pressure within the system, which will cause a change in the position schedule. This change will be 
detected by the microprocessor and the microprocessor will process it as a malfunction. 
 
Tubing Subsystem: The tubing subsystem is the connection between the blood reservoirs, the syringes, 
and the neonate. It is the pathway for the blood. The pathway that the blood takes from fresh blood bag, to 
syringe, to neonate; and waste blood from neonate, to syringe, to waste bag, is thoroughly described in the 
preceding section Process Description. This section is fairly synonymous with the parameter analysis 
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section of medical components on p. 42. The reason for this is that the components for this subsystem 
were chosen mainly on a function basis. For example, 20 and 25 mL syringes are the most readily 
available syringe at KATH, therefore they shall be the primary syringes that this device is designed for.  
 
While the tubing and its related components such as the one-way valves is considered its own subsystem, 
its design has already fully been described in the Process Description section. Description of the 
individual components can be found the Parameter Analysis of Medical Components Section. Therefore, 
we refer the reader to those two sections to understand the final design of this subsystem.  
Prototype Description 
The purpose of the prototype that will be available at the Design Expo on April 16 is to prove the most 
important elements of the final design. For the most part, the prototype will be highly similar to the final 
design because of the large quantity of commercially-made components that the final design is expected 
to contain. The slider, holding block, brace, and housing container will be the only components not 
acquired through suppliers. Therefore, the material difference between these fabricated parts will be the 
biggest difference between the prototype and the final design. Because of this fact, the operation of the 
device at the design expo will be staunchly similar to the how the manufactured device is expected to 
work in the field. 
 
A description of the differences between the prototype and final design will be discussed. For an 
evaluation of how the prototype will prove the most important elements of the final design, despite the 
few differences between the two, please refer to the validation section of the report. 
Prototype/Final Design Differences 
 
Materials: The material that the slider is made out of will be different for the prototype and the final 
design. The prototype slider will be made out of ABS plastic because it will be rapid prototyped with 3D 
printing technology. The 3D printing supplier that will be used utilizes ABS plastic in their processes. 
The slider final design will be machined out of PVC material. The use of ABS plastic in place of PVC 
poses no inconsistencies with the final design material of PVC because the slider does not experience any 
stresses that come close to the yield strengths of either material. ABS plastic is also just as 
manufacturable as PVC. 
 
Power Supply: The power source for the working prototype will be 120 V AC, while the final design is 
compatible with both AC and DC power sources. Also, while the prototype will be tested in the United 
States where a 120 Hz AC is used, a 220 Hz AC adaptor must be used to make the final design 
compatible in the intended location of Ghana. 
 
Protective Casing Material (Walls and Lid): Because it was the most convenient material in the 
machine shop and it was perfect for laser cutting, we used plexi-glass as the material for our overall 
system casing and lid. However, plexi-glass is not an available material in Ghana, so for our final design, 
we recommend that this casing and lid should be made out of transparent PVC instead.  
 
Circuit Board Casing: To protect the circuit board and the user interface from debris from the outside or 
from blood possibly coming into contact with it from the inside, an additional casing should be made for 
the final design specifically for this electrical component in addition to the overall casing to surround the 
entire device. The circuit board would be the most difficult component of our device to replace if it was 
ever damaged, so the final design should definitely include some kind of additional transparent PVC 
casing to surround its entire body. The material should be transparent PVC because it is conveniently 
available in Ghana, and because the interface would still be visible from the outside. A slit would need to 
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be manufactured into this electrical component casing to still allow the user input knobs to be accessible 
from the outside, however. 
 
Circuit Board Placement: For our prototype, the circuit board was secured into the slot cut into the side 
wall of the plexi-glass casing near the sliding mechanism. This was probably not the best spot for the 
circuit board to be placed as it is in very close proximity to many moving parts. For the final design, we 
would recommend changing the circuit board location to the opposite side wall of the casing, and towards 
the end of the wall where the linear actuator is. There is more free space near the linear actuator end, so 
the circuit board would have less of a chance of coming into contact with moving parts if placed there 
instead of where it was for the prototype. 
 
Track Casing: Along with manufacturing a casing for our electrical component, an additional casing 
should be made to protect the stainless steel, ball-bearing track that slides the slider back and forth and 
allows the plunger movement in and out of the syringe. This casing wouldn’t necessarily need to be 
transparent, but there should be a casing made for this for the final design so that no blood could 
accidentally come into contact with the sliding mechanism. If this was to happen, corrosion could build 
up in the track and the slider might eventually stop sliding correctly. A recommended material for this 
casing would be the same PVC used to manufacture the syringe holder, or the same transparent PVC used 
for the final design outside casing. 
 
Tubing Size: To ensure that we had a working prototype in time for the Design Expo, we used regular 
tubing purchased from Home Depot to test our system with. This tubing fit over both the one way valves 
and the y-connectors nicely, so it worked for functionality purposes. However, for the final design, we 
recommend using 2.5 mm inner diameter medical tubing instead of standard tubing purchased at a 
hardware store. This 2.5 mm inner diameter medical tubing is designed to be more air-tight than the 
hardware tubing, and this closer connection would prevent air bubbles from entering the system, thus 
providing a safer device overall. We should note that smaller one way valves than the ones used for the 
prototype would need to be used for the final design to be compatible with 2.5 mm inner diameter 
medical tubing. The one way valves used for the prototype are too big to fit inside the medical tubing. 
The y-connectors used for the prototype will still fit with the 2.5 mm inner diameter medical tubing, so 
those would not need to be changed. 
 
Manufacturing, Fabrication and Assembly Plan 
The following section will provide the fabrication and assembly process utilized to create the function 




Syringe slots: The syringe holder will be made out of PVC from a blank with dimensions of 5.00” x 1.50” 
x 2.50”. Using the band saw, two vertical cuts will be made 1.80” away from each edge to a depth of 
0.575”. The work piece will then be placed at a 45° to the band saw and 1.225” away from the edge. A 
cut will be made into the work piece until the saw reaches the intersection of the first vertical cut (a 
cutting distance of 0.813”). Another cut will then be made, mirroring the first cut about the original 






Figure 53. Layout of how the syringe holder should be cut. 
 
These slits need to be centered in order for the syringes to lie straight with the other components, however 
the angle of the cut can vary up to 2 degrees as long as it’s consistent throughout. 
 
 
Track hole: After the syringe holder is cut with a band saw, it needs to have a piece from the bottom 
milled out. Using a ¾ in. diameter end mill bit at a speed of 800 RPM, make an initial cut at 2.50” from 
the side and the center of your mill bit 0.425” from the bottom as depicted in the Figure 54 below. 
  
 
Figure 54. Layout of how syringe holder should be milled. 
 
This size of this space is not that critical. It just needs to allow the track to slide underneath it. 
 
Post placements: The syringe holder will need four holes in order to place the posts which will hold the 
top plate and the collar lock. Each hole will be 0.50” in diameter and be threaded with an 8-20 tap. The 
holes are 0.50” in from one side and are symmetric about the short axis of the piece. The dimensions of 






Figure 55. Layout of how syringe holder should be drilled and tapped. 
 
Top Plate: The top plate will be composed of two separate parts, the feet and top face. Two identical feet 
will need to be created, made up of three parts; two PVC plates and a middle block made up of 
compressible foam. The top face is made up of PVC 
 
Feet: To create the feet, take two blocks of PVC measuring 1.00” x 0.125” x 1.125” as well as a block of 
compressible foam measuring 1.00” x 0.750” x 1.125”.  Place the compressible foam in between the two 
pieces of PVC. Drill a hole with the center 0.50” from the long end and centered on the short axis. Drill 
through all of them with a 0.750” diameter drill bit as seen in Figure 56 below. Do this process twice to 








Top Face: To create the top face, take a piece of plexi glass measuring 3.00” x 1.00” with a thickness of 




Figure 57. Layout of how top plate should be drilled. 
 
Locking Plate: The locking plate will be created from plexi glass cut from a laser cutter. Its overall 
dimensions are 5.00” x 1.25” with a thickness of about 0.22”. A rectangular hole with dimensions 2.50” x 
0.50” centered at the bottom is cut from piece. Two holes with diameter 0.75” each centered vertically on 
the plate with each hole’s center placed 0.50” from either end. The final piece would be symmetric about 
its short axis as depicted in Figure 58 below. 
 
Figure 58. Layout of the locking plate’s final dimensions. 
 
Insure that the holes are can fit around the holes drilled into the back of the syringe holder.  
 
Track: The commercial drawer slider will need to be cut so that our design stays consistent with our 
minimum size constraints. Using a band saw, two cuts that are perpendicular to the track’s axis of motion 
will be made. One of the cuts will need to be made at a distance of 6.00” from the back of the slider. The 
other cut will need to be made at a distance of 6.50” from the front of the slider. The layout of how the 






Figure 59. Layout of how the track should be cut. 
 
The track needs to be able to slide a minimum of 4.00”. Larger than 4.00” would also work, but 4.00” is 
the lowest one can go for a fully functional assembly. 
 
Slider: Due to the fine tolerances needed for the slider, creating it in the machine shop would have been 
extremely difficult and impractical. Therefore, in order to accomplish this fine detail, 3D printing in the 
Duderstadt Center will be used to create it. Though this method will slightly increase cost, we feel the 
precision it will give our slider will be worth the extra expense. Also, since the total volume is only 
1.33·10-4 m3, the 3-D printing will actually be quite inexpensive. 
 
Container Walls: The container walls are to be made from plexi-glass with a thickness of about 0.22”. 
Due to the walls being put together with multiple box joints, a laser cutter is the quickest and most 
accurate means to make the walls of the container. The dimensions of all four final walls are shown below 
in Figure 60. One would have to upload these designs into a CAD software that works with a laser cutter 





Figure 60. Layout of how walls would look after cut. 
 
Base Board: The base board will be made out of wood and be 6.50” long by 23.50” wide and at least 
0.50” thick. Eight separate, rectangular holes (all measuring 0.25” x 0.50”) will be cut into the board. 
They will be needed for the peg placements for the walls and create a concentric rectangle boarder within 
the board measuring 6.00” x 23.00” as seen in Figure 61 below. 
 
 




The holes need to be totally enclosed within the board. A recommended strategy would be to drill a small 
hole where the center of each rectangular will need to be and then put together a saber saw within the hole 
to complete the rectangular cut. These holes need to be fairly precise, due to the walls, which were 
machined by the laser cutter being put into the slots. A tolerance of + 0.005” could be tolerated.  
 
Fabrication Plan 
Top Plate: The top plate consists of two feet (Figure 55, p. 56) and a top face (Figure 56, p. 56). Place the 
feet under the top face with a 0.125” overlap. Press all parts together securing all parts with appropriate 





Figure 62. Layout of how feet and top face come together to form the top plate.  
 
Syringe holder and posts: The posts that will hold the top plate and the collar plate will be screwed into 
the tapped holes. Screw four 2.00” long, threaded posts with a 0.50” diameter into the four holes (posts 
have an 8-20 pitch). To create the posts, cut the heads off of bolts with the proper diameter and threading. 





Figure 63. Layout of syringe holder with posts. 
 
Fastening components on base board and track: There are three components that need to be fastened 
to the base board; the syringe holder, the track, and the bracket for the linear actuator. All three 
components will be fastened by 0.50” long screw with 0.25” diameters. The screws securing the track and 
the bracket go down into the board, whereas all others come up in the board. All holes are symmetric 
about the long axis of the board. The slider is also fastened to the track with these screws. Pre-drilling 
with a 0.125” diameter bit is recommended. The full layout of where to drill and place all components is 
shown in Figure 64 below. 
 
 




Collar Lock and Top Plate: The collar lock and top plate need to be put onto the assembly. The top 
plate sits on the vertical posts whereas the collar lock slides onto the horizontal posts. It’s recommended 
to keep the nuts on the posts after the plate and lock have been put onto the posts to keep them where they 




Figure 65. Layout of collar lock and top plate in position. 
 
Walls: The walls are the last of the fabrication. Fit the walls together so they form a box. Adhere the 
seams with acrylic glue. Once acrylic glue is set, place walls onto baseboard in appropriate slots. Make 
note of the orientation of the walls. Ensure that the long wall window is closest to the circular hole as 
shown in Figure 66 below. 
 
 






To validate a working prototype, assembly of the device with all of its components was first required. 
Once assembly was complete, system testing began and several different experiments were conducted to 
verify that the device met all of our key customer requirements and engineering specifications. 
Descriptions of the validation tests and results are described below. 
 
Before we began running our device, we first tested our one way valves to ensure that fluid was restricted 
to only flow in the one direction that it was supposed to once the valves were in place. For the test, we 
attached the one way valves to our 2.5 mm inner diameter tubing and manually tried pumping water 
through the tube both ways using a syringe to make sure that that the water could only flow through the 
valve in one direction, but could not flow through the valve in the other direction. Once we confirmed that 
the one way valves functioned properly, we carefully secured the tubing with all attached one way valves 
to our syringes, our y-junctions, and our IV bags to complete the flow system assembly of the device. 
 
Following the validation of our one way valves and tubing, we tested the time it took to prepare the 
system. This preparation time consisted of securing the two syringes to the device, inputting sample 
desired values for the volume flow rate, total volume to be transfused, and inner diameter of the syringes 
into the user interface, and prepping the tubing with water to act as blood to eliminate any air bubbles 
from the tubing before attempting to run the system. Syringes of size 20 mL and 25 mL were used at 
different times during experimentation to ensure that the device was compatible with multiple size 
syringes and that engineering specification was met. To test the preparation time, we gathered six random 
participants. Each participant took two turns trying to set up the system. For the first attempt, each of the 
six participants was given personal help by one of our group members to set up the system. On average, 
the setup time for this test took approximately 16 minutes and 16 seconds. For the second attempt, each 
participant had to set up the system using only the instruction manual; no help from any of the group 
members was given. On average, the setup time for this test took approximately 19 minutes and 17 
seconds. A graph of the experimental results can be seen below in Figure 67. Both tests resulted in an 
average setup time of less than the desired 20 minutes, thus ensuring that the setup time and ease of use 







Figure 67. Average setup time of 1st time users with personal help compared to 2nd time users with 
the instruction manual only. 
 
To have a better understanding of fluid flow throughout the system, we used red and blue colored water 
for all system tests to act as the blood coming out of the neonate, and the blood going into the neonate, 
respectively. We also used three IV bags for our testing: one bag was filled completely with red water to 
act as the fresh blood bag, one bag was left empty to act as the waste blood bag, and the last bag was 
filled completely with blue water to act as the neonate. 
 
Once the preliminary tests and measures were taken, it was time to power the system to begin testing the 
functionality of the device as it was running. The linear actuator motor was driven by our AC adaptor to 
ensure that our device functioned with AC power as required. Because an adjustable and consistent 
volume flow rate is so important to the proper functionality of our system, we conducted several tests to 
ensure that the rate stayed consistent with the input value, and that the system could run properly at 
volume flow rates between 0 and 10 mL/min. For tests running at 2,4,6,8 and 10 mL/min, we manually 
recorded how long it took the syringe to displace 15 mL of fluid. After calculating the measured volume 
flow rate, we compared it to the desired volume flow rate. For each of the 5 different flow rates tested, an 
accuracy of over 99.5% was achieved. A table displaying the full results of the experiment can be seen 
below as Table 7. This easily satisfied the adjustable volume flow rate engineering specification. We 
would like to note that it is reasonable to assume that the system had a constant flow rate at all times 
because the linear actuator’s potentiometer is constantly detecting position to ensure a steady volume flow 
rate. 
 




To validate that the total volume to be transfused was correct, we ran the system twice for a full two hour 
cycle at a volume flow rate of 10 mL/min. For these two tests, we first filled the fresh blood IV bag with 
1800 ± 25 mL of red water. We then filled the waste blood IV bag with only about 50 ± 25 mL of blue 
water, and finally the IV bag representing the neonate was filled with 1500 ± 50 mL of blue water. After 
both two-hour tests, the new total volumes from the bags were recorded. For both tests, the fresh blood 
bag was reduced by 600 ± 50 mL of water, the waste blood bag was increased by 600 ± 50 mL of water, 
and the bag representing the neonate remained at a constant volume. A picture clearly depicting these 
results can be seen in Figure 68. Validating the amount of blood displaced in the fresh blood bag, the 
waste blood bag, and the “baby” blood bag by color pigment and volume change. From these results, we 
concluded that the total volume to be transfused was correct for each system test. For further verification 
that fluid flow was correct going into and out of the bag representing the neonate, we witnessed a color 
change near the end of the bag where the fluid was flowing in. The color of the water changed from a 
solid blue to a more purple color as the “fresh blood” red water was injected and mixed with the old, 
“waste blood” blue water. This color change proved that “fresh blood” was correctly entering the neonate 




As stated above, numerous tests were conducted where the system was allowed to run through a full 
transfusion. For each of these tests, once the device had transfused the desired total volume of blood, the 
microprocessor sent a signal to the motor to shut down. At this shut down point, an alarm went off as 
programmed to alert personnel that the transfusion had completed. Once the alarm sounded and the 
transfusion was complete, we visually confirmed that no more fluid was flowing into the end of the bag 
representing the neonate. From these results, we concluded that our device had a working automatic shut-
off function and that corresponding engineering specification was met.  
 
Engineering specifications that were not directly tested were as follows: inexpensive, functions with DC 
power, and prevents disease transmission. Because of the power supply and linear actuator, our system is 
more expensive than originally anticipated. However, we feel that sacrificing cost for safety and 
efficiency is worth the difference. We did not directly test our system to ensure that it functions with DC 
power because we could not afford purchasing a battery of any kind for our prototype, but this is 
definitely something that could be tested in further work beyond this semester. Also, we could not 
directly test whether or not our device would prevent disease transmission; however, we are confident that 
because the parts of the device that will come into contact with blood are mostly disposable, this 




Figure 68. Validating the amount of blood displaced in the fresh blood bag, the waste blood bag, 
and the “baby” blood bag by color pigment and volume change. 
 
In summary, our device successfully functions as intended. The one way valves allow the fluid to flow 
properly into and out of the bags and the neonate, and the motor and pumping mechanism allow the 
transfusion to take place at various, but constant volume flow rates. The desired total volume to be 
transfused is what gets transfused, and the device is compatible with multiple size syringes. Also, with 
proper preparation, air bubbles will be eliminated from the system thus eliminating any kind of danger 
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regarding air embolism. All of these factors combined allow us to conclude that our automated exchange 
transfusion device functions safely and successfully. 
 
For future validation of our system functionality beyond practice with IV bags and colored water, we 
recommend animal testing if all safety requirements have been met and the process is allowable. This 
would be the next step to take before using the system on neonates. We should note that a great deal of 
further testing would need to be conducted on our device to ensure maximum performance before animal 
testing could even be considered. 
 
If animal testing with our device was an option to be considered, a full scale process would need to be 
conducted first to obtain permission for this. A shortened version of the process for obtaining permission 
is as follows: First, a premarket approval (PMA) would be required from the FDA. The PMA application 
would need to contain sufficient information to reasonably assure the FDA of the safety and effectiveness 
of the device. This required information consists of valid scientific data to demonstrate that the device is 
safe and effective for its intended use. Once the FDA signed off on the premarket approval, a 510(k) 
application would have to be sent to the FDA informing them of the exact testing procedure to be done on 
possible animal subjects. If this application was approved by the FDA, subsequent animal testing could 
then be legally performed. 
Discussion 
As we stated in the validation section of our report, we are very pleased with the functionality of our 
device overall. The device successfully meets all of our key engineering specifications. The true strengths 
of our device lie in its functionality. First of all, the user interface is easy to understand with its directions 
and the input values remain consistent with the actual values while the system is running. The linear 
actuator is a perfect motor for creating the linear motion necessary to move the syringe plungers in and 
out. The syringe holder and top plate designs are more than sufficient for allowing multiple size syringes 
to be used. The slider mechanism allows for the proper syringe plunger movement. And finally, the one 
way valves and tubing allow for the correct fluid flow for an exchange transfusion to take place. Given 
the 400 USD budget we had for the semester, we could not have hoped for a much better end result. 
 
Although we are satisfied with the functionality of our device, there are some things we may have done 
differently if we could do the project over again along with some weaknesses that could be addressed in 
the future. First of all, we would possibly try and find a smaller, more inexpensive linear actuator to better 
fit the size constraints at the KATH hospital in Ghana. The linear actuator we purchased worked perfectly 
for our prototype needs and it was one of the cheapest we could find at the time, but further research 
could possibly find an even better product. The linear actuator we purchased was capable of pushing 
forces well beyond anything we needed it to do, so a smaller scale actuator would definitely be more 
desirable. Also, the linear actuator was approximately half of the total cost of our device so if that cost 
could be decreased even a little bit, it would be very beneficial. 
 
Another change we would make to our prototype if we could do things differently would be to add 
another casing to put around the electrical component. We have an outside casing to surround our entire 
unit, but a separate casing around the circuit board would be beneficial to eliminate the possibility of fluid 
ever accidentally coming into contact with the circuitry. Also regarding the circuit board/user interface, 
we would probably attach that to the top of the casing instead of the side of the casing next time so that it 
would be more convenient to the user. At this point, the user has to bend down quite a bit to input the 
values into the user interface and to read the values off the interface while the system is running. As for 
the outside casing, instead of using plexi-glass, we would probably use transparent PVC if we could make 




One more improvement to be made to the final design would be to use actual medical tubing that fits 
correctly with the y-connectors and one way valves we purchased. Because of time limitations, we used 
tubing purchased from home depot for testing purposes. This tubing allowed for proper functionality of 
the system, but medical tubing that would correctly fit with the y-connectors and one way valves would 




Although we successfully created a working automated exchange transfusion device, there are still quite a 
few recommendations we have for Dr. Adabie that could significantly increase the likelihood of this 
device becoming a real medical device some day. Obviously, we were only given a semester’s time to 
work on this project, and we were working under a limited budget of 400 USD. With a larger budget and 
more time to work, we feel the in-phase slider could definitely be turned into a realistic medical device. 
Several recommendations are given in the following paragraphs to make that happen. 
The first recommendation we would give would be to find a smaller scale linear actuator that could be 
purchased in Ghana. The linear actuator is a perfect motor to drive the rest of the device properly, but it is 
by far the most expensive part of the device. If a smaller, but still effective, similar motor could be used 
for this device in Ghana, the device would be much more likely to succeed long term. Next, we would 
recommend a better way to secure the circuit board and user interface. Right now, it is snugly fit into the 
wall of the casing, but an electrical component with that kind of importance should probably be more 
securely attached. We recommend using very small screws such as 1 mm diameter screws to fasten the 
circuit board to the casing wall, and also developing a casing to go around the board to protect it even 
more. 
 
While manufacturing the prototype, we had to make several compromises because of time constraints and 
material constraints. Many of the parts were bolted down quickly, and in one instance we had to use super 
glue to lock the ball-bearing track into place on the mounting board to prevent wiggle. With more time 
available, we recommend more precise measurements and more quality methods of securing the 
components to each other and to the mounting board. This would prevent things like slanted bolt 
attachments, which could result in slipping or wiggling of components later on. More specifically, wing 
nuts should be used for all attachments that will need to be detached constantly such as the syringe cover 
plate and the syringe plunger bracket to allow for an easier assembly and setup for the user. 
 
If more circuit boards were to be assembled in order to mass produce this device some day, we would 
recommend having 4 knobs on the user interface instead of 3. This would make the user input a little 
easier for the intended user, because one knob wouldn’t have to be pushed in to allow for two different 
functions using that same knob. If this were to happen, the programming would also need to change so 
that the new fourth knob carried out the same task that the one knob did once it was pushed in to perform 
its second function. 
Conclusions 
After the completion of our alpha design, we incorporated several new developments into the design that 
significantly changed the device. The first new development into the design was the change of the driving 
mechanism from a gear/crank and connecting rod to a commercial, linear actuator. Using this linear 
actuator also changed our feedback system. The linear actuator has a built-in potentiometer which will 
detect position, and the microprocessor will use this position sensing to calculate volume flow rate 
throughout the transfusion. This differs from our original plan to use pressure transducers to directly 
detect volume flow rate inside the tubing. Another new development since the alpha design was the 
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evolution of our sliding mechanism. The new sliding mechanism now has a ball-bearing stainless steel 
track to glide on that will significantly reduce friction, and a new slider and slider holder design.  
 
These new developments in our design changed quite a few of our engineering specifications. First, we 
increased the importance of having a design that functions with AC power and decreased the importance 
of compatibility with DC power. We feel that AC power is more reliable and safe, and should be the 
primary source for powering our prototype. Because of the evolution in our sliding mechanism, we 
changed the specification of our device being compatible with various size syringes from 10-25 mL 
syringes to 20-25 mL syringes. Finally, because of the cost of the linear actuator, we changed the 
specification of having a device cost less than 100 USD to 200 USD. We felt that because our device 
could potentially be saving a life, increasing cost was worth the increase in safety and stability. The 
mobility engineering specification also changed because of the weight of the linear actuator from needing 
to weigh less than 45 N to 65 N. This is still more than acceptable for mobility purposes. 
 
In order to incorporate the new developments into the slider mechanism and the driving mechanism, and 
to design for overall compatibility with all of the components of our system, we had to perform parameter 
analysis for each part of the design. Force analysis was conducted on the slider parts to ensure their 
stability to prevent buckling or failure once manufactured. Functional analysis was performed on the 
electrical components of the system before the development of the circuit board and purchasing of the 
power supply. Experimental analysis was performed on our medical supplies, particularly the syringes, to 
determine the parameter requirements for our linear actuator. Once this analysis was completed, we 
moved forward toward the purchasing and manufacturing of all of our system components. 
 
As we have previously stated, we have named our device to be the in-phase slider mechanism. This is an  
exchange transfusion system utilizing an AC power supply, a linear actuator with a built-in potentiometer 
as a driving mechanism, a dual-syringe pumping mechanism with a stainless steel, ball bearing track and 
PVC slider mechanism, a one-way valve configuration, and one IV insertion point into the neonatal 
umbilical vein. There are some differences between our prototype and our final design, however. As 
previously stated, our prototype will function strictly with AC power because DC power is not really 
necessary. However, for our final design, we recommend a power supply that is compatible with both AC 
power and DC power. The AC power supply for our final design needs to be 220 Hz compatible for the 
KATH hospital in Ghana, as opposed to 120 Hz compatible for in the U.S. Also, the syringe holder and 
slider should possibly be made out of other materials aside from PVC and ABS plastic if a different 
material is as safe, but more convenient to be used for manufacturing these parts in Ghana. 
 
Once we manufactured the mounting board, locking plates, and Plexiglas casing, we attached everything 
securely onto the mounting board. While the manufacturing was going on, we were also assembling the 
circuit board and programming it to function as intended to allow for user input of desired volume flow 
rates, total volumes to be transfused and inner diameters of syringes. Once these tasks were completed, 
and the rest of the system components were purchased and acquired, we began testing and validating our 
design. We used red and blue colored water to represent fresh and waste blood, respectively, throughout 
the transfusion. We also created an instruction manual for setting up the system and performed an 
experiment using random test subjects to see how long it took them to set up our system both with our 
help and with just the aid of the instruction manual. The average set up time was less than 20 minutes, so 
that was desirable according to our engineering specifications. 
 
We also validated the volume flow rate throughout the system for several different flow rates by 
recording the time passed by for the device to inject or withdraw 15 mL of fluid. All of these tests 
resulted in a volume flow rate accuracy of above 99.5% so we concluded that the volume flow rate at any 
given time throughout the transfusion was extremely accurate. To ensure that the total volume being 
transfused was accurate and that the neonate would be losing the same amount of waste blood as he/she 
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would be gaining in fresh blood, we measured volume displacement after several full, two-hour 
transfusions at 10 mL/min each. The accuracy for these was again extremely high. 
 
From these validation tests, we concluded that our device met all of the key customer requirements and 
engineering specifications, and it functioned properly. The motor provided the correct force, the slider 
and pumping mechanism pushed and pulled the syringe plungers properly, and the tubing and one way 
valves allowed the fluid to flow properly. If any of these mechanisms malfunctioned, the validation tests 
would have failed, and that was never the case. Therefore, we are pleased to say that we successfully 
developed an automated exchange transfusion device as intended. 
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Dan Ciko is from Livonia, Michigan, United States of America, North 
America, Western Hemisphere, Earth, Sun’s Solar System, Milky Way 
Galaxy, Local Group, Virgo Supercluster. He has interest in mechanical 
engineering because he wants to make the Earth a better place for humans to 
live in by manipulating the god-given raw resources left here for us. A 
humanist at heart; he seeks to combine the cold, ruthless calculations of an 
engineer with a curious, empathetic worldview, to solve problems that are both 
technological and human in nature. 
 
Dan interned at the Toyota Technical Center in Ann Arbor last fall, and would 
like to get an internship in either the aerospace or medical technology industry 
for this upcoming summer. He would like to experience as many industries 
involving mechanical engineering as he can, before he makes a decision on which one to settle in after 
graduation. Dan has his sights set on getting a master’s degree in mechanical engineering from the 





My name is Brad Herron. I am from Clarkston, Michigan. I have 
lived in Clarkston my whole life. I chose Mechanical Engineering 
to be my major because I have always loved cars and how engines 
work. I have not yet had a summer internship since I have attended 
the University, but I plan to attend the career fair this term and 
pursue an internship this summer and hopefully extend that work 
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basketball and football I could watch all day. I don’t think I could be as happy doing anything else as I 
would be working as an anchor for ESPN. I majored in mechanical engineering because of the prestige 
and the money security, but working in sports has always been my dream. In my spare time, I like playing 
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Late onset alkalosis 
  







Cardiovascular Complications Arrhythmia or arrest 
Volume overload 
  
Catheter Complications Umbilical vein/artery perforation 
Air embolism 
Thromboembolism 





Other Change in intracranial pressure 
Hypothermia/hyperthermia 










< 0.1 mL air bubbles in syringe
Synchronous intrusion/extrusion strokes
Device compatibility with syringes between 5 mL and 25 mL 3
Adjustable volume flow rate (0 - 25 ml/min) 1 3
Meets the Health and Safety Codes of Ghana
Audio alarm of 80 dB
Audio alarm of 60 dB 9
Spare parts available within 1 week's time 9
1 IV attachment
Setup <5 min
Stepper motor -9 -1
Minimum instruction necessary (1 page of instruction) 9
Baby and device must fit in 19x40x22 in. incubator
Motor does not exceed 45 dB -3
Device Weight <10 lbs.
220 V 50 Hz compatiblity
Takes less than 5 min to fully charge mechanism
Total cost is less than US $100 -3
Feedback system 3 9 -9 3 -3
50% disposable parts 3







































































































































































































































































































































































Adjustable volume flow rate 3 3 9 9
Alarm device to detect malfunction 1 9 1 1
Alarm device to detect the end of the process 1 1 9 1
Applicable with various syringe sizes 9 9 3 3
Automatic shutoff at the end of process 9 9 9
Available spare parts 3 9
Blood volume control 3 9
Constant monitoring from doctor is not required 9 9 3 3 1 3
Ease of assembly/disassembly 9 9 1 9 3
Ease of sanitizing/cleaning 1 3 9
Ease of use 9 1 1 9 1 1
Easily maintained and repaired 3 9 3 3
Easy transition to manual process 1 9
Functions with AC power 3 9 9 9
Functions with battery power 9 1 9 3 9
Functions without the use of electricity 1 9
Inexpensive 9 3 9 9
Instruction manual 9 9
Minimize sound 1 1 1 1 9
Minimize the size 1 1 9 9
Mobile 3 1 9 9
Operable for both blood transfusion and exchange transfusion 3 3
Prevents air bubbles 9 9
Prevents disease transmission 9 9
Safety of neonate 3 1 9 1 9
Transfuse various types of blood (PRBC, FFB, platelets, etc.) 3 3 3









































































2% 1% 4% 2% 1% 6% 1% 6% 14
%
Rank 9 9 7 12 21 13 13 7 15 6 1 3 15 18 11 17 19 4 19 4 2
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Energy for Fluid Flow 
Transport Old Blood from 
Neonate into Disposal 
Reservoir 
Pre-Procedure/Preparation 
Transport New Blood 
from Supply Reservoir 
into Neonate 
Procedure Post-Procedure/Evaluation 
Motor Transmits Energy 
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Energy to Syringe 
Syringe Exerts Pressure on 
Fluid 
Transport Old Blood from 
Neonate into Syringe 
Transport Old Blood from 
Syringe into Disposal 
Reservoir 
Transport Bagged New 
Blood in Syringe 
Transport New Blood 
from Syringe into Neonate 
Energy: Energy Source 
Material: Old Blood 
Signal: Human Input 
Energy: Fluid Flow Energy 
Material: New Blood 
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Connect Syringe to 
Tubing/IV 




Attach Blood Bag 
to System 








System Shuts Off 















Appendix A-4: Brainstorm Concept Drawings 
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Appendix A-5: Pugh Chart 
 
  Concept 1 Concept 2 Concept 3 Concept 4 Concept 5 
Criteria 









Way Stop Cock 
Adjustable volume flow rate 1 1 -1 -1 1 
Alarm device to detect malfunction easily implemented 1 1 1 1 1 
Alarm device to detect the end of process easily implemented 1 1 1 1 1 
Available spare parts 0 0 -1 -1 -1 
Comfortability of neonate (Number of insertion points) -1 0 -1 -1 0 
Constant monitoring from doctor is not required 1 1 1 1 1 
Ease of assembly/disassembly 0 0 -1 1 -1 
Ease of sanitizing/cleaning -1 -1 -1 0 -1 
Ease of use (Number of steps after setup) 1 1 1 1 1 
Easily maintained and repaired -1 -1 -1 -1 -1 
Functions without the use of electricity -1 -1 1 -1 -1 
Inexpensive -1 -1 -1 -1 -1 
Minimize Sound 0 0 1 1 -1 
Minimize the size 0 0 -1 -1 0 
Mobile 1 1 -1 -1 0 
Prevents air bubbles 0 0 0 0 0 
Prevents disease transmission 0 0 -1 0 0 
Transfuse various types of blood (PRCB, FFB, platelets, etc.) 1 1 0 -1 1 
Σ+ +7 +7 +6 +6 +6 
Σ- -5 -4 -9 -10 -7 
Σ 2 3 -3 -4 -1 
Appendix A-6: Gantt Chart 
 
ID Task Name Duration Start Finish Predecessors Resource Names
1 Interview Sponsor 2 days Fri 1/23/09 Mon 1/26/09 Ashley
2 Interview Professionals 1 day? Fri 1/30/09 Fri 1/30/09 Contacts,phone,filed tr
3 QFD 1 day? Tue 1/27/09 Tue 1/27/09 Dan-All
4 DR1 Outline 4 days Tue 1/27/09 Fri 1/30/09
5 DR1 Practice 1 day? Wed 1/28/09 Wed 1/28/09
6 DR1 Paper-Final Revision 1 day Wed 1/28/09 Wed 1/28/09
7 Design Review 1 1 day Thu 1/29/09 Thu 1/29/09
8 Professional Contacts 7 days Sat 1/31/09 Mon 2/9/09 4 Dan,Devon
9 Brain Storm 3 days Sat 1/31/09 Tue 2/3/09 Brad-All
10 Contact Sponsor 1 day Wed 2/4/09 Wed 2/4/09 CAEN-Devon-All
11 Design 1 (CAD) 8 days Tue 2/3/09 Thu 2/12/09
12 DR2 Outline 1 day Mon 2/16/09 Mon 2/16/09 Ashley
13 DR2 Revision 3 days Mon 2/16/09 Wed 2/18/09
14 DR2 Practice 2 days Tue 2/17/09 Wed 2/18/09
15 DR2 Final Paper Review 1 day Wed 2/18/09 Wed 2/18/09
16 DR2 Presentation 1 day Thu 2/19/09 Thu 2/19/09
17 DR2 Final Paper Due 1 day Fri 2/20/09 Fri 2/20/09
18 Order Parts 5 days Mon 2/16/09 Fri 2/20/09 Dan-All
19 Safety Review 1 day Mon 2/16/09 Mon 2/16/09
20 Spring Break 10 days Fri 2/20/09 Thu 3/5/09 SB
21 Manufacturing Plan Alpha-Alpha 9 days Wed 3/4/09 Mon 3/16/09 Brad-All
22 Manufacture 2 days Wed 3/18/09 Thu 3/19/09 Devon-All
23 Contact Sponsor 1 day Fri 3/20/09 Fri 3/20/09 22 Ashley-All
24 Test 2 days Mon 3/23/09 Tue 3/24/09 23 Dan-All
25 Final Design-CADDED 2 days Mon 3/23/09 Tue 3/24/09 Brad-All
26 DR3 Presentation Outline 1 day Fri 3/20/09 Fri 3/20/09
27 DR3 Practice/Final Revision 1 day Fri 3/20/09 Fri 3/20/09
28 DR3 Presentation 1 day Mon 3/23/09 Mon 3/23/09
29 New Manufacturing Plan-Alpha 2 days Wed 3/25/09 Thu 3/26/09 Devon-All
30 Re-manufacture-Alpha Prototyp 2 days Fri 3/27/09 Mon 3/30/09 Ashley-All
31 Test 2 days Mon 3/30/09 Tue 3/31/09 Dan-All
32 Final Report outlined and Assig 2 days Fri 3/27/09 Mon 3/30/09 Brad-All
33 Rough Copies of report sections 2 days Wed 4/1/09 Thu 4/2/09
34 DR4 tasking and practicing 2 days Sun 4/5/09 Mon 4/6/09
35 DR4 1 day Tue 4/7/09 Tue 4/7/09
36 Design Expo Prep 3 days Wed 4/8/09 Fri 4/10/09 Devon-All
37 Design Expo 1 day Thu 4/16/09 Thu 4/16/09
38 Final Report Revision 2 days Thu 4/16/09 Fri 4/17/09
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ID Task Name Duration Start Finish Predecessors Resource Names
40 Final Report Due 1 day Tue 4/21/09 Tue 4/21/09
41 Party 7 days Tue 4/21/09 Wed 4/29/09
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Appendix C: Description of Engineering Changes since Design Review III 
The final prototype of the automatic exchange transfusion device exhibited a handful of engineering 
changes since Design Review #3. Most of these changes were discovered to be necessary during the 
manufacturing process where components were physically coming together and issues became more 
evident. Outlined below are the changes that were made with descriptions why. The subsequent pages 
consist of Engineering Change Notices (ECN) which provides more detailed and dimensioned 
descriptions of our design changes. 
 
Syringe Holding Bracket 
The holding piece that presses the syringes down onto the holding block went through a few design 
changes after Design Review #3. After we realized during the assembly process that its dimensions did 
not allow a normal force to hold the syringes down, we had to make the bracket legs less thick. However, 
instead of just reducing the thickness of the legs, we installed a foam layer at the bottom of the legs to 
allow the bracket to comply with various syringe diameters, rather than just having a rigid bracket bolted 
down on top. We also eliminated fillets throughout the bracket to make manufacturing easier. Also, since 
all of the component will be placed in to a protective case, 90˚ edges would not be expected to cause any 
safety issues with the user. 
 
Syringe Holding Base 
The base that the syringes lie upon had a design change regarding the slot that was placed in the top face. 
The slot was originally designed into the top face to accept the syringe collar and prevent it from sliding 
in the direction of the slider during operation. The slot was originally 0.1 in. and it was determined that it 
would be easier from a manufacturing standpoint to fabricate a piece that simply screws onto the base to 
hold the collars in. 
 
Syringe Collar Holding Plate 
As mentioned in the preceding paragraph, a design change to a moveable plate, rather than a slot was 
issued in order to hold the syringe collars to the base. This consisted of a simple piece of plexiglass 
dimensioned to the geometry of the block, with two 3/16” screws and wing nuts to hold it in place. The 
engineering change notice regarding this change provides an illustrative explanation of this modification. 
 
Slider Holding Gap 
An issue arose during initial testing regarding the plunger head and the gap of the slider that it is placed 
in. When the linear actuator is extending the plunger head was in contact with the far face of the gap. 
However, when the linear actuator changed directions from extension to retraction, there was a period of 
play where the plunger head had to change contact faces in the gap of the slider. This play accounted for a 
considerable distance of actuator movement, and during the course of a whole transfusion, the 
displacement losses would add up. Therefore, we had to redesign the slider gap to fit the plunger head 
more snugly and avoid the region of play between extension and retraction. To solve the problem we 
installed a 1/16” layer of foam to the far side of the slider to reduce the size of the gap. This solution 
solved the issue of play during linear actuator direction changes. 
 
Protective Casing 
The last engineering change we conducted after Design Review #3 was a material change for the 
protective casing which would surround of all of the system components. Instead of purchasing or 
fabricating a rigid one-piece protective casing, we designed one that is made of transparent plexiglass 
consisting of four interlocking walls and an opening top via hinges. Plexiglass was chosen because it can 
protect the system components, while still allowing observation of the system. The four walls were 




Engineering Change Notices 












Appendix D: Design Analysis 
Appendix D-1: Material Selection (Functional Performance) 
The two main components of the automated ET device that will require manufacturing in Ghana are the 
slider and the syringe holder. Due to the minimal amount of available resources in Ghana, an appropriate 
material must be selected, which will be readily available in Ghana, while still adhering to the appropriate 
engineering standards. The Cambridge Engineering Selector (CES) was utilized to determine a variety of 
materials applicable for the necessary engineering applications. The parameter analysis of the syringe 
holder and the slider was used to determine material constraints. 
 
Slider 
The function of the slider is to provide a holding mechanism for the plunger of the syringe; therefore, the 
plunger of the syringe will extend and retract depending on the position of the linear actuator compared to 
the position of the syringe holder. The slider may experience bending from the force of the syringe; 
therefore, the syringe holder must have a yield strength of at least 1.06 MPa (the in depth calculation is 
provided in the “Slider” section of the Parameter Analysis). The slider is also prone to failure due to 
fracture. It was determined through a thorough engineering analysis that the slider should have a 
minimum fracture toughness of 0.0670 √ . The slider must also have a maximum density of 2637 
kg/m3 to prevent the device from being over the weight specification. Not only are there various material 
property specifications, which need to be considered, but the material cost also needs to be investigated. 
The automated ET device must be as low cost as possible; therefore, a maximum cost of 2 USD/lb was 
determined. 
 
The CES software was utilized to find an appropriate material, which adheres to all of the material 
specifications listed above. Various materials maintained the material requirements; therefore, a material 
index was determined. The function of the slider closely resembles that of a beam. One of the main 
objectives of the slider material is to minimize the weight, while constraining the prescribed strength; 
therefore, the material index expressed in Eq. 14 below was utilized for this application 
 
/
  (Eq. 14) 
 
where σy is the yield strength and ρ is the density. For the slider, the logarithmic material index used was 
770 inches. The material selection was limited by comparing the yield strength and density exhibited in 
Figure 69 (p. 84). 
 
After analyzing the various materials above the material index exhibited in Figure 69 (p. 84), the 
following five materials were identified as the most applicable: hard rubber, polyethylene (high density, 
low/medium molecular weight), polymethylmethacrylate (molding and extrusion), polypropylene 
(copolymer, UV stabilized), and poly vinyl chloride (rigid, molding and extrusion). Polypropylene and 
poly vinyl chloride are the two best materials primarily due to its durability in various fluids, its low cost, 
and its availability in Ghana. 
 
Hard rubber 
Hard rubber would be a sufficient material to manufacture the slider. Hard rubber has a density ranging 
from 0.039 lb/in3 (1080 kg/m3) to 0.0462 lb/in3 (1279 kg/m3), which is significantly below the maximum 
material density of 0.096 lb/in3 (2637 kg/m3). The yield strength of hard rubber is well above 0.154 ksi 
(1.06 MPa) for the yield strength of hard rubber ranges from 8.7 ksi (60.0 MPa) to 11.6 ksi (80.0 MPa), 
almost sixty-times greater than the required yield strength. The fracture toughness of hard rubber is 0.182 







Figure 69. Slider material selection comparison using CES. 
 
Hard rubber is resistive to most chemicals. It resists carboxylic acids and oils. It is also very resistive to 
fresh water, salt water, and alkalis; therefore, any leakage of blood should not affect the slider. The slider 
can also be easily cleaned with a bleach solution if created from hard rubber. It is also fairly resistive to 
acids, oils, and fuels. UV radiation should have a negligible impact on the material properties as well. 
 
Hard rubber only absorbs 0.01 to 0.1 percent of water over a 24 hour period; therefore, the hard rubber 
should not become contaminated from any blood that may be spilt. Hard rubber has good adhesion to 
metal, which is necessary for the slider to be attached to the track. It is an opaque material. Hard rubber is 
fairly expensive compared to other materials. It costs between 1.30 and 1.43 USD/lb. 
 
Polyethylene (High Density, Low/Medium Molecular Weight) 
The slider could be produced out of polyethylene (PE). PE has a density ranging from 0.0342 lb/in3 (947 
kg/m3) to 0.0345 lb/in3 (955 kg/m3), which is significantly below the maximum material density of 0.096 
lb/in3 (2637 kg/m3). The yield strength of PE is almost twenty-times greater than the required yield 
strength of 0.154 ksi (1.06 MPa) for the yield strength of PE ranges from 2.8 ksi (19.3 MPa) to 3.9 ksi 
(26.9 MPa). The fracture toughness of PE ranges between 1.04 √  (1.14  √ ) and 1.9  √  




If the slider is to be molded, the mold temperature is between 86 and 122 °F, while the molding pressure 
range is between 12 ksi (83 MPa) and 14.9 ksi (103 MPa). There is also a minimal amount of mold 
shrinkage for it only shrinks 1.5 to 4 percent of its original size. 
 
PE is resistive to most chemicals. It is very resistive to fresh water, salt water, weak acids, and alkalis; 
therefore, blood and cleaning solutions (i.e. bleach) should not affect the material properties of the slider 
if made out of PE. It is fairly resistive to organic solvents. UV radiation should not have a significant 
impact on the material properties either. 
 
PE absorbs between 0.005 and 0.01 percent of water over a 24 hour period; therefore, it should absorb a 
minimal amount of liquid if spilt on the slider. It is a translucent material; therefore, one can see through 
the material. PE is not too costly; it costs between 0.98 and 1.08 USD/lb. 
 
Polymethylmethacrylate (Molding and Extrusion) 
Polymethylmethacrylate (PMMA) would be an adequate material to produce the slider from. PMMA has 
a density ranging from 0.0423 lb/in3 (1171 kg/m3) to 0.0434 lb/in3 (1201 kg/m3), which is significantly 
below the maximum material density of 0.096 lb/in3 (2637 kg/m3). The yield strength of PMMA is over 
fifty-times greater than the required yield strength of 0.154 ksi (1.06 MPa) for the yield strength of 
PMMA ranges from 7.8 ksi (53.8 MPa) to 10.5 ksi (72.7 MPa). The fracture toughness of PMMA ranges 
between 0.637 √  (0.670  √ ) and 1.46  √  (1.60  √ ), which is about ten times greater 
than the required value. 
 
If the slider is to be molded, the mold pressure range will between 4.99 ksi (34 MPa) and 20 ksi (138 
MPa). There will only be 0.1 to 0.8 percent mold shrinkage from the original size, which is minimal. 
 
PMMA resists most chemicals. It is very resistive to fresh water, salt water, and alkalis; therefore, bodily 
fluids will not affect the material properties of the slider. A base, such as bleach, will not affect the slider 
either. PMMA does not resist organic solvents very well. Acids will cause corrosion to occur. Sunlight 
will not impact the slider either. 
 
PMMA absorbs between 0.1 and 0.4 percent of water over a 24 hour period. PMMA is not overly 
expensive for it costs a maximum of 1.22 USD/lb. 
 
Polypropylene (Copolymer, UV Stabilized) 
The slider could be manufactured from polypropylene (PP). PP has a density ranging from 0.0325 lb/in3 
(900 kg/m3) to 0.0328 lb/in3 (908 kg/m3), which is significantly below the maximum material density of 
0.096 lb/in3 (2637 kg/m3). The yield strength of PP is over twenty-times greater than the required yield 
strength of 0.154 ksi (1.06 MPa) for the yield strength of PP ranges from 3.42 ksi (23.6 MPa) to 3.91 ksi 
(27.0 MPa). The fracture toughness of PP ranges between 1.37 √  (1.51  √ ) and 1.44  √  
(1.58  √ ), which is about twenty times greater than the required value. 
 
If the slider is to be molded, the mold temperature of PP is between 451 and 497 °F, while the molding 
pressure range is between 0.394 ksi (2.72 MPa) and 1.22 ksi (8.41 MPa). The mold will also only shrink 
1.41 to 1.51 percent of its original size. 
 
PP resists most chemicals. It is very resistive to fresh water, salt water, acids, alkalis, and organic 





PP absorbs between 0.0195 and 0.0205 percent of water over a 24 hour period. It is a translucent material. 
It is slow burning. PP has a unit cost of 0.968 to 1.07 USD/lb, which is not too expensive. It is typically 
used for medical components. 
 
Poly Vinyl Chloride (Rigid, Molding and Extrusion) 
Poly Vinyl Chloride (PVC) would be a sufficient material to manufacture the slider from. PVC has a 
density ranging from 0.047 lb/in3 (1301 kg/m3) to 0.0538 lb/in3 (1489 kg/m3), which is significantly 
below the maximum material density of 0.096 lb/in3 (2637 kg/m3). The yield strength of PVC is almost 
forty-times greater than the required yield strength of 0.154 ksi (1.06 MPa) for the yield strength of PVC 
ranges from 6.00 ksi (41.4 MPa) to 7.64 ksi (52.7 MPa). The fracture toughness of PVC ranges between 
3.3 √  (3.6  √ ) and 3.5  √  (3.8  √ ), which is about sixty times greater than the 
required value. 
 
If the slider is to be molded, the mold temperature of PVC is between 351 and 390 °F, while the molding 
pressure range is between 9.98 ksi (68.8 MPa) and 39.9 ksi (275 MPa). The mold will also only shrink 0.2 
to 0.6 percent of its original size. 
 
PVC resists most chemicals. It is very resistive to fresh water, salt water, acids, and alkalis; therefore, the 
slider should be durable when exposed to such fluids. PVC is fairly resistive to organic solvents. PVC is 
also very durable to sunlight (UV radiation). 
 
PVC absorbs between 0.04 and 0.40 percent of water over a 24 hour period. It is a transparent material. It 
is self-extinguishing. PVC has a unit cost of 0.689 to 0.758 USD/lb, which is one of the cheapest 
materials. PVC is also a readily available material in Ghana. 
 
Syringe Holder 
The function of the syringe holder is to provide a suitable housing unit for the syringes. The syringe 
holder will experience a minimal force exerted by the weight syringes; therefore, the weight of the 
syringes is considered negligible in determining the material properties of the syringe holder. The lip of 
the syringe will exert a force on the side of the syringe holder when the linear actuator is extending, or 
applying a force to the syringe. The force from the lip of the syringe should also not affect the material 
property greatly for the force from linear actuator will be minimal due to the low speed of the linear 
actuator. The stress exerted by the lip of the syringe onto the syringe holder will be approximately the 
same the stress exerted on the slider; therefore, it can be assumed that the maximum stress exerted on the 
syringe holder from the lip of the syringe is approximately 1.06 MPa. The syringe holder must also have a 
maximum density of 2637 kg/m3 to prevent the device from being over the weight specification. Not only 
are there various material property specifications, which need to be considered, but the material cost also 
needs to be investigated. The automated ET device must be as low cost as possible; therefore, a maximum 
cost of 2 USD/lb was determined. 
 
The CES software was utilized to find an appropriate material, which adheres to all of the material 
specifications listed above. Various materials maintained the material requirements; therefore, a material 
index was determined. The function of the slider closely resembles that of a beam. One of the main 
objectives of the slider material is to minimize the weight, while constraining the prescribed strength; 
therefore, the material index expressed in Eq. 14 above was utilized for this application. For the slider, the 
logarithmic material index used was 770 inches. The material selection was limited by comparing the 




Figure 70. Syringe holder material selection comparison using CES. 
 
Since the yield strength and the density remained the same, the material index also remained the same. 
The fracture toughness of the slider did have a large impact on the material selection; therefore the same 
five materials resulted from this analysis. Once again, polypropylene and poly vinyl chloride are the two 




Appendix D-2: Material Selection (Environmental Performance) 
The following two materials provide the best functional performance for the slider and the syringe holder:  
polypropylene (copolymer, UV stabilized) and poly vinyl chloride (rigid, molding and extrusion). 
Although PP and PVC are adequate materials for maintaining functionality of the system, the 
environmental performance of the two materials must be investigated before determining the best material 
for manufacturing. 
 
The total mass of air emissions, water emissions, use of raw materials, and (solid) waste must be 
investigated for each material, which is depicted in Figure 1Figure 71 below. To determine the total 
emissions of each material, the amount of material must be specified by the mass of the material. The 
volume of the slider and the syringe holder totals to 2.51 x 10-4 m3; therefore, the mass of PP would be 
approximately 0.373 kg (assuming a density of 1489 kg/m3) and the mass of PVC would be 
approximately 0.228 kg (assuming a density of 908 kg/m3). 
 
Based off the SimaPro 7 software, PP generates 4% more air emissions than PVC; however, PVC 
generates more water emissions, uses more raw materials, and waste than PP. PVC emits 98% more water 
emissions than PP; however, PVC only releases 45.5 g of water emissions. PVC utilizes 37% more raw 
materials than PP. PVC also produces 69% more waste than PP, but PVC only gives off 120.4 g of waste. 
 
Figure 71. Total emissions generated by PVC and Polypropylene. 
 
Each material can also have its environmental performance characterized based on the amount of 
carcinogen emissions, respiratory organics carbon consumption, respiratory inorganics carbon 
consumption, climate change, radiation, ozone layer destruction, ecotoxicity, acidification/eutrophication, 
and mineral depletion, which is depicted in Figure 72( p. 89). PVC emits more carcinogens, consumes 
more respiratory organic carbon, consumes more respiratory inorganic carbon, causes a greater amount of 

































Figure 72. Environmental performance characterization comparing polypropylene and poly vinyl 
chloride. 
 
PP and PVC also have an environmental impact on human health, ecosystem quality, and resources. 
Figure 73 below reveals the environmental damage on human health, ecosystem quality, and resources 
available. PVC has a greater environmental damage percentage than PP. A normalization graph of the 
environmental damage is represented in Figure 74 (p. 90). The normalization graph reveals that human 
health is impacted the most by the used of PP and/or PVC. The damage caused to human health is only 7 











Figure 74. Normalized environmental damage assessment of polypropylene and poly vinyl chloride. 
 
The environmental damage caused by PP and PVC can be compared through the use of single score 
comparison, which is depicted in Figure 75 below. Figure 75 reveals that PVC causes much more 
environmental damage than PP. Although PVC has a high EcoIndicator 99 point value of 33, the PVC 









The PP seems to be the most environmentally friendly material; however, PP is not readily available in 
Ghana. Due to such circumstances, PVC would be the recommended material. PVC is also less expensive 
than PP. 
 
Poly vinyl chloride (rigid, molding and extrusion) is also a transparent material; therefore, the material 
can also be used for the casing of the automated ET device. This will allow for medical personnel to view 
the operation of the device to insure that it is not malfunctioning. The casing will add a volume of 
0.00254 m3; therefore, causing the amount of PVC to increase to 4.16 kg. When the casing is produced 
from PVC as well, the EcoIndicator 99 point value increases to 480, which is depicted in Figure 76 
below. As mentioned previously, the PVC components of the automated ET device should have a long 








Appendix D-3: Manufacturing Process Selection 
There may eventually be 1,000 automated ET devices around the world; however, all 1,000 automated ET 
devices will not be produced at the same time. The production volume for the automated ET device will 
consist of approximately 5 to 10. The automated ET device also consists of medical equipment, electrical 
components, and PVC components. A majority of the components, including the medical equipment and 
the electrical components, will be outsourced; therefore, only a small portion of the device will need to be 
produced. 
 
Due to the minimal production volume, the manufacturing process should consist of the standard shop 
equipment (i.e. mill, band saw, hand drill, etc.). The standard shop equipment should also be readily 
available in Ghana; therefore, manufacturing can be done in-country. The manufacturing process should 
not extend far beyond the standard shop equipment for the tooling cost involved in processes, such as 
injection molding, are too expensive. The components are also not too intricate to require such complex 
processes. To make the manufacturing process slightly easier, a CNC mill could be programmed to 
manufacture the slider and the syringe holder, if accessible. The electrical components will need to be 
soldered onto the circuit board by hand; therefore, requiring access to a soldering iron. Other than those 
manufacturing the processes, the microprocessor will need to be programmed and the device will need to 
be assembled. 
Appendix E: Electrical Components 
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PRICING REPORT for BloodTransfusion.SCHDOC
Part Desc (Q) Supplier Price/100 Price/1000
PIC32MX440F512H PIC32 Processor USB Microchip 6.22 5.73
SiT8002AI-23-33E 4MHz Oscillator Mouser 1.30 0.98
MSS1P4-E3/89A Schottky Mouser 0.081 0.054
S1A NRD4001   Newark 0.074 0.045
SI9183DT-33-T1-E3 3.3V LinearReg Newark 0.238 0.203
L7805ACD2T-TR 5V LinearReg Newark 0.322 0.276
2908-05WB-MG Normal microSD Mouser 0.93 0.82
67503-1020 Normal mini-B Mouser 0.690 0.517
CMD15-22SRUGC Red/Green LED Digikey 0.455 0.364
CRCW08056R98F 7ohm 0805 Newark 0.003 0.003
CRCW0805100RJ 100ohm 0805 (2) Newark 0.052 0.034
CRCW0805240RJ 240ohm 0805 Newark 0.026 0.017
MCHP05W4F4701 4.7Kohm 0805 (14) Newark 0.266 0.266
U0805R104KCT 0.1uF 0805 (5) Newark 0.08 0.07
UMK212F105ZG 1.0uF 0805 Newark 0.025 0.019
EMK212F225ZG 2.2uF 0805 (2) Newark 0.021 0.021
JMK212F106ZG 10uF 0805 6.3V Newark 0.026 0.026
JMK212BJ226MG 22uF 0805 Newark 0.159 0.124
MMBT3904LT1G NPN Transistor Newark 0.019 0.015
CEM-1203(42) Buzzer Digikey 0.52 0.377
TB6612FNG Motor driver Digikey 0.885 0.767
HDM16216L-5-E30S LCD Mouser 7.11 6.66
PJ-202A Barrel Power Plug Digikey 0.254 0.191
RE130F-41-175F-12P Rot enc (3) Mouser 1.55 1.32
412-112104 12V Wall supply Mouser 8.50 7.19





























































































































































































































































































































































































































































































































































































Appendix E-2: Microprocessor Specifications 
   
Appendix E-3: Oscillator Specifications 
  


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix E-7: LCD Specifications 
   
 














   
   
   
   
   











   
   
   
   
   
   
   
   











   
   
   
   
   
   
   



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   











   
   
   
   
   
   
   
   











   
   
   
   
   
   
   
























































































































































































































































































































































































































































































































































Forward Surge Current (Amps pk)
(Half Sine-wave)
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Appendix F: Engineering Drawings 
  















Appendix G: Instruction Manual 
Directions: 
 
1. Connect port A of the Y-connector to the umbilical 
catheter. (Refer to Figure 1.) 
Figure 1. 
B 
2. Connect port B and C of a Y-connector (refer to 
Figure 1) to 5 cm of 4 mm Inner Diameter Tubing. 
(Refer to Figure 3.) 
3. Connect the front side of the one-way valve (refer 
to Figure 2 for the orientation of the one-way valve) 
to port D (refer to Figure 3 for the location of port 
D). (Refer to Figure 4.) 
4. Connect the back side (refer to Figure 2 for the 
orientation of the one-way valve) of the one-way 
valve to port E (refer to Figure 3 for the location of 
port E). (Refer to Figure 4.) 
5. Connect 15 cm of 4 mm Inner Diameter Tubing to 
port F and G (refer to Figure 4 for the location of 
port F and G). (Refer to Figure 5.) 
6. Connect the front side of the one-way valve (refer 
to Figure 2 for the orientation of the one-way valve) 
to port H (refer to Figure 5 for the location of port 
H). (Refer to Figure 6.) 
7. Connect the back side (refer to Figure 2 for the 
orientation of the one-way valve) of the one-way 
valve to port I (refer to Figure 5 for the location of 
port I). (Refer to Figure 6.) 
8. Connect 5 cm of 4 mm Inner Diameter Tubing to 
port J and K (refer to Figure 6 for the location of 
port J and K). (Refer to Figure 7.) 
9. Connect port A of a Y-connector to port L and M 
(refer to Figure 7 for the location of port L and M). 
(Refer to Figure 8.) 
10. Connect no less than 30 cm of 4 mm Inner 
Diameter Tubing to port N and Q (refer to Figure 8 
for the location of port N and Q). (Refer to Figure 
9.) 
11. Connect 15 cm of 4 mm Inner Diameter Tubing to 
port O and P (refer to Figure 9 for the location of 
port N and Q). (Refer to Figure 10.) 
12. Connect the front side of the one-way valve (refer 
to Figure 2 for the orientation of the one-way valve) 
to port R (refer to Figure 10 for the location of port 
R). (Refer to Figure 11.) 
13. Connect the back side of the one-way valve (refer 
to Figure 2 for the orientation of the one-way valve) 
to port S (refer to Figure 11 for the location of port 
S). (Refer to Figure 12.) 
Front Side Back Side 

























14. Connect port V (refer to Figure 12 for the location 
of port V) to a fresh blood bag of the required 
blood type. (Refer to Figure 13.) 
R Figure 9. 
15. Connect port W (refer to Figure 13 for the location 
of port W) to a empty IV bag. (Refer to Figure 
14.) 
O 
16. Connect the fresh blood bag onto an IV stand so 
that the fresh blood bag is at a lower level than the 
neonate. 
17. Connect the empty IV bag onto an IV stand so that 
the empty IV bag is at a higher level than the 
neonate. 
18. Obtain two syringes of the same volume and brand 
(between 20 and 25 mL). 
19. Place the syringes in the syringe holder with the 
lip of the syringe hitting the side of the syringe 
holder. (Refer to Figure 15.) 
20. Plug the power cord into the DC power jack. 
(Refer to Figure 16.) 
21. Plug the power cord into a wall outlet. 
22. Rotate encoder 1 (refer to Figure 17), located on 
the front side of the device, so that the slider (refer 
to Figure 18) is translated to the position just 
before it hits the syringe holder. 
a. Rotate the encoder clockwise to translate the 
slider to the left. 
b. Rotate the encoder counterclockwise to 
translate the slider to the right. 
23. Place the syringe plunger snuggly into the slider. 
(Refer to Figure 19.) 
24. With the syringe plunger still snuggly fit into the 
slider, extend plunger so that the lip of the plunger 
is flush with the side of the syringe holder. 
25. Create a snug fit between the plate on the side of 
the syringe holder and the syringe lip by tightening 
the wing nuts. (Refer Figure 20.)   
26. Place the brace of the syringe holder of the 
syringes. 
27. Lock the syringes in place by tightening the nut 
above the brace. (Create a snug fit between the 
brace and the syringe holder.) (Refer to Figure 21.) 
28. Rotate encoder 1(refer to Figure 17) to the right 
until the plunger of the syringe is fully extended. 
(Do not extend the plunger further than the syringe 
can handle.) 
29. Press encoder 1 (refer to Figure 17) to set the 




























30. Rotate encoder 1 (refer to Figure 17) to the left 
until the plunger is fully retracted into the syringe. 
(Do not retract the plunger more than the syringe 
can handle.) 
31. Press encoder 2 (refer to Figure 17) to set the 
position of the syringe when the plunger is fully 
retracted. 
32. Rotate encoder 2 to adjust the volume flow rate 
(mL/min) in which the blood will be transfused 
into and out of the neonate. 
33. Hold down encoder 2 for 3 seconds. Rotate 
encoder 2 to adjust the inner diameter of the 
syringe (measured in millimeters). Press encoder 2 
to set the inner diameter of the syringe. 
34. Rotate encoder 3 to adjust the total volume to be 
transfused into the neonate (measure in milliliters). 
35. Prime the blood administration set and the 
umbilical catheter using standard hospital 
procedures. 
a. Squeeze and release the drip chamber until 
the solution/blood level has reached the Y 
connector connected to the umbilical 
catheter. 
b. Obtain two spare syringes of any size. 
c. Depress the plunger of each syringe to expel 
the air. 
d. Connect the spare syringes to ports T and U 
(refer to Figure 14 for the location of ports T 
and U). 
e. Pull out the syringe plunger until all of the 
air plus 8-10 mL of solution/blood are in the 
syringe. 
f. Remove the syringes connected to ports T 
and U (refer to Figure 14) and attach the 
ports T and U to the syringes currently in the 
syringe holder. 
36. Follow hospital procedures to insert and secure 
the umbilical catheter in the vein. 
37. Press encoder 3 to start the transfusion process. 
(It is recommended that medical personnel 
check on the neonate periodically to insure that 
the device is functioning correctly, as well as to 
monitor the vitals of the neonate.) 
38. If the LCD screen does not reveal the correct 
input data after the start button is pressed, the 
press encoder 3 (refer to Figure 17) again to stop 



















Figure 20. 39. ERROR ALERT: If the system puts out an 
error message, then reset all of the input 
variables. 
40. If the transfusion process needs to be paused 
mid-cycle, press encoder 1 (refer to Figure 17) 
to pause the cycle. To resume the cycle, press 
encoder 1 (refer to Figure 17) again and the 





41. When the transfusion has been completed, a 
beeping noise will sound to alert the medical 
personnel. 
42. When the transfusion process is completed, 
dispose of the tubing, syringes, Y connectors, 
and one-way valves. Also, unplug the power 
cord when the transfusion process is completed.
 
Appendix H: Safety Reports  
Automated Exchange Transfusion Device 
Project 17 
Dan Ciko, Brad Herron, Ashley May, Devon Stanforth 
 
Safety Report 0.1 – Force Transducer Syringe Testing 
 
 
1. EXECUTIVE SUMMARY 
The planned experimentation for Thursday, March 12, 2009 is to test the force required to 
inject water out of several different size syringes. This experimentation is necessary to 
determine the capabilities the motor will need to have that we will be purchasing later. 
The experimentation will take place in Professor Gillespie’s lab. Using a force 
transducer, we will measure how much force is required to push each different syringes’ 
plunger in where the water flows out at a constant rate. The major risk involved with this 
experimentation will be containing the water while injecting it out of the syringe so it 
does not go everywhere and become a safety hazard. To avoid any harm to our eyes, we 
will use safety goggles while performing this experimentation.  
 
2. EXPERIMENTATION PLANS 
The experimentation will consist of pushing the force transducer against several different 
size syringes’ plunger, while each syringes’ plunger is fully extended out. The syringe 
will be held parallel to the ground, and the force transducer will be pushed against the 
syringe plunger while perpendicular to the ground at a constant rate to determine how 
much force is required to push the water out of the syringe. This experimentation will be 
performed with syringe sizes of 10, 20, and 25 mL, with two tests being conducted for 
each size syringe. 
 
3. PURCHASED COMPONENT AND MATERIAL INVENTORY 
The material being used for this experimentation is the three different size syringes, the 
force transducer, and tap water. 
 
4. CAD DRAWINGS AND DESIGNSAFE SUMMARY FOR DESIGNED PARTS 
No CAD drawings for this experimentation. 
 
5. MANUFACTURING 
There is no manufacturing necessary for this experimentation. 
 
6. ASSEMBLY 
There is no real assembly for this experimentation. The only requirement will be to fill 
the syringes with tap water, and then eject that water by pressing the force transducer 




7. DESIGN TESTING AND VALIDATION 
The force transducer should give us a good idea of how much force is required to push 
the syringe plunger in to eject fluid from the syringe. This force will be the overlying 
force that the motor will need to overcome for the pumping mechanism to function 
properly. Once we have an idea of how much force is required, we will move on to 
purchasing a compatible motor. 
Automated Exchange Transfusion Device 
Project 17 
Dan Ciko, Brad Herron, Ashley May, Devon Stanforth 
 
Safety Report 0.2 – Syringe Holder 
 
 
1. EXECUTIVE SUMMARY 
The planned experimentation for March 19, 2009 is to manufacture a holder for two 
syringes to be placed on. The material we plan to use to make this holder is the standard 
PVC plastic provided in the machine shop. We plan to use the mill and the band saw to 
manufacture this holder. We will not be using a CNC program for manufacturing as we 
will perform this particular experimentation by hand. The risks involved include possibly 
cutting ourselves, getting pinched fingers, and having debris fly into our eyes if the 
proper safety precautions are not followed. We will take the safety rules in the machine 
shop very seriously and handle the machine equipment very carefully to avoid any 
dangerous or harmful situations, and we will obviously wear safety goggles to avoid 
damage to our eyes. 
 
2. EXPERIMENTATION PLANS PRIOR TO DESIGN COMPLETION 
Measurements were taken on several dimensions of a 20 and 25 mL syringe to determine 
the syringe holder parameters prior to making the CAD model of the holder. Strength 
tests will be performed on this holder after manufacturing to determine if it is capable of 
withstanding the friction and other forces that will be put on it as the slider moves back 
and forth. 
 
3. PURCHASED COMPONENT AND MATERIAL INVENTORY 
Because materials from the machine shop are both cost effective and conveniently 
available, we will use PVC plastic from the machine shop as the material for 
manufacturing this holder. 
 
4. CAD DRAWINGS AND DESIGNSAFE SUMMARY FOR DESIGNED PARTS 
See attached CAD drawing.  
 
5. MANUFACTURING 
The manufacturing will be done in the machine shop (1302 GGB). We will first use the 
mill to cut away any unnecessary, excess material from the PVC plastic block we will be 
given, and then we will finish manufacturing the part with the band saw. Two parallel, 
triangular grooves will be cut into the top of the syringe holder to accommodate where 
the syringes will be placed. These grooves will be cut at a 45 degree angle for both sides 
of each groove, down to a depth of 1 inch from the top of the holder so that the syringes 
can rest easily in the grooves. Once the holder has been manufactured, we will briefly use 
sandpaper in the lab to smooth the edges out so there are no dangerous, sharp points.  
 
6. ASSEMBLY 
There will be no assembly of this syringe holder required. It will be manufactured in one 
piece. We will later assemble the holder to the slider outside of the machine shop to 
verify that the entire mechanism works properly. 
 
7. DESIGN TESTING AND VALIDATION 
We will test the holder and its strength along with its compatibility with the slider made 
in rapid prototyping in Professor Gillespie’s lab. Once we verify that this sliding 
mechanism functions properly, we will test it with syringes in place. We will have our 
linear actuator move the slider back and forth eventually, but that will come later once 
further testing has been completed on the linear actuator. 
Automated Exchange Transfusion Device 
Project 17 
Dan Ciko, Brad Herron, Ashley May, Devon Stanforth 
 
Safety Report 0.3 – Track Cutting 
 
 
1. EXECUTIVE SUMMARY 
The planned experimentation for Thursday, April 2, 2009 is to cut our ball bearing, 
stainless-steel track to a size that fits with the dimension limitations of our overall device. 
Cutting the track will take place in the GG Brown machine shop, and a band saw will be 
used to make the cuts. Only two, straight cuts will be necessary. The major risk involved 
with this procedure includes cutting ourselves with the band saw if the track is not 
properly held in place while cutting. To avoid any harm or injury, we will ensure that the 
track is safe and secure before running it through the band saw. We will also obviously 
wear safety goggles to avoid getting any debris from the track in our eyes. 
 
2. EXPERIMENTATION PLANS 
No experimentation will be performed on this track. 
 
3. PURCHASED COMPONENT AND MATERIAL INVENTORY 
The track is a ball bearing track made of stainless steel. 
 
4. CAD DRAWINGS AND DESIGNSAFE SUMMARY FOR DESIGNED PARTS 
See attached CAD drawing. 
 
5. MANUFACTURING 
Two cuts will be made on the track. One straight cut will be made across the slider at a 
distance of 6” from the back of the track. The other straight cut will be made across the 




The track will be assembled later to the slider and the syringe holder, but that will take 
place at Iosix, Industries. No assembly will take place in the machine shop where the 
cutting will take place. 
 
7. DESIGN TESTING AND VALIDATION 
Once the track has been cut to size, we will validate that its dimensions are correct and it 
fits properly with our slider and syringe holder by assembling the three together. The 
track, after cutting, should still allow the smooth movement of our slider. This will allow 
the syringes to move back and forth, thus allowing the fluid to be ejected and injected 
properly. 
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Safety Report 0.4 – Syringe Holding Plate 
 
 
1. EXECUTIVE SUMMARY 
The planned manufacturing for April 6, 2009 is to manufacture a syringe holding plate 
that will be placed on top of the syringes while the syringes lie in the grooves of the 
syringe holder. This plate will be bolted down to prevent movement or rotation of the 
syringes while the device is running, and it will be manufactured with an adjustable 
height so that various size syringes will work with our device. All components of the 
holder will be manufactured using the band saw. There will be two flat PVC plates, two 
L-shaped PVC plates, two pieces of compressible foam that will be put in between each 
flat PVC plate and each L-shaped PVC plate, and finally a rectangular plate made of 
plexi-glass to attach the two PVC plate sides together. The risks involved include 
possibly cutting ourselves with the band saw and having debris fly into our eyes if the 
proper safety precautions are not followed. We will take the safety rules in the machine 
shop very seriously and handle the machine equipment very carefully to avoid any 
dangerous or harmful situations, and we will wear safety goggles to avoid damage to our 
eyes. We will also handle the super glue very carefully when pasting all of the plate 
components together to make sure that we do not attach anything that should not be 
attached. 
 
2. EXPERIMENTATION PLANS PRIOR TO DESIGN COMPLETION 
Measurements were taken on the outside diameters of a 20 and 25 mL syringe to 
determine the height at which the syringes would be resting above the syringe holder to 
ensure that we made a plate tall enough to cover at least that height.  
 
3. PURCHASED COMPONENT AND MATERIAL INVENTORY 
Because materials from the machine shop are both cost effective and conveniently 
available, we will be using PVC plastic and plexi-glass from the machine shop as the 
material for manufacturing this holder. The compressible foam to be placed in between 
the PVC plates to make the plate have an adjustable height was purchased from Home 
Depot. The top part of the top plate is being made of plexi-glass so the user can see 
through the glass to see where the syringe plunger position is at while the system is 
running. 
 
4. CAD DRAWINGS AND DESIGNSAFE SUMMARY FOR DESIGNED PARTS 





The manufacturing will be done in the machine shop (1302 GGB). We will first use the 
band saw to cut two 1 in. by 1 in. flat plates of PVC. We will then cut two more 
equivalent plates of the same PVC, but these two plates will have an added height of 
PVC on one side to resemble an L shape. The added height will be approximately ½ in. 
We will then cut two 1 in. by 1 in. pieces of compressible foam to be placed in between 
each flat PVC plate and each L-shape PVC plate. The thickness of the compressible foam 
should be approximately ¼ in. We will then cut a piece of plexi-glass to lie across the 
two sides using the band saw. The dimensions for this plexi-glass piece are 1 in. by 4 in. 
Once all pieces have been cut using the band saw and attached with super glue 
accordingly, ¼ in. diameter holes will be drilled using the drill press through each side of 
the plate so that it will be able to be bolted down to the syringe holder properly. 
 
6. ASSEMBLY 
The assembly for this manufacturing consists of using super glue to attach all the plate 
components together, and then drilling holes in the plate and the syringe holder 
accordingly to fasten the plate to the syringe holder. Each hole in the syringe holder will 
have to be tapped once it has been drilled to allow for a bolt to be screwed in to secure 
the plate to the holder. 
 
7. DESIGN TESTING AND VALIDATION 
We will validate that this plate secures the syringes into the syringe holder and prevents 
the syringes from moving or rotating while the system is running by making sure that the 
syringes stay in place once the system has been turned on. We will also validate that both 
20 mL syringes and 25 mL syringes can be locked into place using the plate to ensure 
that our device is compatible with multiple size syringes as required. 
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Safety Report 0.5 – Mounting Board 
 
 
1. EXECUTIVE SUMMARY 
The planned manufacturing for April 9, 2009 is to manufacture a mounting board for all 
of our device components to be attached to. The board will be made from the wood 
boards available in the machine shop. The board will be cut into a rectangular shape with 
dimensions of 23.5 in. by 6.5 in. The cuts will be made using the band saw. Once the 
board has been cut to size, holes will be drilled into it in several places so that all of the 
device components can be attached to it such as the stainless steel track, the syringe 
holder, the linear actuator bracket, and the plexi-glass casing. The risks involved include 
possibly cutting ourselves while using the band saw, and having debris fly into our eyes if 
the proper safety precautions are not followed. We will take the safety rules in the 
machine shop very seriously and handle the machine equipment very carefully to avoid 
any dangerous or harmful situations, and we will obviously wear safety goggles to avoid 
damage to our eyes. 
 
2. EXPERIMENTATION PLANS PRIOR TO DESIGN COMPLETION 
Measurements were taken on several dimensions of all device components to be attached 
to the board to determine where each hole would need to be drilled into the board. There 
was no real experimentation done prior to this manufacturing other than measuring 
dimensions. 
 
3. PURCHASED COMPONENT AND MATERIAL INVENTORY 
Because materials from the machine shop are both cost effective and conveniently 
available, we will use the wood boards from the machine shop to make our board out of, 
and we will use the bolts and screws available in the shop to attach the components onto 
the board. 
 
4. CAD DRAWINGS AND DESIGNSAFE SUMMARY FOR DESIGNED PARTS 
See attached CAD drawing.  
 
5. MANUFACTURING 
The manufacturing will be done in the machine shop (1302 GGB). We will first use the 
band saw to cut the wood board to the correct size of 23.5 in. by 6.5 in. We will then 
measure on the board where each hole needs to be drilled to attach the device 
components onto the board. As stated above, the syringe holder, the stainless steel track, 
the linear actuator bracket, and the casing will all be attached to the board, so holes need 
to be drilled on several different parts of the board for these components to be attachable. 
The holes will be drilled using the drill press, and tapped using a manual tap.   
 
6. ASSEMBLY 
Once the board has been manufactured and all necessary holes have been drilled into it, 
we will assemble all of the components onto the board by screwing the bolts in where the 
holes were drilled and attaching the components. 
 
7. DESIGN TESTING AND VALIDATION 
We will validate that all components have been properly secured to the board by testing 
the functionality of the system later and making sure that there are no components 
moving that shouldn’t be moving.  
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Safety Report 0.6 – Casing 
 
 
1. EXECUTIVE SUMMARY 
The planned experimentation for April 13, 2009 is to manufacture a plexi-glass casing to 
be attached to the mounting board that will surround and protect our device. The casing 
will be made into four separate pieces using the laser cutter in the machine shop, and then 
the four pieces will be attached using superglue. We will also have a casing roof that will 
also be laser cut. This roof will be attached to one of the sides of the casing using hinges 
purchased at Home Depot. A CAD file of the four sides of the casing and the casing roof 
was made in CATIA, and that file was input into the laser cutting program so the laser 
cutter could properly cut the four walls of the casing and the roof. Once the four walls 
have been attached using super glue, we will drill four holes into the roof and four holes 
into one of the side walls of the casing to attach the hinges so the roof can open as a lid. 
The risks involved include possibly drilling into our fingers if we are not careful and 
having debris fly into our eyes if the proper safety precautions are not followed. We will 
take the safety rules in the machine shop very seriously and handle the machine 
equipment very carefully to avoid any dangerous or harmful situations, and we will 
obviously wear safety goggles to avoid damage to our eyes. 
 
2. EXPERIMENTATION PLANS PRIOR TO DESIGN COMPLETION 
Measurements were taken from where the holes were drilled in the mounting board to let 
us know how and where the casing would attach to the board. We also took 
measurements on the CAD file before laser cutting the walls so we knew where the 
hinges would need to be attached. 
 
3. PURCHASED COMPONENT AND MATERIAL INVENTORY 
Because plexi-glass is the best material to use for the laser cutter in the machine shop, 
and because plexi-glass is transparent so people can still see the device running while 
enclosed in the casing, we chose to use that for our casing walls and roof. As stated 
above, the hinges used to attach the casing wall to the casing roof were purchased at 
Home Depot and are made of stainless steel. 
 
4. CAD DRAWINGS AND DESIGNSAFE SUMMARY FOR DESIGNED PARTS 
See attached CAD drawing.  
 
5. MANUFACTURING 
We will not be doing much manufacturing in the machine shop. The laser cutter will cut 
all four casing walls and the casing roof for us. The only manufacturing we will have to 
do is drilling holes into the casing wall and roof. These holes will be drilled using a 
power drill instead of a drill press because it is more convenient.  
 
6. ASSEMBLY 
As stated above, once the four walls have been successfully laser cut, we will attach all 
four of them together using super glue. We will then attach the hinges to the casing wall 
and roof to create a lid for the casing using shortened bolts that we will cut using a hack 
saw.  
 
7. DESIGN TESTING AND VALIDATION 
There will not be very much validation for the plexi-glass casing. As long as it stays 
upright and protects the device from outside debris, it will perform its function properly. 
We will validate that the lid opens properly and that the circuit board fits correctly into 
the corresponding side wall, but that will be the only validation required. 
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Safety Report 0.7 – System Assembly 
 
 
1. EXECUTIVE SUMMARY 
The planned experimentation for Friday, April 3, 2009 is to assemble our device and all 
of its components. The plan is to first solder the circuit board materials onto the circuit 
board. Using a soldering iron presents a burning risk as the iron will be used at extremely 
high heats. To avoid any injury, we will use careful precision while soldering the circuit 
board together. To avoid any potential damage to our eyes, we will wear safety goggles 
throughout the entire procedure. Following the circuit board assembly, we will assemble 
the device with all of its components. Once the device has been fully assembled, we will 
test its functionality. Testing the functionality presents several risks that need to be 
considered before this experimentation can be conducted. The risks involved include 
being in contact with needles and the possibility of objects flying into the air if the linear 
actuator is run at a speed greater than it should be. Again, to avoid any injury, we will be 
extremely cautious while handling the needles and we will be wearing safety goggles 
while testing in case any objects fly into the air because of a system malfunction. All 
experimentation will take place at Iosix Industries in Ypsilanti, MI. To help eliminate the 
possibility of misusing any equipment, we will perform all experimentation with the 
supervision of our mentor Robert Vogt IV, CEO of Iosix Industries. 
 
2. EXPERIMENTATION PLANS 
For this particular experiment, we will focus on the functionality of a few key 
components of our device. After soldering the circuit board together and developing the 
program to run our system, we will first test the functionality of our linear actuator. The 
linear actuator will be powered by an AC power supply, and should move back and forth 
in a linear motion. We need to experiment with this linear actuator to make sure that it is 
capable of performing at extremely low speeds, which will be required for exchange 
transfusions. While this linear actuator is in motion, we will verify that the slider and 
slider holder are securely holding the syringes in place and that the syringes are allowed 
their necessary motion so fluid is able to flow in and out of them. We will also 
experiment with the one way valves that will go inside our tubing to ensure that they only 
allow fluid to flow in one direction as expected. This experimentation will consist of 
connecting the one way valves to the tubing and manually injecting water with a syringe 
through both sides of the tubing. If the one way valves function correctly, water should 
only actually flow through the tubing to the other side for one of the two ways. The 
proper functionality of the one way valves will eliminate the danger of blood traveling 
into places it shouldn’t while the transfusion is taking place. 
 
 
3. PURCHASED COMPONENT AND MATERIAL INVENTORY 
There are several materials that will be assembled and used for our device. The electrical 
components consist of a circuit board, an AC power supply, and a linear actuator. The 
slider track is a ball-bearing track made from stainless steel, the actual slider is made 
from ABS plastic, and the syringe holder is made from PVC. The syringes are standard 
20 or 25 mL syringes. The tubing is 2.5” diameter tubing. Other materials such as the one 
way valves and the y-junctions are made from plastic. Standard hospital IV bags and 
needles will also be used. 
 
4. CAD DRAWINGS AND DESIGNSAFE SUMMARY FOR DESIGNED PARTS 
See attached CAD drawings.  
 
5. MANUFACTURING 
The only manufacturing for this experiment will be the manufacturing/assembly of the 
circuit board. As stated earlier, this assembly will take place at Iosix Industries in 
Ypsilanti, MI with the help of Robert Vogt, IV, CEO of Iosix Industries. The circuit 
board will be assembled with all of its components using a soldering iron. There should 




The assembly is the main focus of this experiment. We need to ensure that our device can 
be assembled the way it was designed. First, we will connect our power supply to our 
linear actuator. We will then attach our linear actuator to the slider using a bolt. Next, we 
will secure the syringes into place in the slider holder by locking the syringes down with 
our syringe cover plate that rests above the syringes and is bolted down to the slider 
holder. We will then properly place the one way valves in the tubing, and then attach the 
tubing to the syringes and the IV bags. Finally, we will attach the y-junction to the two 
tubes coming from the syringes and insert a needle into the one IV bag that will be used 
to represent the baby. 
 
7. DESIGN TESTING AND VALIDATION 
Because water and blood have very similar fluid properties, we will experiment with 
water instead of blood. To help us visualize the path that the fluid will be taking while 
our system is in use, we will use red-colored water to represent the fresh blood and blue-
colored water to represent the waste blood being removed from the baby. As stated 
earlier, we will use three IV bags. One will be used as the fresh blood bag, one will be 
used as the waste blood bag, and the last one will have a needle going into it to represent 
the baby. 
 
We will validate that our user input function works correctly by entering in different 
values into the LCD screen for volume flow rate, total volume to be transfused, and 
syringe inner diameter. We will manually measure these values for the first few 
experiments to ensure that the numbers displayed on the screen are correct. We will then 
validate the functionality of our linear actuator, our slider mechanism, and our one way 
valves by watching the system run through a few tests, making sure along the way that all 
fluid is flowing properly into its intended destinations. 
 
Appendix I: Prototype Photo 
 
 
 
 
